CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: hydroperoxy group
Accession: CHEBI:29792
browse the term
Synonyms: exact_synonym: dioxidanyl; hydroperoxy
related_synonym: -OOH; Formula=HO2; SMILES=O(O[H])*
G
Gpx1
glutathione peroxidase 1
increases response to substance
ISO
GPX1 protein results in increased susceptibility to 12-HPETE
CTD
PMID:11115402
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx4
glutathione peroxidase 4
increases chemical synthesis
ISO
GPX4 protein results in increased chemical synthesis of 12-HPETE
CTD
PMID:11115402
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
12-HPETE inhibits the reaction [Sodium Salicylate inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid]]; 12-HPETE inhibits the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein]
CTD
PMID:12538810
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Cat
catalase
increases expression
ISO
13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of CAT protein
CTD
PMID:10946007
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
increases expression
ISO
13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of CAV1 mRNA
CTD
PMID:27257344
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
[13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of CCL2 mRNA; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of CCL2 protein; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of CCL2 mRNA; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of CCL2 protein
CTD
PMID:22135674
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Egr1
early growth response 1
multiple interactions
EXP
[13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of EGR1 mRNA; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of EGR1 protein; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of EGR1 mRNA; [13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of EGR1 protein
CTD
PMID:22135674
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Ppara
peroxisome proliferator activated receptor alpha
increases expression
EXP
13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of PPARA protein
CTD
PMID:22135674
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
EXP
13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of PPARG protein
CTD
PMID:22135674
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
increases expression
ISO
perfosfamide results in increased expression of ABL1 mRNA
CTD
PMID:19429390
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
G
Actb
actin, beta
decreases expression
ISO
perfosfamide results in decreased expression of ACTB mRNA
CTD
PMID:19429390
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Agt
angiotensinogen
decreases response to substance
ISO
AGT protein results in decreased susceptibility to perfosfamide
CTD
PMID:11034089
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions increases response to substance
ISO
Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of AIFM1 protein]; perfosfamide results in increased expression of and results in increased localization of AIFM1 protein AIFM1 results in increased susceptibility to perfosfamide
CTD
PMID:18034189
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Akr1b10
aldo-keto reductase family 1 member B10
affects response to substance
ISO
AKR1B10 protein affects the susceptibility to perfosfamide
CTD
PMID:18473730
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases response to substance
ISO
ALDH1A1 protein results in decreased susceptibility to perfosfamide
CTD
PMID:8662658 PMID:16614850
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases response to substance
ISO
ALDH1A2 protein results in decreased susceptibility to perfosfamide
CTD
PMID:22079344
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
affects response to substance
ISO
ALDH1B1 protein affects the susceptibility to perfosfamide
CTD
PMID:18473730
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
G
Aldh2
aldehyde dehydrogenase 2 family member
decreases response to substance
ISO
ALDH2 protein results in decreased susceptibility to perfosfamide
CTD
PMID:22079344
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
decreases response to substance
ISO
ALDH3A1 protein results in decreased susceptibility to perfosfamide
CTD
PMID:16614850
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
decreases expression
EXP
perfosfamide results in decreased expression of APEX1 mRNA
CTD
PMID:11754170
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions affects folding increases expression
ISO
Acetylcysteine inhibits the reaction [perfosfamide affects the folding of BAX protein]; Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of BAX]; perfosfamide results in increased expression of and results in increased localization of BAX perfosfamide results in increased expression of BAX protein
CTD
PMID:16488414 PMID:18034189
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
increases expression
ISO
perfosfamide results in increased expression of BBC3 mRNA
CTD
PMID:17068108
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bmpr1b
bone morphogenetic protein receptor type 1B
decreases expression
ISO
perfosfamide results in decreased expression of BMPR1B mRNA
CTD
PMID:19429390
NCBI chr 2:230,538,252...230,871,077
Ensembl chr 2:230,541,558...230,871,368
G
C1d
C1D nuclear receptor corepressor
increases expression
ISO
perfosfamide results in increased expression of C1D mRNA
CTD
PMID:19429390
NCBI chr14:91,660,951...91,673,177
Ensembl chr14:91,660,989...91,672,852
G
Casp3
caspase 3
increases activity multiple interactions
ISO
perfosfamide results in increased activity of CASP3 perfosfamide promotes the reaction [TNF results in increased activity of CASP3 protein]
CTD
PMID:16488414 PMID:17434952
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases activity
ISO
perfosfamide results in increased activity of CASP9 protein
CTD
PMID:16488414
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
perfosfamide results in increased expression of CDKN1A perfosfamide results in increased expression of CDKN1A mRNA; perfosfamide results in increased expression of CDKN1A protein
CTD
PMID:17068108 PMID:18034189
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cxcl9
C-X-C motif chemokine ligand 9
decreases expression
ISO
perfosfamide results in decreased expression of CXCL9 mRNA
CTD
PMID:19429390
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
E2f1
E2F transcription factor 1
increases expression
ISO
perfosfamide results in increased expression of E2F1 mRNA
CTD
PMID:19429390
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Egr1
early growth response 1
decreases expression
ISO
perfosfamide results in decreased expression of EGR1 mRNA
CTD
PMID:19429390
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Endog
endonuclease G
increases response to substance multiple interactions
ISO
ENDOG results in increased susceptibility to perfosfamide Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of ENDOG protein]; perfosfamide results in increased expression of and results in increased localization of ENDOG protein
CTD
PMID:18034189
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
G
Epas1
endothelial PAS domain protein 1
increases expression
ISO
perfosfamide results in increased expression of EPAS1 protein
CTD
PMID:23251655
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Epha6
Eph receptor A6
decreases expression
ISO
perfosfamide results in decreased expression of EPHA6 mRNA
CTD
PMID:19429390
NCBI chr11:39,757,501...40,708,901
Ensembl chr11:39,757,181...40,698,311
G
Eya1
EYA transcriptional coactivator and phosphatase 1
decreases expression
ISO
perfosfamide results in decreased expression of EYA1 mRNA
CTD
PMID:19429390
NCBI chr 5:4,863,501...5,101,483
Ensembl chr 5:4,955,543...5,101,483
G
Faslg
Fas ligand
increases expression
ISO
perfosfamide results in increased expression of FASLG mRNA; perfosfamide results in increased expression of FASLG protein
CTD
PMID:14760101
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Foxf1
forkhead box F1
affects expression
ISO
perfosfamide affects the expression of FOXF1 mRNA
CTD
PMID:19429390
NCBI chr19:49,153,949...49,157,741
Ensembl chr19:49,153,699...49,157,738
G
Gjc1
gap junction protein, gamma 1
increases expression
ISO
perfosfamide results in increased expression of GJC1 mRNA
CTD
PMID:19429390
NCBI chr10:87,758,192...87,785,443
Ensembl chr10:87,760,528...87,785,867
G
Gli2
GLI family zinc finger 2
decreases expression
ISO
perfosfamide results in decreased expression of GLI2 mRNA
CTD
PMID:19429390
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
G
Hes1
hes family bHLH transcription factor 1
increases expression
ISO
perfosfamide results in increased expression of HES1 mRNA
CTD
PMID:19429390
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
perfosfamide results in increased expression of HIF1A mRNA; perfosfamide results in increased expression of HIF1A protein
CTD
PMID:19429390 PMID:23251655
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hoxa11
homeobox A11
decreases expression
ISO
perfosfamide results in decreased expression of HOXA11 mRNA
CTD
PMID:19429390
NCBI chr 4:81,342,527...81,346,189
Ensembl chr 4:81,342,528...81,346,232
G
Hoxa13
homeo box A13
increases expression
ISO
perfosfamide results in increased expression of HOXA13 mRNA
CTD
PMID:19429390
NCBI chr 4:81,358,956...81,361,091
Ensembl chr 4:81,358,956...81,361,091
G
Hoxd10
homeo box D10
increases expression
ISO
perfosfamide results in increased expression of HOXD10 mRNA
CTD
PMID:19429390
NCBI chr 3:59,594,516...59,597,725
Ensembl chr 3:59,594,516...59,597,725
G
Hras
HRas proto-oncogene, GTPase
decreases expression
ISO
perfosfamide results in decreased expression of HRAS mRNA
CTD
PMID:19429390
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Kl
Klotho
decreases expression
ISO
perfosfamide results in decreased expression of KL mRNA
CTD
PMID:19429390
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Lig3
DNA ligase 3
decreases expression
EXP
perfosfamide results in decreased expression of LIG3 mRNA
CTD
PMID:11754170
NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
perfosfamide results in increased expression of MDM2
CTD
PMID:18034189
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mgmt
O-6-methylguanine-DNA methyltransferase
decreases expression
EXP
perfosfamide results in decreased expression of MGMT mRNA
CTD
PMID:11754170
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mlh1
mutL homolog 1
decreases expression
EXP
perfosfamide results in decreased expression of MLH1 mRNA
CTD
PMID:11754170
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
G
Mpg
N-methylpurine-DNA glycosylase
decreases expression
EXP
perfosfamide results in decreased expression of MPG mRNA
CTD
PMID:11754170
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
G
Mre11
MRE11 homolog, double strand break repair nuclease
decreases expression
EXP
perfosfamide results in decreased expression of MRE11A mRNA
CTD
PMID:11754170
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
G
Myo1b
myosin Ib
increases expression
ISO
perfosfamide results in increased expression of MYO1B mRNA
CTD
PMID:19429390
NCBI chr 9:49,690,043...49,852,373
Ensembl chr 9:49,690,086...49,850,798
G
Myog
myogenin
increases expression
ISO
perfosfamide results in increased expression of MYOG mRNA
CTD
PMID:19429390
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Ndn
necdin, MAGE family member
increases expression
ISO
perfosfamide results in increased expression of NDN mRNA
CTD
PMID:19429390
NCBI chr 1:115,849,168...115,850,767
Ensembl chr 1:115,849,105...115,850,767
G
Odc1
ornithine decarboxylase 1
decreases expression
ISO
perfosfamide results in decreased expression of ODC1 mRNA
CTD
PMID:19429390
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Pea15
proliferation and apoptosis adaptor protein 15
decreases expression
ISO
perfosfamide results in decreased expression of PEA15 mRNA
CTD
PMID:19429390
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
perfosfamide results in increased expression of PMAIP1 mRNA
CTD
PMID:17068108
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pms1
PMS1 homolog 1, mismatch repair system component
decreases expression
EXP
perfosfamide results in decreased expression of PMS1 mRNA
CTD
PMID:11754170
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
G
Pms2
PMS1 homolog 2, mismatch repair system component
decreases expression
EXP
perfosfamide results in decreased expression of PMS2 mRNA
CTD
PMID:11754170
NCBI chr12:10,676,818...10,701,161
Ensembl chr12:10,676,764...10,701,066
G
Polb
DNA polymerase beta
decreases expression
EXP
perfosfamide results in decreased expression of POLB mRNA
CTD
PMID:11754170
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
perfosfamide results in decreased expression of POLD1 mRNA
CTD
PMID:19429390
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
G
Rad21
RAD21 cohesin complex component
decreases expression
ISO
perfosfamide results in decreased expression of RAD21 mRNA
CTD
PMID:19429390
NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817
G
Rad50
RAD50 double strand break repair protein
decreases expression
EXP
perfosfamide results in decreased expression of RAD50 mRNA
CTD
PMID:11754170
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Rad51
RAD51 recombinase
decreases expression
EXP
perfosfamide results in decreased expression of RAD51 mRNA
CTD
PMID:11754170
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Sdf4
stromal cell derived factor 4
decreases expression
ISO
perfosfamide results in decreased expression of SDF4 mRNA
CTD
PMID:19429390
NCBI chr 5:166,586,581...166,606,661
Ensembl chr 5:166,586,390...166,604,521
G
Sfrp2
secreted frizzled-related protein 2
decreases expression
ISO
perfosfamide results in decreased expression of SFRP2 mRNA
CTD
PMID:19429390
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
G
Slc30a4
solute carrier family 30 member 4
decreases expression
ISO
perfosfamide results in decreased expression of SLC30A4 mRNA
CTD
PMID:19429390
NCBI chr 3:109,753,270...109,775,306
Ensembl chr 3:109,753,273...109,775,306
G
Smad1
SMAD family member 1
decreases expression
ISO
perfosfamide results in decreased expression of SMAD1 mRNA
CTD
PMID:19429390
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Tap1
transporter 1, ATP binding cassette subfamily B member
affects response to substance
ISO
TAP1 protein affects the susceptibility to perfosfamide
CTD
PMID:18473730
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tcf12
transcription factor 12
increases expression
ISO
perfosfamide results in increased expression of TCF12 mRNA
CTD
PMID:19429390
NCBI chr 8:72,490,447...72,799,265
Ensembl chr 8:72,492,567...72,799,201
G
Terc
telomerase RNA component
decreases expression
ISO
perfosfamide results in decreased expression of TERC mRNA
CTD
PMID:24571982
NCBI chr 2:112,815,654...112,816,041
G
Tert
telomerase reverse transcriptase
decreases expression
ISO
perfosfamide results in decreased expression of TERT mRNA
CTD
PMID:24571982
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tnf
tumor necrosis factor
multiple interactions
ISO
perfosfamide promotes the reaction [TNF results in increased activity of CASP3 protein]
CTD
PMID:16488414
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [perfosfamide results in increased expression of TP53] perfosfamide results in increased expression of and results in increased phosphorylation of and results in increased activity of TRP53 protein
CTD
PMID:17068108 PMID:18034189
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trim27
tripartite motif-containing 27
decreases expression
ISO
perfosfamide results in decreased expression of TRIM27 mRNA
CTD
PMID:19429390
NCBI chr17:43,538,282...43,550,633
Ensembl chr17:43,538,285...43,550,643
G
Ttf1
transcription termination factor 1
decreases expression
ISO
perfosfamide results in decreased expression of TTF1 mRNA
CTD
PMID:19429390
NCBI chr 3:12,384,626...12,409,257
Ensembl chr 3:12,384,655...12,409,257
G
Ubb
ubiquitin B
decreases expression
ISO
perfosfamide results in decreased expression of UBB mRNA
CTD
PMID:19429390
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
perfosfamide results in increased expression of VEGFA mRNA
CTD
PMID:19429390
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
decreases expression
ISO
perfosfamide results in decreased expression of VIM mRNA
CTD
PMID:19429390
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Wnt11
Wnt family member 11
increases expression
ISO
perfosfamide results in increased expression of WNT11 mRNA
CTD
PMID:19429390
NCBI chr 1:153,134,503...153,154,294
Ensembl chr 1:153,138,197...153,154,294
G
Xrcc1
X-ray repair cross complementing 1
decreases expression
EXP
perfosfamide results in decreased expression of XRCC1 mRNA
CTD
PMID:11754170
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Xrcc5
X-ray repair cross complementing 5
decreases expression
EXP
perfosfamide results in decreased expression of XRCC5 mRNA
CTD
PMID:11754170
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
decreases expression
ISO
perfosfamide results in decreased expression of YWHAZ mRNA
CTD
PMID:19429390
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
G
Ephx3
epoxide hydrolase 3
multiple interactions
ISO
[EPHX3 gene mutant form results in decreased hydrolysis of Epoxy Compounds] results in decreased abundance of [9,10,13-trihydroxy-11-octadecenoic acid binds to Ceramides]; [EPHX3 gene mutant form results in decreased hydrolysis of Epoxy Compounds] which results in decreased chemical synthesis of 9,10,13-trihydroxy-11-octadecenoic acid
CTD
PMID:33334892
NCBI chr 7:11,206,812...11,212,122
Ensembl chr 7:11,206,812...11,212,122
G
Cat
catalase
decreases activity increases activity multiple interactions
ISO EXP
cumene hydroperoxide results in decreased activity of CAT protein cumene hydroperoxide results in increased activity of CAT protein Iron promotes the reaction [cumene hydroperoxide results in decreased activity of CAT protein]; Iron-Dextran Complex promotes the reaction [cumene hydroperoxide results in decreased activity of CAT protein]
CTD
PMID:12065085 PMID:12423650 PMID:16928893
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
affects oxidation
EXP
CYP2B1 protein affects the oxidation of cumene hydroperoxide
CTD
PMID:17478480
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
affects oxidation
EXP
CYP2B6 protein affects the oxidation of cumene hydroperoxide
CTD
PMID:17478480
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
affects oxidation
ISO
CYP2C19 protein affects the oxidation of cumene hydroperoxide
CTD
PMID:17478480
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
affects oxidation
ISO
CYP2C8 protein affects the oxidation of cumene hydroperoxide
CTD
PMID:17478480
G
Cyp2d1
cytochrome P450, family 2, subfamily d, polypeptide 1
affects oxidation
EXP
CYP2D1 protein affects the oxidation of cumene hydroperoxide
CTD
PMID:17478480
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
G
Cyp2s1
cytochrome P450, family 2, subfamily s, polypeptide 1
multiple interactions
ISO
[[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results in increased abundance of benzo(a)pyrene-7,8,9,10-tetrol; [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-1,6-quinone; [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-3,6-quinone; [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-6,12-quinone; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-dihydrobenzo(a)pyrene; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-Dimethyl-1,2-benzanthracene; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Aflatoxin B1; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Tretinoin
CTD
PMID:19713358
NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
G
Eef2
eukaryotic translation elongation factor 2
multiple interactions decreases expression
EXP
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein]; Vitamin E analog inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] cumene hydroperoxide results in decreased expression of EEF2; cumene hydroperoxide results in decreased expression of EEF2 protein
CTD
PMID:16469450 PMID:17510559 PMID:19447174
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Fgfr2
fibroblast growth factor receptor 2
multiple interactions
ISO
cumene hydroperoxide results in increased phosphorylation of and results in increased activity of FGFR2 protein
CTD
PMID:12717419
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
G6pd
glucose-6-phosphate dehydrogenase
increases activity
EXP
cumene hydroperoxide results in increased activity of G6PD protein
CTD
PMID:16928893
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
cumene hydroperoxide results in increased expression of GAPDH protein
CTD
PMID:11295360
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
cumene hydroperoxide results in increased expression of GCLC mRNA
CTD
PMID:30547568
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
cumene hydroperoxide results in increased expression of GCLM mRNA
CTD
PMID:30547568
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gpx1
glutathione peroxidase 1
decreases response to substance increases metabolic processing increases reduction
ISO
GPX1 protein results in decreased susceptibility to cumene hydroperoxide GPX1 protein results in increased metabolism of cumene hydroperoxide GPX1 protein results in increased reduction of cumene hydroperoxide
CTD
PMID:1740415 PMID:1939125 PMID:8428933 PMID:9126277
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases reduction
ISO
GPX2 protein results in increased reduction of cumene hydroperoxide
CTD
PMID:8428933
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gpx4
glutathione peroxidase 4
decreases response to substance
ISO
GPX4 results in decreased susceptibility to cumene hydroperoxide
CTD
PMID:18206984
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Gsr
glutathione-disulfide reductase
decreases activity
EXP
cumene hydroperoxide results in decreased activity of GSR protein
CTD
PMID:16928893
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta1
glutathione S-transferase alpha 1
increases metabolic processing
ISO
GSTA1 protein results in increased metabolism of cumene hydroperoxide
CTD
PMID:1985777
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta2
glutathione S-transferase alpha 2
decreases metabolic processing increases metabolic processing
ISO
GSTA2 protein polymorphism results in decreased metabolism of cumene hydroperoxide GSTA2 protein results in increased metabolism of cumene hydroperoxide
CTD
PMID:3138230 PMID:15077012 PMID:15128049
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3
glutathione S-transferase alpha 3
decreases response to substance affects metabolic processing
EXP
GSTA3 protein results in decreased susceptibility to cumene hydroperoxide GSTA3 protein affects the metabolism of cumene hydroperoxide
CTD
PMID:1740415 PMID:2768223
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gstm5
glutathione S-transferase, mu 5
decreases metabolic processing increases metabolic processing
ISO
GSTM3 protein polymorphism results in decreased metabolism of cumene hydroperoxide GSTM3 protein polymorphism results in increased metabolism of cumene hydroperoxide
CTD
PMID:15247628
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gstp1
glutathione S-transferase pi 1
increases metabolic processing
ISO
GSTP1 protein results in increased metabolism of cumene hydroperoxide
CTD
PMID:2747627
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
affects oxidation affects metabolic processing
ISO
GSTT1 protein affects the oxidation of cumene hydroperoxide GSTT1 protein affects the metabolism of cumene hydroperoxide
CTD
PMID:9854036 PMID:19664997
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gstt2
glutathione S-transferase theta 2
affects metabolic processing
EXP
GSTT2 protein affects the metabolism of cumene hydroperoxide
CTD
PMID:2114406
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
G
Gstz1
glutathione S-transferase zeta 1
affects metabolic processing
ISO
GSTZ1 protein affects the metabolism of cumene hydroperoxide
CTD
PMID:9396740
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
G
Gusb
glucuronidase, beta
multiple interactions decreases uptake increases secretion
ISO
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in decreased uptake of GUSB protein]; alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of GUSB protein]
CTD
PMID:19135433
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
Hmox1
heme oxygenase 1
increases expression
ISO
cumene hydroperoxide results in increased expression of HMOX1 mRNA
CTD
PMID:30547568
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspb1
heat shock protein family B (small) member 1
increases expression
ISO
cumene hydroperoxide results in increased expression of HSPB1 protein
CTD
PMID:11295360
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
increases activity
EXP
cumene hydroperoxide results in increased activity of IDH1 protein
CTD
PMID:16928893
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
G
Il1b
interleukin 1 beta
multiple interactions increases secretion
ISO
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of IL1B protein]
CTD
PMID:19135433
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide; Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide]
CTD
PMID:19608619
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Mb
myoglobin
affects metabolic processing
ISO
MB protein mutant form affects the metabolism of cumene hydroperoxide
CTD
PMID:8855949
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
G
Mgst1
microsomal glutathione S-transferase 1
decreases response to substance
EXP
MGST1 results in decreased susceptibility to cumene hydroperoxide
CTD
PMID:17306223
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mpo
myeloperoxidase
multiple interactions
ISO
[9,10-Dimethyl-1,2-benzanthracene co-treated with cumene hydroperoxide] results in increased activity of MPO protein
CTD
PMID:14972014
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases response to substance affects response to substance multiple interactions
ISO
NFE2L2 gene mutant form results in increased susceptibility to cumene hydroperoxide [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to cumene hydroperoxide Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to cumene hydroperoxide]]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to cumene hydroperoxide] [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide; Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide]
CTD
PMID:19303893 PMID:19608619 PMID:20932822
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased expression of NOS2 protein]
CTD
PMID:19135433
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
cumene hydroperoxide results in increased expression of NQO1 mRNA
CTD
PMID:30547568
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Odc1
ornithine decarboxylase 1
increases activity multiple interactions
ISO
cumene hydroperoxide results in increased activity of ODC1 protein Iron promotes the reaction [cumene hydroperoxide results in increased activity of ODC1 protein]; Iron-Dextran Complex promotes the reaction [cumene hydroperoxide results in increased activity of ODC1 protein]
CTD
PMID:12065085
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Ppia
peptidylprolyl isomerase A
decreases response to substance
EXP
PPIA protein results in decreased susceptibility to cumene hydroperoxide
CTD
PMID:17011206
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Prdx1
peroxiredoxin 1
increases expression
ISO
cumene hydroperoxide results in increased expression of PRDX1 protein
CTD
PMID:11295360
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prdx2
peroxiredoxin 2
increases expression
ISO
cumene hydroperoxide results in increased expression of PRDX2 protein
CTD
PMID:11295360
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Prdx6
peroxiredoxin 6
increases expression
ISO
cumene hydroperoxide results in increased expression of PRDX6 protein
CTD
PMID:11295360
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression multiple interactions
ISO
cumene hydroperoxide results in increased expression of PTGS2 protein [cumene hydroperoxide results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [cumene hydroperoxide results in increased expression of PTGS2 protein]
CTD
PMID:14972014
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Sord
sorbitol dehydrogenase
increases activity
EXP
cumene hydroperoxide results in increased activity of SORD protein
CTD
PMID:16928893
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
cumene hydroperoxide results in increased expression of TGFB1 mRNA
CTD
PMID:8148055
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions increases secretion
ISO
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of TNF protein]
CTD
PMID:19135433
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Agt
angiotensinogen
multiple interactions increases lipidation
ISO
Ascorbic Acid promotes the reaction [linoleic acid hydroperoxide results in increased lipidation of AGT protein modified form]
CTD
PMID:26111765
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Cygb
cytoglobin
increases metabolic processing
EXP
CYGB protein results in increased metabolism of linoleic acid hydroperoxide
CTD
PMID:11320098
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Gpx1
glutathione peroxidase 1
increases reduction
ISO
GPX1 protein results in increased reduction of linoleic acid hydroperoxide
CTD
PMID:8428933
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases reduction
ISO
GPX2 protein results in increased reduction of linoleic acid hydroperoxide
CTD
PMID:8428933
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCA1 mRNA
CTD
PMID:15336504
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases expression affects localization
EXP ISO
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein tert-Butylhydroperoxide results in decreased expression of ABCB11 mRNA
CTD
PMID:16452108 PMID:24306262 PMID:34767876
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCB1A mRNA
CTD
PMID:14729362
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression affects localization multiple interactions
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ABCC2 mRNA tert-Butylhydroperoxide affects the localization of ABCC2 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein
CTD
PMID:22956110 PMID:24306262 PMID:34303734
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcd1
ATP binding cassette subfamily D member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCD1 mRNA
CTD
PMID:15003993
NCBI chr X:151,428,334...151,450,115
Ensembl chr X:151,428,578...151,450,115
G
Abhd17a
abhydrolase domain containing 17A, depalmitoylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ABHD17A mRNA
CTD
PMID:15336504
NCBI chr 7:9,124,332...9,132,762
Ensembl chr 7:9,124,332...9,130,762
G
Ablim1
actin-binding LIM protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ABLIM1 mRNA
CTD
PMID:15336504
NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969
G
Abr
ABR activator of RhoGEF and GTPase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABR mRNA
CTD
PMID:15003993
NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505
G
Acads
acyl-CoA dehydrogenase short chain
increases expression multiple interactions decreases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of ACADS mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein
CTD
PMID:15003993 PMID:26989860
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
G
Ache
acetylcholinesterase
multiple interactions increases secretion increases expression
EXP
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of ACHE protein] tert-Butylhydroperoxide results in increased expression of ACHE mRNA alternative form
CTD
PMID:16903848
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ackr3
atypical chemokine receptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACKR3 mRNA
CTD
PMID:15336504
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Aco1
aconitase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACO1 mRNA
CTD
PMID:15336504
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Acot1
acyl-CoA thioesterase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACOT1 mRNA
CTD
PMID:14729362
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Acot7
acyl-CoA thioesterase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACOT7 mRNA
CTD
PMID:15003993
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
G
Acsl3
acyl-CoA synthetase long-chain family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACSL3 mRNA
CTD
PMID:15336504
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Actb
actin, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACTB mRNA
CTD
PMID:12419474
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actg2
actin gamma 2, smooth muscle
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTG2 mRNA
CTD
PMID:15336504
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
G
Actn1
actinin, alpha 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTN1 mRNA
CTD
PMID:15336504
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
G
Actr3
actin related protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTR3 mRNA
CTD
PMID:15336504
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
G
Actr3b
actin related protein 3B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACTR3B mRNA
CTD
PMID:15336504
NCBI chr 4:9,261,631...9,355,496
Ensembl chr 4:9,262,233...9,355,441
G
Acy3
aminoacylase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACY3 mRNA
CTD
PMID:15003993
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
G
Acyp1
acylphosphatase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACYP1 mRNA
CTD
PMID:15336504
NCBI chr 6:104,919,162...104,932,348
Ensembl chr 6:104,919,162...104,932,387
G
Adam19
ADAM metallopeptidase domain 19
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAM19 mRNA
CTD
PMID:15336504
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
G
Adam8
ADAM metallopeptidase domain 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAM8 mRNA
CTD
PMID:15003993
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adam9
ADAM metallopeptidase domain 9
multiple interactions affects expression increases expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADAM9 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA] tert-Butylhydroperoxide affects the expression of ADAM9 mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
G
Adar
adenosine deaminase, RNA-specific
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAR mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282
G
Adat1
adenosine deaminase, tRNA-specific 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADAT1 mRNA
CTD
PMID:15963989
NCBI chr19:39,918,083...39,956,886
Ensembl chr19:39,918,227...39,956,883
G
Adcy3
adenylate cyclase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADCY3 mRNA
CTD
PMID:12414654
NCBI chr 6:27,100,089...27,203,686
Ensembl chr 6:27,124,828...27,203,686
G
Adcy9
adenylate cyclase 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADCY9 mRNA
CTD
PMID:15336504
NCBI chr10:11,138,966...11,262,067
Ensembl chr10:11,139,446...11,262,066
G
Add2
adducin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADD2 mRNA
CTD
PMID:15336504
NCBI chr 4:118,444,594...118,538,505
Ensembl chr 4:118,497,416...118,538,505
G
Add3
adducin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADD3 mRNA
CTD
PMID:15336504
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adgrg6
adhesion G protein-coupled receptor G6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADGRG6 mRNA
CTD
PMID:15336504
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADH7 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
G
Adipor2
adiponectin receptor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADIPOR2 mRNA
CTD
PMID:15336504
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adm
adrenomedullin
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:20847119 PMID:29432895
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adora1
adenosine A1 receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADORA1 mRNA
CTD
PMID:12419474
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adora2b
adenosine A2B receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADORA2B mRNA
CTD
PMID:15336504
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
G
Agk
acylglycerol kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AGK mRNA
CTD
PMID:15336504
NCBI chr 4:69,114,850...69,193,989
Ensembl chr 4:69,114,269...69,193,934
G
Ago2
argonaute RISC catalytic component 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AGO2 mRNA
CTD
PMID:15336504
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
G
Agpat1
1-acylglycerol-3-phosphate O-acyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AGPAT1 mRNA
CTD
PMID:15003993
NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278
G
Ahsa1
activator of Hsp90 ATPase activity 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AHSA1 mRNA
CTD
PMID:15336504
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions increases expression
ISO
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of AIFM1 protein]
CTD
PMID:25522270
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Aip
aryl-hydrocarbon receptor-interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AIP mRNA
CTD
PMID:15336504
NCBI chr 1:201,408,002...201,419,220
Ensembl chr 1:201,407,288...201,419,122
G
Ajuba
ajuba LIM protein
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AJUBA mRNA]
CTD
PMID:20847119
NCBI chr15:28,019,775...28,031,537
Ensembl chr15:28,019,778...28,030,021
G
Ak2
adenylate kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AK2 mRNA
CTD
PMID:15336504
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
G
Ak4
adenylate kinase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AK4 mRNA
CTD
PMID:15003993
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akap12
A-kinase anchoring protein 12
affects expression
ISO
tert-Butylhydroperoxide affects the expression of AKAP12 mRNA
CTD
PMID:23410634
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
G
Akap9
A-kinase anchoring protein 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AKAP9 mRNA
CTD
PMID:15336504
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1B10 mRNA
CTD
PMID:23410634 PMID:34767876
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1C1 mRNA
CTD
PMID:15336504
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1C2 mRNA
CTD
PMID:12414654 PMID:15336504 PMID:23410634
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in decreased phosphorylation of AKT1 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of AKT1 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA]
CTD
PMID:29128606 PMID:35690295
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of AKT2 mRNA tert-Butylhydroperoxide results in increased methylation of AKT2 gene
CTD
PMID:27509014
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Alad
aminolevulinate dehydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALAD mRNA
CTD
PMID:15336504
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Alas1
5'-aminolevulinate synthase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALAS1 protein
CTD
PMID:21659532
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH1A1 mRNA tert-Butylhydroperoxide affects the expression of ALDH1A1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ALDH1A3 mRNA
CTD
PMID:15336504
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
G
Aldh2
aldehyde dehydrogenase 2 family member
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of ALDH2 mRNA ALDH2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH3A2 mRNA
CTD
PMID:15336504
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Aldh4a1
aldehyde dehydrogenase 4 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH4A1 mRNA
CTD
PMID:15336504
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH6A1 mRNA
CTD
PMID:15336504
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH7A1 mRNA
CTD
PMID:15336504
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
G
Alox5
arachidonate 5-lipoxygenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALOX5 mRNA
CTD
PMID:15336504
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Amd1
adenosylmethionine decarboxylase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMD1 mRNA
CTD
PMID:27509014
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
G
Amigo2
adhesion molecule with Ig like domain 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMIGO2 mRNA
CTD
PMID:15336504
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
G
Amotl2
angiomotin like 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AMOTL2 mRNA]
CTD
PMID:20847119
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
G
Ampd3
adenosine monophosphate deaminase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMPD3 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Amph
amphiphysin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AMPH mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:45,739,385...45,982,905
Ensembl chr17:45,739,395...45,983,315
G
Anapc5
anaphase-promoting complex subunit 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANAPC5 mRNA
CTD
PMID:15336504
NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781
G
Angptl2
angiopoietin-like 2
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]
CTD
PMID:15003993 PMID:20847119
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
G
Angptl7
angiopoietin like 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANGPTL7 mRNA
CTD
PMID:15336504
NCBI chr 5:158,932,096...158,937,281
Ensembl chr 5:158,932,794...158,937,324
G
Ankmy2
ankyrin repeat and MYND domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKMY2 mRNA
CTD
PMID:15336504
NCBI chr 6:52,888,959...52,930,343
Ensembl chr 6:52,888,963...52,930,394
G
Ankra2
ankyrin repeat family A member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ANKRA2 mRNA
CTD
PMID:23410634
NCBI chr 2:29,612,867...29,623,748
Ensembl chr 2:29,612,925...29,623,730
G
Ankrd10
ankyrin repeat domain 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKRD10 mRNA
CTD
PMID:15336504
NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745
G
Ankrd2
ankyrin repeat domain 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKRD2 mRNA
CTD
PMID:15336504
NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566
G
Ankrd37
ankyrin repeat domain 37
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]
CTD
PMID:20847119
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Ankrd6
ankyrin repeat domain 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANKRD6 mRNA
CTD
PMID:15336504
NCBI chr 5:47,197,981...47,343,183
Ensembl chr 5:47,202,873...47,343,090
G
Anp32a
acidic nuclear phosphoprotein 32 family member A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANP32A mRNA
CTD
PMID:15336504
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
G
Anpep
alanyl aminopeptidase, membrane
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANPEP mRNA
CTD
PMID:15336504
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
G
Anxa4
annexin A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANXA4 mRNA
CTD
PMID:15336504
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Anxa8
annexin A8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANXA8 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
G
Aox1
aldehyde oxidase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AOX1 mRNA
CTD
PMID:15336504
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Ap3b1
adaptor related protein complex 3 subunit beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AP3B1 mRNA
CTD
PMID:15336504
NCBI chr 2:25,600,069...25,800,937
Ensembl chr 2:25,600,040...25,800,935
G
Ap3d1
adaptor related protein complex 3 subunit delta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AP3D1 mRNA
CTD
PMID:15336504
NCBI chr 7:8,970,249...9,005,651
Ensembl chr 7:8,970,291...9,005,643
G
Apaf1
apoptotic peptidase activating factor 1
increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of APAF1 protein [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA] Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of APAF1 protein]
CTD
PMID:15877105 PMID:17419000 PMID:35690295
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Aplp2
amyloid beta precursor like protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APLP2 mRNA
CTD
PMID:15336504
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
G
Apoa5
apolipoprotein A5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of APOA5 mRNA
CTD
PMID:23410634
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apoe
apolipoprotein E
increases expression affects localization
ISO EXP
tert-Butylhydroperoxide results in increased expression of APOE mRNA tert-Butylhydroperoxide affects the localization of APOE protein
CTD
PMID:15336504 PMID:19720132
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Apold1
apolipoprotein L domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APOLD1 mRNA
CTD
PMID:15336504
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
G
App
amyloid beta precursor protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APP mRNA
CTD
PMID:12419474
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Appl1
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APPL1 mRNA
CTD
PMID:15336504
NCBI chr16:2,118,503...2,166,741
Ensembl chr16:2,121,255...2,166,692
G
Appl2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APPL2 mRNA
CTD
PMID:15336504
NCBI chr 7:20,135,248...20,184,757
Ensembl chr 7:20,135,375...20,184,754
G
Aqp1
aquaporin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AQP1 mRNA
CTD
PMID:15336504
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Aqp4
aquaporin 4
multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of and affects the localization of AQP4 protein
CTD
PMID:20648640
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Aqr
aquarius intron-binding spliceosomal factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AQR mRNA
CTD
PMID:15336504
NCBI chr 3:100,874,987...100,945,026
Ensembl chr 3:100,874,987...100,945,044
G
Areg
amphiregulin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AREG mRNA
CTD
PMID:12414654
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arf6
ADP-ribosylation factor 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ARF6 mRNA
CTD
PMID:15336504
NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114
G
Arg2
arginase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ARG2 mRNA
CTD
PMID:23410634
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arhgdia
Rho GDP dissociation inhibitor alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGDIA mRNA
CTD
PMID:12419474
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
G
Arhgef10
Rho guanine nucleotide exchange factor 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGEF10 mRNA
CTD
PMID:15336504
NCBI chr16:74,647,147...74,738,784
Ensembl chr16:74,647,153...74,738,173
G
Arhgef7
Rho guanine nucleotide exchange factor 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGEF7 mRNA
CTD
PMID:15336504
NCBI chr16:77,671,021...77,782,593
Ensembl chr16:77,671,023...77,782,697
G
Arid3a
AT-rich interaction domain 3A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ARID3A mRNA
CTD
PMID:23410634
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
G
Arl6ip1
ADP-ribosylation factor like GTPase 6 interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARL6IP1 mRNA
CTD
PMID:15336504
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
G
Arl6ip5
ADP-ribosylation factor like GTPase 6 interacting protein 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARL6IP5 mRNA
CTD
PMID:15336504
NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA]
CTD
PMID:35690295
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Arpc1a
actin related protein 2/3 complex, subunit 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARPC1A mRNA
CTD
PMID:15336504
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
G
Asf1a
anti-silencing function 1A histone chaperone
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ASF1A mRNA
CTD
PMID:23410634
NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808
G
Asf1b
anti-silencing function 1B histone chaperone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASF1B mRNA
CTD
PMID:15336504
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
G
Asph
aspartate-beta-hydroxylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASPH mRNA
CTD
PMID:15336504
NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:22,603,486...22,813,876
G
Aspscr1
ASPSCR1 tether for SLC2A4, UBX domain containing
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASPSCR1 mRNA
CTD
PMID:15336504
NCBI chr10:105,952,215...105,990,059
Ensembl chr10:105,952,227...105,989,904
G
Ass1
argininosuccinate synthase 1
decreases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ASS1 mRNA; tert-Butylhydroperoxide results in decreased expression of ASS1 protein
CTD
PMID:15336504 PMID:24394546
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Asxl1
ASXL transcriptional regulator 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASXL1 mRNA
CTD
PMID:15336504
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
G
Atad2
ATPase family, AAA domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA
CTD
PMID:15336504
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
multiple interactions decreases expression increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA] tert-Butylhydroperoxide results in decreased expression of ATF3 mRNA
CTD
PMID:12414654 PMID:20196124 PMID:20847119
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atg4b
autophagy related 4B, cysteine peptidase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATG4B mRNA
CTD
PMID:15336504
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
G
Atg5
autophagy related 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATG5 mRNA
CTD
PMID:15336504
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Atp13a3
ATPase 13A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP13A3 mRNA
CTD
PMID:15336504
NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATP2A2 mRNA
CTD
PMID:15336504
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP2B1 mRNA
CTD
PMID:15336504
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
G
Atp6v1a
ATPase H+ transporting V1 subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATP6V1A mRNA
CTD
PMID:15336504
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
G
Atp6v1c1
ATPase H+ transporting V1 subunit C1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP6V1C1 mRNA
CTD
PMID:15336504
NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278
G
Atr
ATR serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATR mRNA
CTD
PMID:12419474
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
Atxn1
ataxin 1
affects localization decreases expression multiple interactions
ISO
tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form tert-Butylhydroperoxide results in decreased expression of ATXN1 mRNA Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form]; Buthionine Sulfoximine promotes the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form]
CTD
PMID:12893416 PMID:15336504
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
G
Atxn3
ataxin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATXN3 mRNA
CTD
PMID:15336504
NCBI chr 6:121,072,228...121,107,902
Ensembl chr 6:121,074,448...121,107,902
G
Aurka
aurora kinase A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AURKA mRNA
CTD
PMID:15003993
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AURKB mRNA tert-Butylhydroperoxide results in increased expression of AURKB mRNA
CTD
PMID:12414654 PMID:29432895
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Auts2
activator of transcription and developmental regulator AUTS2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AUTS2 mRNA
CTD
PMID:15336504
NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416
G
Azin1
antizyme inhibitor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AZIN1 mRNA
CTD
PMID:15336504
NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
G
Babam1
BRISC and BRCA1 A complex member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BABAM1 mRNA
CTD
PMID:15336504
NCBI chr16:18,068,830...18,074,938
Ensembl chr16:18,068,884...18,074,923
G
Babam2
BRISC and BRCA1 A complex member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BABAM2 mRNA
CTD
PMID:15003993
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
G
Bace2
beta-secretase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BACE2 mRNA
CTD
PMID:15336504
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
G
Bad
BCL2-associated agonist of cell death
decreases expression increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in decreased expression of BAD mRNA tert-Butylhydroperoxide results in increased expression of BAD protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAD protein]
CTD
PMID:12419474 PMID:15569404 PMID:17419000
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAK1 mRNA
CTD
PMID:12419474
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bambi
BMP and activin membrane-bound inhibitor
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAMBI mRNA tert-Butylhydroperoxide affects the expression of BAMBI mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions affects localization increases expression decreases expression
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] tert-Butylhydroperoxide results in decreased expression of BAX mRNA
CTD
PMID:12419474 PMID:15569404 PMID:17419000 PMID:18552516 PMID:20510348 PMID:23994092 PMID:25522270 PMID:26989860 PMID:28063877 PMID:29111459 PMID:35690295 More...
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Baz1b
bromodomain adjacent to zinc finger domain, 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAZ1B mRNA
CTD
PMID:15336504
NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426
G
Bbln
bublin coiled coil protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BBLN mRNA
CTD
PMID:15336504
NCBI chr 3:15,674,577...15,677,322
Ensembl chr 3:15,674,580...15,677,374
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression affects localization
EXP ISO
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA; Genistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] tert-Butylhydroperoxide results in decreased expression of BCL2 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2 protein
CTD
PMID:12782109 PMID:15288519 PMID:15569404 PMID:17419000 PMID:19772912 PMID:20510348 PMID:22659508 PMID:23994092 PMID:25522270 PMID:26989860 PMID:27050144 PMID:29111459 PMID:29128606 PMID:35690295 More...
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions decreases expression
EXP ISO
Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] tert-Butylhydroperoxide results in decreased expression of BCL2L1 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]
CTD
PMID:12419474 PMID:15569404 PMID:26102008 PMID:27050144
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl2l13
Bcl2-like 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BCL2L13 mRNA
CTD
PMID:15336504
NCBI chr 4:154,056,116...154,112,890
Ensembl chr 4:154,056,127...154,108,985
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BDH1 mRNA
CTD
PMID:29432895
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
G
Bdnf
brain-derived neurotrophic factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BDNF mRNA
CTD
PMID:15336504
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bex2
brain expressed X-linked 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BEX1 mRNA
CTD
PMID:15336504
NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503
G
Bex4
brain expressed, X-linked 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BEX4 mRNA
CTD
PMID:15336504
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531
G
Bhmt
betaine-homocysteine S-methyltransferase
increases methylation decreases expression
ISO
tert-Butylhydroperoxide results in increased methylation of BHMT gene tert-Butylhydroperoxide results in decreased expression of BHMT mRNA
CTD
PMID:27509014
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
Bicd1
BICD cargo adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BICD1 mRNA
CTD
PMID:15336504
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
G
Bik
BCL2-interacting killer
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BIK mRNA
CTD
PMID:23410634
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BIRC5 mRNA
CTD
PMID:15003993
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bles03
basophilic leukemia expressed protein BLES03
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of C11ORF68 mRNA
CTD
PMID:15336504
NCBI chr 1:202,734,555...202,736,809
Ensembl chr 1:202,734,555...202,736,804
G
Blnk
B-cell linker
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BLNK mRNA
CTD
PMID:14729362
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
G
Bmal2
basic helix-loop-helix ARNT like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMAL2 mRNA
CTD
PMID:15336504
NCBI chr 4:179,699,432...179,747,710
Ensembl chr 4:179,699,502...179,746,949
G
Bmerb1
bMERB domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMERB1 mRNA
CTD
PMID:15336504
NCBI chr10:1,779,834...1,946,586
Ensembl chr10:1,779,835...1,946,575
G
Bmp1
bone morphogenetic protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMP1 mRNA
CTD
PMID:12419474
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
G
Bmp4
bone morphogenetic protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMP4 mRNA
CTD
PMID:12419474
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Bnip3
BCL2 interacting protein 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BNIP3 mRNA tert-Butylhydroperoxide results in increased expression of BNIP3 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Bora
bora, aurora kinase A activator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BORA mRNA
CTD
PMID:15336504
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRAF mRNA
CTD
PMID:12419474
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Brd3
bromodomain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRD3 mRNA
CTD
PMID:15336504
NCBI chr 3:10,773,163...10,829,675
Ensembl chr 3:10,775,272...10,829,577
G
Brd3os
BRD3 opposite strand
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRD3OS mRNA
CTD
PMID:15336504
NCBI chr 3:10,770,229...10,771,860
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BSCL2 mRNA
CTD
PMID:22003191
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
G
Bst1
bone marrow stromal cell antigen 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BST1 mRNA
CTD
PMID:15336504
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BST2 mRNA
CTD
PMID:15336504
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Btbd2
BTB domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTBD2 mRNA
CTD
PMID:15336504
NCBI chr 7:9,058,609...9,075,341
Ensembl chr 7:9,060,788...9,075,344
G
Btd
biotinidase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTD mRNA
CTD
PMID:15336504
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
G
Btf3
basic transcription factor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BTF3 mRNA
CTD
PMID:15336504
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879
G
Btg1
BTG anti-proliferation factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTG1 mRNA
CTD
PMID:15003993
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BTG2 mRNA
CTD
PMID:12414654 PMID:21382384
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of BUB1 mRNA
CTD
PMID:23410634
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
Bud23
BUD23, rRNA methyltransferase and ribosome maturation factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BUD23 mRNA
CTD
PMID:15336504
NCBI chr12:21,629,551...21,640,758
Ensembl chr12:21,629,536...21,640,751
G
Bzw1
basic leucine zipper and W2 domains 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]
CTD
PMID:20847119
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
G
C10h17orf100
similar to human chromosome 17 open reading frame 100
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C17ORF100 mRNA
CTD
PMID:23410634
NCBI chr10:56,840,451...56,843,674
Ensembl chr10:56,832,412...56,843,871
G
C13h1orf115
similar to human chromosome 1 open reading frame 115
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C1ORF115 mRNA
CTD
PMID:15336504
NCBI chr13:96,422,308...96,432,044
Ensembl chr13:96,422,302...96,432,068
G
C17h6orf62
similar to human chromosome 6 open reading frame 62
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C6ORF62 mRNA
CTD
PMID:23410634
NCBI chr17:40,256,211...40,267,851
Ensembl chr17:40,256,211...40,276,020
G
C1r
complement C1r
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C1R mRNA
CTD
PMID:15336504
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C2CD2 mRNA
CTD
PMID:15336504
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
G
C5
complement C5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C5 mRNA
CTD
PMID:15336504
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C7h8orf76
similar to human chromosome 8 open reading frame 76
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C8ORF76 mRNA
CTD
PMID:23410634
NCBI chr 7:89,558,890...89,569,810
Ensembl chr 7:89,558,909...89,569,810
G
Cadm1
cell adhesion molecule 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CADM1 mRNA
CTD
PMID:15336504
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
G
Cadm4
cell adhesion molecule 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CADM4 mRNA
CTD
PMID:15336504
NCBI chr 1:80,075,163...80,097,423
Ensembl chr 1:80,075,202...80,097,423
G
Calhm2
calcium homeostasis modulator family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALHM2 mRNA
CTD
PMID:15336504
NCBI chr 1:246,022,324...246,028,050
Ensembl chr 1:246,022,324...246,028,218
G
Calm1
calmodulin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALM1 mRNA
CTD
PMID:15336504
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
G
Calm3
calmodulin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALM3 mRNA
CTD
PMID:15003993
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
G
Calml4
calmodulin-like 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALML4 mRNA
CTD
PMID:15003993
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
G
Calr
calreticulin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALR mRNA
CTD
PMID:15336504
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Calu
calumenin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALU mRNA
CTD
PMID:15336504
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAMK2N1 mRNA
CTD
PMID:15336504
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Camlg
calcium modulating ligand
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAML mRNA
CTD
PMID:14729362
NCBI chr17:8,992,697...9,003,576
Ensembl chr17:8,992,696...9,003,552
G
Camp
cathelicidin antimicrobial peptide
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAMP mRNA
CTD
PMID:22659508
NCBI chr 8:109,841,729...109,843,543
Ensembl chr 8:109,841,729...109,843,543
G
Cand1
cullin-associated and neddylation-dissociated 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAND1 mRNA
CTD
PMID:15336504
NCBI chr 7:54,681,114...54,719,002
Ensembl chr 7:54,680,900...54,718,993
G
Capn1
calpain 1
increases response to substance increases expression
ISO
CAPN1 protein results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CAPN1 mRNA
CTD
PMID:12842444 PMID:15003993
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
G
Capn2
calpain 2
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPN2 mRNA tert-Butylhydroperoxide affects the expression of CAPN2 mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Capn5
calpain 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAPN5 mRNA
CTD
PMID:15003993
NCBI chr 1:152,416,252...152,472,923
Ensembl chr 1:152,416,252...152,472,923
G
Capn7
calpain 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPN7 mRNA
CTD
PMID:15336504
NCBI chr16:6,545,630...6,581,908
Ensembl chr16:6,545,731...6,581,905
G
Capns1
calpain, small subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPNS1 mRNA
CTD
PMID:12419474
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
G
Caprin2
caprin family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPRIN2 mRNA
CTD
PMID:15336504
NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830
G
Car8
carbonic anhydrase 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CA8 mRNA
CTD
PMID:15336504
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
G
Cars2
cysteinyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CARS2 mRNA
CTD
PMID:15336504
NCBI chr16:77,945,468...77,987,163
Ensembl chr16:77,950,008...77,987,772
G
Cask
calcium/calmodulin dependent serine protein kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CASK mRNA
CTD
PMID:12419474
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
G
Casp3
caspase 3
multiple interactions decreases activity increases cleavage decreases expression increases activity increases expression
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA; acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; KN 93 inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; zinc protoporphyrin inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]] tert-butylhydroperoxide decreases activity of Casp3 protein in hepatocyte cytosol acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] caffeoylquinic acid analog inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; tert-Butylhydroperoxide results in increased expression of and results in increased cleavage of CASP3 protein tert-Butylhydroperoxide results in increased expression of CASP3 protein; tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form
CTD RGD
PMID:12406338 PMID:15496407 PMID:15569404 PMID:15611089 PMID:15877105 PMID:16753784 PMID:17419000 PMID:19647727 PMID:19772912 PMID:20510348 PMID:20847119 PMID:26102008 PMID:26989860 PMID:27511913 PMID:28025122 PMID:28063877 PMID:28733231 PMID:35690295 PMID:18316105 More...
RGD:2311460
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CASP6 mRNA
CTD
PMID:15003993
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
multiple interactions decreases activity increases cleavage
ISO EXP
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein] tert-butylhydroperoxide decreases activity of Casp7 protein in hepatocyte cytosol
CTD RGD
PMID:27050144 PMID:18316105
RGD:2311460
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]
CTD
PMID:35690295
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage decreases activity multiple interactions increases expression
EXP ISO
tert-Butylhydroperoxide results in increased cleavage of CASP9 protein Tert-butylhydroperoxide decreases activity of Casp9 protein in hepatocyte cytosol Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] tert-Butylhydroperoxide results in increased expression of CASP9 protein Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein]
CTD RGD
PMID:15877105 PMID:17003459 PMID:19772912 PMID:20510348 PMID:27050144 PMID:18316105 More...
RGD:2311460
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAST mRNA
CTD
PMID:15336504
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
affects response to substance increases activity decreases activity multiple interactions increases expression decreases expression decreases response to substance
ISO EXP
CAT protein affects the susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased activity of CAT protein tert-Butylhydroperoxide results in decreased activity of CAT protein CAT protein results in increased susceptibility to [tert-Butylhydroperoxide co-treated with Desoxycorticosterone co-treated with tempol] tert-Butylhydroperoxide results in increased expression of CAT mRNA CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of CAT protein] tert-Butylhydroperoxide results in decreased expression of CAT mRNA; tert-Butylhydroperoxide results in decreased expression of CAT protein [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CAT mRNA; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CAT protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CAT protein] CAT protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:10754530 PMID:11178967 PMID:12423650 PMID:12628296 PMID:12646410 PMID:14729362 PMID:15003993 PMID:15105052 PMID:15207383 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16753784 PMID:16928893 PMID:17003459 PMID:20100471 PMID:34303734 PMID:35690295 More...
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAV1 mRNA
CTD
PMID:15963989
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cav2
caveolin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAV2 mRNA
CTD
PMID:15336504
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
G
Cavin2
caveolae associated protein 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CAVIN2 mRNA
CTD
PMID:23410634
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
G
Cbfb
core-binding factor subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CBFB mRNA
CTD
PMID:15336504
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
G
Cbr3
carbonyl reductase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CBR3 mRNA
CTD
PMID:21382384
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
G
Cbs
cystathionine beta synthase
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of CBS mRNA tert-Butylhydroperoxide results in increased methylation of CBS gene
CTD
PMID:15336504 PMID:27509014
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Ccdc25
coiled-coil domain containing 25
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCDC25 mRNA
CTD
PMID:15336504
NCBI chr15:40,055,368...40,087,758
Ensembl chr15:40,055,368...40,087,758
G
Ccdc86
coiled-coil domain containing 86
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCDC86 mRNA
CTD
PMID:15336504
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
G
Ccdc93
coiled-coil domain containing 93
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCDC93 mRNA
CTD
PMID:15336504
NCBI chr13:32,607,618...32,675,993
Ensembl chr13:32,607,587...32,676,023
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA]
CTD
PMID:20847119
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCL5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn1
cellular communication network factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCN1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
multiple interactions affects expression decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA] tert-Butylhydroperoxide affects the expression of CCN2 mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccn3
cellular communication network factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCN3 mRNA
CTD
PMID:15336504
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
G
Ccna2
cyclin A2
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNA2 mRNA tert-Butylhydroperoxide affects the expression of CCNA2 mRNA
CTD
PMID:12414654 PMID:12419474 PMID:15336504 PMID:23410634
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb2
cyclin B2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNB2 mRNA
CTD
PMID:15003993
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccne1
cyclin E1
multiple interactions
ISO
ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CCNE1 protein]
CTD
PMID:15606011
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccne2
cyclin E2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNE2 mRNA
CTD
PMID:15336504
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccnf
cyclin F
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNF mRNA
CTD
PMID:15003993
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
G
Ccng2
cyclin G2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNG2 mRNA
CTD
PMID:15336504
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Ccnj
cyclin J
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNJ mRNA
CTD
PMID:15336504
NCBI chr 1:239,659,588...239,677,367
G
Ccnk
cyclin K
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNK mRNA
CTD
PMID:12419474
NCBI chr 6:127,090,115...127,113,195
Ensembl chr 6:127,090,569...127,113,191
G
Ccs
copper chaperone for superoxide dismutase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCS mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
G
Cd24
CD24 molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD24 mRNA
CTD
PMID:15336504
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd320
CD320 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD320 mRNA
CTD
PMID:15336504
NCBI chr 7:14,626,171...14,631,976
Ensembl chr 7:14,609,146...14,631,976
G
Cd46
CD46 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD46 mRNA
CTD
PMID:15336504
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
G
Cd47
Cd47 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD47 mRNA
CTD
PMID:12419474
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
G
Cd55
CD55 molecule (Cromer blood group)
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD55 mRNA
CTD
PMID:15336504
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
G
Cd68
Cd68 molecule
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of CD68 mRNA CD68 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cd82
Cd82 molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD82 mRNA
CTD
PMID:15336504
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
G
Cd9
CD9 molecule
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD9 mRNA tert-Butylhydroperoxide affects the expression of CD9 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cd99
CD99 molecule (Xg blood group)
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD99 mRNA
CTD
PMID:15336504
NCBI chr20:54,418,239...54,422,882
G
Cdc16
cell division cycle 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC16 mRNA
CTD
PMID:15336504
NCBI chr16:75,773,026...75,796,586
Ensembl chr16:75,773,028...75,796,550
G
Cdc25b
cell division cycle 25B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC25B mRNA
CTD
PMID:15336504
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
G
Cdc25c
cell division cycle 25C
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC25C mRNA tert-Butylhydroperoxide results in increased expression of CDC25C mRNA
CTD
PMID:12419474 PMID:14729362 PMID:15003993
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Cdc27
cell division cycle 27
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC27 mRNA
CTD
PMID:15336504
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
G
Cdc37l1
cell division cycle 37-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC37L1 mRNA
CTD
PMID:15963989
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
G
Cdc42
cell division cycle 42
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42 mRNA
CTD
PMID:15336504
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdc42ep2
CDC42 effector protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42EP2 mRNA
CTD
PMID:15336504
NCBI chr 1:203,202,000...203,210,891
Ensembl chr 1:203,201,873...203,210,897
G
Cdc42ep3
CDC42 effector protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42EP3 mRNA
CTD
PMID:15336504
NCBI chr 6:15,710,894...15,731,366
Ensembl chr 6:15,708,730...15,732,721
G
Cdc42ep4
CDC42 effector protein 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CDC42EP4 mRNA
CTD
PMID:23410634
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
G
Cdc42se1
CDC42 small effector 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42SE1 mRNA
CTD
PMID:15336504
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
G
Cdc5l
cell division cycle 5-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC5L mRNA
CTD
PMID:15336504
NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDCA3 mRNA
CTD
PMID:15336504
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdcp1
CUB domain containing protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDCP1 mRNA
CTD
PMID:15336504
NCBI chr 8:122,828,685...122,865,345
Ensembl chr 8:122,828,685...122,865,388
G
Cdh11
cadherin 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDH11 mRNA
CTD
PMID:12419474
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
G
Cdh3
cadherin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDH3 mRNA
CTD
PMID:12419474
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdh5
cadherin 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDH5 mRNA
CTD
PMID:22659508
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
G
Cdk1
cyclin-dependent kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDK1 mRNA
CTD
PMID:15003993
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk10
cyclin-dependent kinase 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDK10 mRNA
CTD
PMID:12419474
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
G
Cdk2
cyclin dependent kinase 2
decreases activity decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased activity of CDK2 protein tert-Butylhydroperoxide results in decreased expression of CDK2 mRNA ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDK2 protein]
CTD
PMID:12766906 PMID:15336504 PMID:15606011
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of CDKN1A mRNA; tert-Butylhydroperoxide results in increased expression of CDKN1A protein [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA; ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDKN1A protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]
CTD
PMID:12414654 PMID:12766906 PMID:12782109 PMID:15336504 PMID:15606011 PMID:18619952 PMID:22563892 PMID:35690295 More...
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA
CTD
PMID:35690295
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
multiple interactions increases expression decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA] tert-Butylhydroperoxide results in decreased expression of CDKN1C mRNA
CTD
PMID:12419474 PMID:20847119
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDKN2B mRNA
CTD
PMID:12419474 PMID:14729362
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDKN2C mRNA
CTD
PMID:15336504
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Cdkn3
cyclin-dependent kinase inhibitor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDKN3 mRNA
CTD
PMID:15003993 PMID:27509014
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cebpa
CCAAT/enhancer binding protein alpha
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CEBPA mRNA
CTD
PMID:23410634
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEBPB mRNA
CTD
PMID:15336504
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Celf2
CUGBP, Elav-like family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CELF2 mRNA
CTD
PMID:15336504
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
G
Celsr2
cadherin, EGF LAG seven-pass G-type receptor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CELSR2 mRNA
CTD
PMID:15336504
NCBI chr 2:196,029,206...196,053,848
Ensembl chr 2:196,029,434...196,053,845
G
Cenpa
centromere protein A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CENPA mRNA
CTD
PMID:12414654
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cenpm
centromere protein M
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CENPM mRNA
CTD
PMID:15336504
NCBI chr 7:113,748,026...113,759,296
Ensembl chr 7:113,747,516...113,764,258
G
Cep170
centrosomal protein 170
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP170 mRNA
CTD
PMID:15336504
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
G
Cep170b
centrosomal protein 170B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP170B mRNA
CTD
PMID:15336504
NCBI chr 6:131,780,935...131,806,658
Ensembl chr 6:131,778,957...131,806,658
G
Cep192
centrosomal protein 192
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CEP192 mRNA
CTD
PMID:15336504
NCBI chr18:61,373,937...61,458,405
Ensembl chr18:61,332,158...61,458,379
G
Cep43
centrosomal protein 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP43 mRNA
CTD
PMID:15336504
NCBI chr 1:52,533,418...52,564,025
Ensembl chr 1:52,533,428...52,563,923
G
Cep57
centrosomal protein 57
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CEP57 mRNA
CTD
PMID:15336504
NCBI chr 8:10,669,588...10,689,257
Ensembl chr 8:10,669,590...10,689,249
G
Cep89
centrosomal protein 89
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP89 mRNA
CTD
PMID:15003993
NCBI chr 1:88,058,211...88,100,114
Ensembl chr 1:88,058,227...88,100,112
G
Cfb
complement factor B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CFB mRNA
CTD
PMID:15336504
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cfi
complement factor I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CFI mRNA
CTD
PMID:15336504
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
G
Chaf1a
chromatin assembly factor 1 subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHAF1A mRNA
CTD
PMID:15336504
NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654
G
Chdh
choline dehydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHDH mRNA
CTD
PMID:27509014
NCBI chr16:5,194,269...5,225,541
Ensembl chr16:5,194,269...5,225,537
G
Chek1
checkpoint kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHEK1 mRNA
CTD
PMID:12414654
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chka
choline kinase alpha
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CHKA mRNA
CTD
PMID:23410634
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Chmp2a
charged multivesicular body protein 2A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHMP2A mRNA
CTD
PMID:15336504
NCBI chr 1:73,660,045...73,662,894
Ensembl chr 1:73,660,046...73,662,452
G
Chordc1
cysteine and histidine rich domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CHORDC1 mRNA
CTD
PMID:15336504
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
G
Chrdl1
chordin-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHRDL1 mRNA
CTD
PMID:15336504
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
G
Chst15
carbohydrate sulfotransferase 15
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CHST15 mRNA
CTD
PMID:23410634
NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:187,028,970...187,107,707
G
Chst2
carbohydrate sulfotransferase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CHST2 mRNA
CTD
PMID:15336504
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
G
Clasp1
cytoplasmic linker associated protein 1
decreases methylation decreases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of CLASP1 intron tert-Butylhydroperoxide results in decreased expression of CLASP1 mRNA
CTD
PMID:29432895
NCBI chr13:29,493,554...29,715,151
Ensembl chr13:29,493,596...29,715,146
G
Clcn3
chloride voltage-gated channel 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLCN3 mRNA
CTD
PMID:15003993
NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119
G
Clic3
chloride intracellular channel 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLIC3 mRNA
CTD
PMID:15336504
NCBI chr 3:8,271,416...8,274,023
Ensembl chr 3:8,272,097...8,274,018
G
Cln3
CLN3 lysosomal/endosomal transmembrane protein, battenin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLN3 mRNA
CTD
PMID:15336504
NCBI chr 1:181,156,071...181,169,458
Ensembl chr 1:181,156,073...181,167,434
G
Cln6
CLN6, transmembrane ER protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CLN6 mRNA
CTD
PMID:15003993
NCBI chr 8:63,303,356...63,318,360
Ensembl chr 8:63,303,029...63,318,360
G
Clstn1
calsyntenin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLSTN1 mRNA
CTD
PMID:15336504
NCBI chr 5:160,031,235...160,094,585
Ensembl chr 5:160,031,308...160,094,583
G
Clu
clusterin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CLU mRNA
CTD
PMID:15963989
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cmtm1
CKLF-like MARVEL transmembrane domain containing 1
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of CMTM1 gene
CTD
PMID:29432895
NCBI chr19:651,641...661,184
Ensembl chr19:651,644...661,184
G
Cndp2
carnosine dipeptidase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CNDP2 mRNA
CTD
PMID:15003993
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
G
Cnnm3
cyclin and CBS domain divalent metal cation transport mediator 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CNNM3 mRNA
CTD
PMID:15336504
NCBI chr 9:38,755,374...38,770,740
Ensembl chr 9:38,755,390...38,770,740
G
Cnot8
CCR4-NOT transcription complex, subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CNOT8 mRNA
CTD
PMID:15336504
NCBI chr10:42,281,614...42,294,740
Ensembl chr10:42,281,722...42,294,730
G
Cog5
component of oligomeric golgi complex 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COG5 mRNA
CTD
PMID:15336504
NCBI chr 6:48,242,470...48,545,185
Ensembl chr 6:48,242,482...48,529,009
G
Cog8
component of oligomeric golgi complex 8
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of COG8 mRNA]
CTD
PMID:20847119
NCBI chr19:34,951,625...34,962,377
Ensembl chr19:34,951,627...34,962,397
G
Col13a1
collagen type XIII alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL13A1 mRNA
CTD
PMID:15336504
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL1A2 mRNA
CTD
PMID:15336504
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL3A1 mRNA
CTD
PMID:15336504
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col4a1
collagen type IV alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL4A1 mRNA
CTD
PMID:15336504
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
G
Col4a2
collagen type IV alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL4A2 mRNA
CTD
PMID:15336504
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
G
Col5a1
collagen type V alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL5A1 mRNA
CTD
PMID:15336504
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Col5a2
collagen type V alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL5A2 mRNA
CTD
PMID:15336504
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Col6a1
collagen type VI alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL6A1 mRNA
CTD
PMID:15336504
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
G
Col6a2
collagen type VI alpha 2 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL6A2 mRNA
CTD
PMID:15336504
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Col7a1
collagen type VII alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL7A1 mRNA
CTD
PMID:15336504
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
G
Col8a2
collagen type VIII alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL8A2 mRNA
CTD
PMID:15336504
NCBI chr 5:138,586,201...138,613,627
Ensembl chr 5:138,585,999...138,612,850
G
Comt
catechol-O-methyltransferase
decreases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of COMT mRNA tert-Butylhydroperoxide results in decreased expression of COMT protein
CTD
PMID:12419474 PMID:24394546
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Copa
COPI coat complex subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPA mRNA
CTD
PMID:15336504
NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874
G
Copb1
COPI coat complex subunit beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COPB1 mRNA
CTD
PMID:15336504
NCBI chr 1:168,404,334...168,438,589
Ensembl chr 1:168,404,335...168,438,416
G
Cope
COPI coat complex subunit epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPE mRNA
CTD
PMID:15336504
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
G
Cops6
COP9 signalosome subunit 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPS6 mRNA
CTD
PMID:15336504
NCBI chr12:17,038,979...17,041,818
Ensembl chr12:17,038,979...17,046,371
G
Cops8
COP9 signalosome subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPS8 mRNA
CTD
PMID:15336504
NCBI chr 9:91,207,427...91,217,258
Ensembl chr 9:91,207,395...91,217,258
G
Cox7a1
cytochrome c oxidase subunit 7A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COX7A1 mRNA
CTD
PMID:15003993
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
G
Cp
ceruloplasmin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CP mRNA
CTD
PMID:14729362
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpe
carboxypeptidase E
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CPE mRNA tert-Butylhydroperoxide results in increased expression of CPE mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Cpm
carboxypeptidase M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CPM mRNA
CTD
PMID:15336504
NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:53,225,696...53,286,220
G
Cpne1
copine 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CPNE1 mRNA
CTD
PMID:15336504
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
G
Cpq
carboxypeptidase Q
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CPQ mRNA
CTD
PMID:15336504
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
G
Crat
carnitine O-acetyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CRAT mRNA
CTD
PMID:15336504
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
G
Creb1
cAMP responsive element binding protein 1
decreases expression increases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of CREB1 mRNA tert-Butylhydroperoxide results in increased phosphorylation of CREB1 protein U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of CREB1 protein]
CTD
PMID:12419474 PMID:17003459
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crip1
cysteine rich protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CRIP1 mRNA
CTD
PMID:15003993
NCBI chr 6:132,226,746...132,234,620
Ensembl chr 6:132,226,746...132,234,620
G
Crispld2
cysteine-rich secretory protein LCCL domain containing 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CRISPLD2 mRNA
CTD
PMID:15336504
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
G
Cryab
crystallin, alpha B
multiple interactions decreases expression increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA] tert-Butylhydroperoxide results in decreased expression of CRYAB mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Cryz
crystallin zeta
decreases response to substance increases expression
ISO
CRYZ protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CRYZ mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
G
Csf1
colony stimulating factor 1
decreases response to substance
ISO
CSF1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:16446085
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csnk1d
casein kinase 1, delta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CSNK1D mRNA
CTD
PMID:15336504
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
G
Cspg4
chondroitin sulfate proteoglycan 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CSPG4 mRNA
CTD
PMID:15336504
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
G
Ctdspl
CTD small phosphatase like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTDSPL mRNA
CTD
PMID:15336504
NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:118,642,672...118,767,117
G
Cth
cystathionine gamma-lyase
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of CTH protein
CTD
PMID:18184479
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctnna1
catenin alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTNNA1 mRNA
CTD
PMID:12419474
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
G
Ctnnb1
catenin beta 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]
CTD
PMID:20847119
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctsb
cathepsin B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CTSB mRNA
CTD
PMID:15336504
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsl
cathepsin L
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of CTSL mRNA tert-Butylhydroperoxide results in decreased expression of CTSL mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cttn
cortactin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTTN mRNA
CTD
PMID:12419474
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
G
Cul4a
cullin 4A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CUL4A mRNA
CTD
PMID:15336504
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
G
Cux1
cut-like homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CUX1 mRNA
CTD
PMID:12419474
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866
G
Cxadr
CXADR, Ig-like cell adhesion molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CXADR mRNA
CTD
PMID:15336504
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA
CTD
PMID:15336504
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL10 mRNA
CTD
PMID:15003993
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL2 mRNA
CTD
PMID:15336504
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA
CTD
PMID:15336504
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]
CTD
PMID:20847119
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cxxc5
CXXC finger protein 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CXXC5 mRNA
CTD
PMID:29432895
NCBI chr18:27,427,591...27,458,579
Ensembl chr18:27,427,230...27,458,673
G
Cyb561
cytochrome b-561
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CYB561 mRNA
CTD
PMID:15336504
NCBI chr10:90,878,052...90,888,734
Ensembl chr10:90,878,054...90,884,787
G
Cyb5d2
cytochrome b5 domain containing 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CYB5D2 mRNA
CTD
PMID:23410634
NCBI chr10:57,394,268...57,413,336
Ensembl chr10:57,396,765...57,413,715
G
Cyb5r2
cytochrome b5 reductase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYB5R2 mRNA
CTD
PMID:15336504
NCBI chr 1:161,655,862...161,664,359
Ensembl chr 1:161,655,864...161,664,097
G
Cybc1
cytochrome b-245 chaperone 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CYBC1 mRNA
CTD
PMID:15336504
NCBI chr10:106,498,730...106,505,549
Ensembl chr10:106,498,725...106,505,596
G
Cycs
cytochrome c, somatic
affects localization multiple interactions
ISO
tert-Butylhydroperoxide affects the localization of CYCS protein hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein]
CTD
PMID:18552516
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cygb
cytoglobin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYGB mRNA
CTD
PMID:27509014
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYP1B1 mRNA
CTD
PMID:12414654
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CYP24A1 mRNA
CTD
PMID:23410634
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Cyria
CYFIP related Rac1 interactor A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYRIA mRNA
CTD
PMID:15336504
NCBI chr 6:35,045,208...35,150,669
Ensembl chr 6:35,045,208...35,150,668
G
Dap3
death associated protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DAP3 mRNA
CTD
PMID:14729362
NCBI chr 2:174,319,341...174,347,489
Ensembl chr 2:174,318,983...174,346,461
G
Dapk1
death associated protein kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DAPK1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Dars1
aspartyl-tRNA synthetase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DARS1 mRNA
CTD
PMID:15336504
NCBI chr13:39,857,936...39,913,055
Ensembl chr13:39,857,936...39,913,116
G
Dazap2
DAZ associated protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DAZAP2 mRNA
CTD
PMID:15336504
NCBI chr 7:131,714,749...131,720,266
Ensembl chr 7:131,714,745...131,720,265
G
Dbi
diazepam binding inhibitor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DBI mRNA
CTD
PMID:15336504
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
G
Dcaf7
DDB1 and CUL4 associated factor 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DCAF7 mRNA
CTD
PMID:15336504
NCBI chr10:90,974,095...90,996,275
Ensembl chr10:90,974,095...90,996,275
G
Dctn5
dynactin subunit 5
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of DCTN5 gene
CTD
PMID:29432895
NCBI chr 1:176,689,176...176,705,907
Ensembl chr 1:176,689,156...176,705,906
G
Ddb2
damage specific DNA binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDB2 mRNA
CTD
PMID:15336504
NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of DDIT3 mRNA; tert-Butylhydroperoxide results in increased expression of DDIT3 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]
CTD
PMID:12414654 PMID:22659508 PMID:24394546
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DDIT4 mRNA
CTD
PMID:23410634
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddr1
discoidin domain receptor tyrosine kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDR1 mRNA
CTD
PMID:15336504
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Ddx11
DEAD/H-box helicase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDX11 mRNA
CTD
PMID:15336504
NCBI chr 9:105,833,234...105,862,844
Ensembl chr 9:105,833,504...105,862,550
G
Ddx21
DExD-box helicase 21
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX21 mRNA
CTD
PMID:15336504
NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
G
Ddx42
DEAD-box helicase 42
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX42 mRNA
CTD
PMID:12414654
NCBI chr10:91,148,926...91,180,940
Ensembl chr10:91,148,254...91,180,939
G
Ddx43
DEAD-box helicase 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX43 mRNA
CTD
PMID:15336504
NCBI chr 8:79,255,001...79,284,468
Ensembl chr 8:79,255,655...79,284,453
G
Ddx50
DExD-box helicase 50
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDX50 mRNA
CTD
PMID:15003993
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
G
Ddx52
DExD-box helicase 52
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX52 mRNA
CTD
PMID:15336504
NCBI chr10:68,824,594...68,847,400
Ensembl chr10:68,824,645...68,848,266
G
Ddx56
DEAD-box helicase 56
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX56 mRNA
CTD
PMID:15336504
NCBI chr14:81,112,008...81,122,331
Ensembl chr14:81,112,012...81,122,333
G
Ddx6
DEAD-box helicase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX6 mRNA
CTD
PMID:15003993
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Dennd3
DENN domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DENND3 mRNA
CTD
PMID:15336504
NCBI chr 7:105,415,870...105,473,583
Ensembl chr 7:105,415,677...105,473,592
G
Depp1
DEPP autophagy regulator 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]
CTD
PMID:20847119
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Derl1
derlin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DERL1 mRNA
CTD
PMID:15003993
NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145
G
Dffb
DNA fragmentation factor subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DFFB mRNA
CTD
PMID:12419474
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dgat2
diacylglycerol O-acyltransferase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DGAT2 mRNA
CTD
PMID:23410634
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dhps
deoxyhypusine synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DHPS mRNA
CTD
PMID:15336504
NCBI chr19:23,082,454...23,086,544
Ensembl chr19:23,082,448...23,086,881
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DHX9 mRNA
CTD
PMID:15336504
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
G
Dimt1
DIM1 rRNA methyltransferase and ribosome maturation factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DIMT1 mRNA
CTD
PMID:15336504
NCBI chr 2:38,343,086...38,368,242
Ensembl chr 2:38,354,854...38,368,227
G
Dip2c
disco-interacting protein 2 homolog C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DIP2C mRNA
CTD
PMID:15336504
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DKK1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
G
Dlg1
discs large MAGUK scaffold protein 1
multiple interactions increases expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DLG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DLG1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]
CTD
PMID:20847119
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
G
Dlg3
discs large MAGUK scaffold protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DLG3 mRNA
CTD
PMID:15336504
NCBI chr X:65,859,653...65,911,887
Ensembl chr X:65,860,172...65,910,322
G
Dlgap4
DLG associated protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DLGAP4 mRNA
CTD
PMID:15336504
NCBI chr 3:145,124,189...145,271,791
Ensembl chr 3:145,175,479...145,270,490
G
Dlgap5
DLG associated protein 5
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of DLGAP5 mRNA tert-Butylhydroperoxide affects the expression of DLGAP5 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dlx2
distal-less homeobox 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DLX2 mRNA
CTD
PMID:14729362 PMID:29432895
NCBI chr 3:56,370,238...56,373,581
Ensembl chr 3:56,370,483...56,373,597
G
Dmpk
DM1 protein kinase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DMPK mRNA
CTD
PMID:15003993
NCBI chr 1:78,730,255...78,740,585
Ensembl chr 1:78,730,275...78,740,593
G
Dnaaf2
dynein, axonemal, assembly factor 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]
CTD
PMID:20847119
NCBI chr 6:87,661,101...87,670,267
Ensembl chr 6:87,660,821...87,670,199
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB1 mRNA
CTD
PMID:15336504
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB11 mRNA
CTD
PMID:15003993
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB4 mRNA
CTD
PMID:15336504
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dnajb7
DnaJ heat shock protein family (Hsp40) member B7
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of DNAJB7 intron
CTD
PMID:29432895
NCBI chr 7:112,932,736...112,934,050
Ensembl chr 7:112,932,616...112,945,537
G
Dnase2
deoxyribonuclease 2, lysosomal
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNASE2 mRNA
CTD
PMID:15336504
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
G
Dnm2
dynamin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNM2 mRNA
CTD
PMID:15336504
NCBI chr 8:19,978,313...20,060,162
Ensembl chr 8:19,978,400...20,060,157
G
Dnmbp
dynamin binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DNMBP mRNA
CTD
PMID:15336504
NCBI chr 1:242,736,189...242,829,431
Ensembl chr 1:242,736,189...242,802,604
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNPH1 mRNA
CTD
PMID:12419474
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
G
Dock2
dedicator of cytokinesis 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DOCK2 mRNA
CTD
PMID:15336504
NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808
G
Dock4
dedicator of cytokinesis 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DOCK4 mRNA
CTD
PMID:15336504
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
G
Dpp4
dipeptidylpeptidase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DPP4 mRNA
CTD
PMID:15336504
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Dpy19l1
dpy-19 like C-mannosyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DPY19L1 mRNA
CTD
PMID:15336504
NCBI chr 8:22,933,163...23,021,461
Ensembl chr 8:22,933,163...23,021,751
G
Dpysl3
dihydropyrimidinase-like 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DPYSL3 mRNA
CTD
PMID:15336504
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
G
Drap1
Dr1 associated protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DRAP1 mRNA
CTD
PMID:15003993
NCBI chr 1:202,731,775...202,734,468
Ensembl chr 1:202,731,788...202,734,425
G
Dsc3
desmocollin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DSC3 mRNA
CTD
PMID:15336504
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
G
Dst
dystonin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DST mRNA
CTD
PMID:12419474
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
G
Dusp1
dual specificity phosphatase 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DUSP1 mRNA
CTD
PMID:23410634
NCBI chr10:16,680,478...16,683,275
G
Dusp10
dual specificity phosphatase 10
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]
CTD
PMID:15336504 PMID:20847119
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DUSP5 mRNA
CTD
PMID:15336504
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Dusp6
dual specificity phosphatase 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DUSP6 mRNA tert-Butylhydroperoxide results in increased expression of DUSP6 mRNA
CTD
PMID:15336504 PMID:17003459
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dusp9
dual specificity phosphatase 9
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DUSP9 mRNA
CTD
PMID:23410634
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
G
Dut
deoxyuridine triphosphatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DUT mRNA
CTD
PMID:15336504
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
G
Dvl3
dishevelled segment polarity protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DVL3 mRNA
CTD
PMID:29432895
NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DYNLL1 mRNA
CTD
PMID:12419474
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Dynlrb1
dynein light chain roadblock-type 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DYNLRB1 mRNA
CTD
PMID:15336504
NCBI chr 3:143,742,427...143,764,227
Ensembl chr 3:143,742,586...143,764,227
G
E2f1
E2F transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of E2F1 mRNA
CTD
PMID:12419474
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Ech1
enoyl-CoA hydratase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ECH1 mRNA
CTD
PMID:15003993
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
G
Echdc2
enoyl CoA hydratase domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECHDC2 mRNA
CTD
PMID:15336504
NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859
G
Echs1
enoyl-CoA hydratase, short chain 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ECHS1 protein
CTD
PMID:24394546
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
G
Eci1
enoyl-CoA delta isomerase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECI1 mRNA
CTD
PMID:15336504
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
G
Ecsit
ECSIT signaling integrator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECSIT mRNA
CTD
PMID:15336504
NCBI chr 8:20,605,583...20,618,453
Ensembl chr 8:20,605,583...20,618,390
G
Edil3
EGF like repeats and discoidin domains 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EDIL3 mRNA
CTD
PMID:15336504
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
G
Edn1
endothelin 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of EDN1 mRNA tert-Butylhydroperoxide affects the expression of EDN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Eef2
eukaryotic translation elongation factor 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EEF2 protein
CTD
PMID:16469450
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFEMP1 mRNA
CTD
PMID:15336504
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
G
Efhd1
EF-hand domain family, member D1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFHD1 mRNA
CTD
PMID:15336504
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
G
Efna4
ephrin A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFNA4 mRNA
CTD
PMID:12419474
NCBI chr 2:174,748,729...174,752,979
Ensembl chr 2:174,748,724...174,752,979
G
Efs
embryonal Fyn-associated substrate
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EFS mRNA
CTD
PMID:15336504
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA]
CTD
PMID:35690295
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of EGR1 mRNA tert-Butylhydroperoxide affects the expression of EGR1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF2AK2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
G
Eif2b4
eukaryotic translation initiation factor 2B subunit delta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF2B4 mRNA
CTD
PMID:15336504
NCBI chr 6:25,183,177...25,188,832
Ensembl chr 6:25,183,186...25,188,829
G
Eif3m
eukaryotic translation initiation factor 3, subunit M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF3M mRNA
CTD
PMID:15336504
NCBI chr 3:91,424,754...91,442,358
Ensembl chr 3:91,416,325...91,442,392
G
Eif5
eukaryotic translation initiation factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF5 mRNA
CTD
PMID:15336504
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
G
Eif5b
eukaryotic translation initiation factor 5B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF5B mRNA
CTD
PMID:15336504
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
G
Elavl1
ELAV like RNA binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELAVL1 mRNA
CTD
PMID:15336504
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELF1 mRNA
CTD
PMID:15336504
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
G
Elf5
E74 like ETS transcription factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ELF5 mRNA
CTD
PMID:15003993
NCBI chr 3:89,808,837...89,836,977
Ensembl chr 3:89,797,880...89,836,973
G
Elob
elongin B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELOB mRNA
CTD
PMID:15336504
NCBI chr10:12,848,830...12,853,897
Ensembl chr10:12,848,827...12,853,635
G
Eme1
essential meiotic structure-specific endonuclease 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EME1 mRNA
CTD
PMID:27509014
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
G
Emilin1
elastin microfibril interfacer 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of EMILIN1 mRNA
CTD
PMID:23410634
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
G
Eml1
EMAP like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EML1 mRNA
CTD
PMID:15336504
NCBI chr 6:127,283,968...127,457,246
Ensembl chr 6:127,284,029...127,457,246
G
Eml4
EMAP like 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EML4 mRNA
CTD
PMID:15336504
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
G
Emp3
epithelial membrane protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EMP3 mRNA
CTD
PMID:15003993
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
G
Eng
endoglin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ENG mRNA
CTD
PMID:15336504
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Epb41l2
erythrocyte membrane protein band 4.1-like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EPB41L2 mRNA
CTD
PMID:15336504
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
G
Epb42
erythrocyte membrane protein band 4.2
increases degradation
ISO
tert-Butylhydroperoxide results in increased degradation of EPB42 protein
CTD
PMID:15040847
NCBI chr 3:107,979,709...107,997,932
Ensembl chr 3:107,979,713...107,997,932
G
Ephb2
Eph receptor B2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHB2 mRNA
CTD
PMID:15336504
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
G
Ephb4
EPH receptor B4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EPHB4 mRNA
CTD
PMID:15336504
NCBI chr12:19,326,411...19,351,667
Ensembl chr12:19,326,427...19,351,314
G
Ephx1
epoxide hydrolase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHX1 mRNA
CTD
PMID:21382384
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Ephx2
epoxide hydrolase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHX2 mRNA
CTD
PMID:14729362
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Erbb2
erb-b2 receptor tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERBB2 mRNA
CTD
PMID:15336504
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERBB4 mRNA
CTD
PMID:12419474
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Erbin
erbb2 interacting protein
multiple interactions increases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of ERBIN mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]
CTD
PMID:20847119
NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:34,928,863...35,027,852
G
Ercc5
ERCC excision repair 5, endonuclease
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERCC5 mRNA
CTD
PMID:12419474
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]
CTD
PMID:24394546
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Erp29
endoplasmic reticulum protein 29
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERP29 mRNA
CTD
PMID:15336504
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
G
Esm1
endothelial cell-specific molecule 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ESM1 mRNA
CTD
PMID:15336504
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
G
Ess2
ess-2 splicing factor homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ESS2 mRNA
CTD
PMID:15336504
NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846
G
Etf1
eukaryotic translation termination factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETF1 mRNA
CTD
PMID:15336504
NCBI chr18:26,502,413...26,530,753
Ensembl chr18:26,504,080...26,530,810
G
Etfa
electron transfer flavoprotein subunit alpha
multiple interactions decreases expression increases expression
ISO EXP
ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; pyrazolanthrone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ETFA protein] tert-Butylhydroperoxide results in decreased expression of ETFA protein
CTD
PMID:24394546
NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
G
Etfb
electron transfer flavoprotein subunit beta
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of ETFB mRNA tert-Butylhydroperoxide results in increased methylation of ETFB gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
G
Ets1
ETS proto-oncogene 1, transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETS1 mRNA
CTD
PMID:12419474
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Ets2
ETS proto-oncogene 2, transcription factor
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETS2 mRNA tert-Butylhydroperoxide results in increased expression of ETS2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Etv3
ETS variant transcription factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETV3 mRNA
CTD
PMID:12419474
NCBI chr 2:172,965,461...172,980,320
Ensembl chr 2:172,965,588...172,980,314
G
Etv4
ETS variant transcription factor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETV4 mRNA
CTD
PMID:15003993
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
G
Etv5
ETS variant transcription factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETV5 mRNA
CTD
PMID:15336504
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
G
Exo1
exonuclease 1
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]
CTD
PMID:35690295
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
Exoc7
exocyst complex component 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EXOC7 mRNA
CTD
PMID:15336504
NCBI chr10:101,521,630...101,540,425
Ensembl chr10:101,520,927...101,540,561
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EZH2 mRNA
CTD
PMID:15336504
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Ezr
ezrin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EZR mRNA
CTD
PMID:12419474
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F2rl1
F2R like trypsin receptor 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of F2RL1 mRNA
CTD
PMID:23410634
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
Fah
fumarylacetoacetate hydrolase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FAH protein
CTD
PMID:24394546
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fam110b
family with sequence similarity 110, member B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FAM110B mRNA
CTD
PMID:29432895
NCBI chr 5:18,789,362...18,929,647
Ensembl chr 5:18,789,389...18,929,828
G
Fam111a
FAM111 trypsin like peptidase A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM111A mRNA
CTD
PMID:15336504
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
G
Fam13b
family with sequence similarity 13, member B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM13B mRNA
CTD
PMID:15003993
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
G
Fam171a1
family with sequence similarity 171, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM171A1 mRNA
CTD
PMID:29432895
NCBI chr17:75,024,582...75,148,348
Ensembl chr17:75,024,575...75,150,255
G
Fam210a
family with sequence similarity 210, member A
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]
CTD
PMID:20847119
NCBI chr18:61,846,447...61,886,123
Ensembl chr18:61,852,907...61,886,171
G
Fanci
FA complementation group I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FANCI mRNA
CTD
PMID:15336504
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
G
Farp1
FERM, ARH/RhoGEF and pleckstrin domain protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FARP1 mRNA
CTD
PMID:15336504
NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299
G
Fas
Fas cell surface death receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FAS mRNA
CTD
PMID:12414654 PMID:27509014
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fastk
Fas-activated serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FASTK mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
G
Fbln1
fibulin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FBLN1 mRNA
CTD
PMID:15336504
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbxo30
F-box protein 30
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FBXO30 mRNA
CTD
PMID:23410634
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FDPS mRNA
CTD
PMID:15336504
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fdx1
ferredoxin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FDX1 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414
G
Fdxr
ferredoxin reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FDXR mRNA
CTD
PMID:12414654 PMID:27509014
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Fen1
flap structure-specific endonuclease 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FEN1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fermt2
FERM domain containing kindlin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FERMT2 mRNA
CTD
PMID:15336504
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
G
Fgg
fibrinogen gamma chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FGG mRNA
CTD
PMID:12414654
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Fh
fumarate hydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FH mRNA
CTD
PMID:15336504
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
G
Fhl1
four and a half LIM domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FHL1 mRNA
CTD
PMID:15336504
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
G
Fhl2
four and a half LIM domains 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FHL2 mRNA
CTD
PMID:15336504
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
G
Fhod3
formin homology 2 domain containing 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FHOD3 mRNA
CTD
PMID:15336504
NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796
G
Fibp
FGF1 intracellular binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FIBP mRNA
CTD
PMID:15336504
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
G
Fis1
fission, mitochondrial 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FIS1 mRNA
CTD
PMID:15336504
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
G
Fjx1
four-jointed box kinase 1
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA]
CTD
PMID:20847119
NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:88,774,220...88,776,321
G
Fkbp1a
FKBP prolyl isomerase 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FKBP1A mRNA
CTD
PMID:15336504
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
G
Fkbp8
FKBP prolyl isomerase 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FKBP8 mRNA
CTD
PMID:15336504
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
G
Flnb
filamin B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FLNB mRNA
CTD
PMID:15336504
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FMO1 mRNA
CTD
PMID:12419474
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fn1
fibronectin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FN1 mRNA
CTD
PMID:15963989
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Folr1
folate receptor alpha
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of FOLR1 mRNA tert-Butylhydroperoxide results in decreased expression of FOLR1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:22956110
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression increases methylation increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of FOS mRNA tert-Butylhydroperoxide results in increased methylation of FOS gene tert-Butylhydroperoxide results in increased expression of FOS mRNA CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]
CTD
PMID:12419474 PMID:15105052 PMID:27509014
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FOSL1 mRNA
CTD
PMID:15336504
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Foxd1
forkhead box D1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FOXD1 mRNA tert-Butylhydroperoxide results in increased expression of FOXD1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 2:29,702,558...29,704,978
Ensembl chr 2:29,702,558...29,704,978
G
Foxm1
forkhead box M1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FOXM1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Ftl1
ferritin light chain 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FTL mRNA
CTD
PMID:12414654 PMID:15963989
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
Fubp1
far upstream element binding protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FUBP1 mRNA
CTD
PMID:15336504
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
Fxyd5
FXYD domain-containing ion transport regulator 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FYCO1 mRNA
CTD
PMID:15336504
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
G
Fzd1
frizzled class receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FZD1 mRNA
CTD
PMID:29432895
NCBI chr 4:29,310,303...29,314,701
Ensembl chr 4:29,310,091...29,312,643 Ensembl chr 4:29,310,091...29,312,643
G
Fzr1
fizzy and cell division cycle 20 related 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FZR1 mRNA
CTD
PMID:15336504
NCBI chr 7:8,332,029...8,343,953
Ensembl chr 7:8,332,029...8,343,952
G
G0s2
G0/G1switch 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of G0S2 mRNA
CTD
PMID:15336504
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G6pd
glucose-6-phosphate dehydrogenase
decreases activity increases activity
ISO EXP
tert-Butylhydroperoxide results in decreased activity of G6PD protein tert-Butylhydroperoxide results in increased activity of G6PD protein
CTD
PMID:12628296 PMID:15336504 PMID:16928893
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of GADD45B mRNA tert-Butylhydroperoxide affects the expression of GADD45B mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gak
cyclin G associated kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GAK mRNA
CTD
PMID:12419474
NCBI chr14:1,089,853...1,164,098
Ensembl chr14:1,089,866...1,216,398
G
Galm
galactose mutarotase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALM mRNA
CTD
PMID:15003993
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
G
Galns
galactosamine (N-acetyl)-6-sulfatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GALNS mRNA
CTD
PMID:15336504
NCBI chr19:50,628,639...50,662,477
Ensembl chr19:50,628,552...50,662,246
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALNT1 mRNA
CTD
PMID:15336504
NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
G
Galnt3
polypeptide N-acetylgalactosaminyltransferase 3
increases methylation decreases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of GALNT3 intron tert-Butylhydroperoxide results in decreased methylation of GALNT3 intron
CTD
PMID:29432895
NCBI chr 3:50,742,500...50,779,266
Ensembl chr 3:50,742,512...50,766,268
G
Galnt6
polypeptide N-acetylgalactosaminyltransferase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALNT6 mRNA
CTD
PMID:15336504
NCBI chr 7:131,789,836...131,828,077
Ensembl chr 7:131,789,839...131,819,661
G
Ganab
glucosidase II alpha subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GANAB mRNA
CTD
PMID:15336504
NCBI chr 1:205,793,910...205,813,704
Ensembl chr 1:205,793,895...205,813,695
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GAPDH protein
CTD
PMID:11295360
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GARS1 mRNA
CTD
PMID:15003993
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GAS2 mRNA
CTD
PMID:14729362
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gas2l1
growth arrest-specific 2 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GAS2L1 mRNA
CTD
PMID:29432895
NCBI chr14:79,955,350...79,961,830
Ensembl chr14:79,950,555...79,961,438
G
Gata6
GATA binding protein 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GATA6 mRNA
CTD
PMID:15336504
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
G
Gatd3a
glutamine amidotransferase class 1 domain containing 3A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GATD3 mRNA
CTD
PMID:15336504
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
G
Gbp2
guanylate binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gbp4
guanylate binding protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gbp6
guanylate binding protein family member 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP6 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gchfr
GTP cyclohydrolase I feedback regulator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GCHFR mRNA
CTD
PMID:15336504
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions decreases expression increases expression decreases response to substance
ISO EXP
[Linoleic Acids, Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of GCLC mRNA tert-Butylhydroperoxide results in increased expression of GCLC mRNA [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide GCLC protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:12425961 PMID:17092368 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568 More...
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions increases expression
EXP ISO
[Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLM mRNA
CTD
PMID:12414654 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GCNT1 mRNA
CTD
PMID:15336504
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GCNT3 mRNA
CTD
PMID:23410634
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gdf15
growth differentiation factor 15
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GDF15 mRNA
CTD
PMID:12414654
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gdpd5
glycerophosphodiester phosphodiesterase domain containing 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of GDPD5 mRNA
CTD
PMID:23410634
NCBI chr 1:153,679,718...153,761,452
Ensembl chr 1:153,679,718...153,761,446
G
Gem
GTP binding protein overexpressed in skeletal muscle
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GEM mRNA]
CTD
PMID:20847119
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
G
Gemin4
gem (nuclear organelle) associated protein 4
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of GEMIN4 mRNA]
CTD
PMID:20847119
NCBI chr10:61,062,420...61,073,529
Ensembl chr10:61,066,425...61,073,431 Ensembl chr10:61,066,425...61,073,431
G
Gfap
glial fibrillary acidic protein
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GFAP protein tert-Butylhydroperoxide results in increased expression of GFAP protein
CTD
PMID:24394546
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gfer
growth factor, augmenter of liver regeneration
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GFER mRNA
CTD
PMID:15336504
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GFPT2 mRNA
CTD
PMID:15336504
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
G
Gfra1
GDNF family receptor alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GFRA1 mRNA
CTD
PMID:15336504
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Gins2
GINS complex subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GINS2 mRNA
CTD
PMID:15336504
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
G
Gja1
gap junction protein, alpha 1
decreases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in decreased expression of GJA1 mRNA; tert-Butylhydroperoxide results in decreased expression of GJA1 protein GJA1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15336504 PMID:18235030
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gjb2
gap junction protein, beta 2
decreases response to substance
ISO
GJB2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:18235030
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gla
galactosidase, alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLA mRNA
CTD
PMID:14729362
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
G
Glg1
golgi glycoprotein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GLG1 mRNA
CTD
PMID:15336504
NCBI chr19:39,124,892...39,224,178
Ensembl chr19:39,124,641...39,224,178
G
Glipr1
GLI pathogenesis-related 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLIPR1 mRNA
CTD
PMID:15336504
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Glod4
glyoxalase domain containing 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLOD4 mRNA
CTD
PMID:15003993
NCBI chr10:61,077,535...61,095,876
Ensembl chr10:61,066,421...61,095,898
G
Glrx
glutaredoxin
multiple interactions increases expression
EXP ISO
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] tert-Butylhydroperoxide results in increased expression of GLRX mRNA
CTD
PMID:12414654 PMID:12680778
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glrx3
glutaredoxin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLRX3 mRNA
CTD
PMID:15336504
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
G
Glyr1
glyoxylate reductase 1 homolog
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GLYR1 mRNA
CTD
PMID:15336504
NCBI chr10:10,532,036...10,567,639
Ensembl chr10:10,532,154...10,567,637
G
Gmpr2
guanosine monophosphate reductase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GMPR2 mRNA
CTD
PMID:15336504
NCBI chr15:29,165,421...29,175,933
Ensembl chr15:29,165,783...29,174,935
G
Gna11
G protein subunit alpha 11
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of GNA11 mRNA tert-Butylhydroperoxide results in decreased expression of GNA11 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:8,163,520...8,177,863
Ensembl chr 7:8,162,750...8,179,812
G
Gnai1
G protein subunit alpha i1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of GNAI1 mRNA
CTD
PMID:23410634
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnas
GNAS complex locus
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNAS mRNA
CTD
PMID:12419474
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnb5
G protein subunit beta 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNB5 mRNA
CTD
PMID:15336504
NCBI chr 8:76,076,120...76,105,069
Ensembl chr 8:76,073,306...76,105,069
G
Gnpnat1
glucosamine-phosphate N-acetyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNPNAT1 mRNA
CTD
PMID:15003993
NCBI chr15:18,596,180...18,608,854
Ensembl chr15:18,596,442...18,608,739
G
Gns
glucosamine (N-acetyl)-6-sulfatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNS mRNA
CTD
PMID:15336504
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
G
Gosr2
golgi SNAP receptor complex member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GOSR2 mRNA
CTD
PMID:15003993
NCBI chr10:88,585,291...88,605,642
Ensembl chr10:88,586,299...88,605,625
G
Got1
glutamic-oxaloacetic transaminase 1
multiple interactions increases expression increases activity
EXP
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GOT1 protein]
CTD
PMID:15095147 PMID:15212457 PMID:15645217
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gpat3
glycerol-3-phosphate acyltransferase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPAT3 mRNA
CTD
PMID:23410634
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpc1
glypican 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPC1 mRNA
CTD
PMID:15003993
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
G
Gper1
G protein-coupled estrogen receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPER1 mRNA
CTD
PMID:15336504
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
G
Gpi
glucose-6-phosphate isomerase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPI1 mRNA
CTD
PMID:15003993
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
G
Gpnmb
glycoprotein nmb
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPNMB mRNA
CTD
PMID:15336504
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr107
G protein-coupled receptor 107
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPR107 mRNA
CTD
PMID:15336504
NCBI chr 3:14,431,704...14,497,623
Ensembl chr 3:14,434,723...14,495,958
G
Gpr161
G protein-coupled receptor 161
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPR161 mRNA
CTD
PMID:15336504
NCBI chr13:77,578,257...77,623,661
Ensembl chr13:77,577,739...77,619,613
G
Gpr4
G protein-coupled receptor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPR4 mRNA
CTD
PMID:15336504
NCBI chr 1:78,865,376...78,877,126
Ensembl chr 1:78,865,409...78,876,599
G
Gprc5b
G protein-coupled receptor, class C, group 5, member B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPRC5B mRNA
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932
G
Gpsm2
G-protein signaling modulator 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPSM2 mRNA
CTD
PMID:15336504
NCBI chr 2:196,327,149...196,375,322
Ensembl chr 2:196,327,149...196,375,154
G
Gpsm3
G-protein signaling modulator 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPSM3 mRNA
CTD
PMID:15336504
NCBI chr20:4,157,123...4,158,984
Ensembl chr20:4,157,123...4,159,035
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases activity increases expression
EXP ISO
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GPT protein] rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]
CTD
PMID:15015760 PMID:15095147 PMID:15212457 PMID:15645217 PMID:28025122
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
increases reduction increases expression increases response to substance decreases response to substance
ISO EXP
GPX1 protein results in increased reduction of tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GPX1 mRNA GPX1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide GPX1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:8428933 PMID:9741587 PMID:15182862 PMID:19720132
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases reduction increases expression decreases expression
ISO
GPX2 protein results in increased reduction of tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GPX2 mRNA tert-Butylhydroperoxide results in decreased expression of GPX2 mRNA
CTD
PMID:8428933 PMID:10806356 PMID:12414654 PMID:12419474
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gpx4
glutathione peroxidase 4
multiple interactions decreases response to substance increases response to substance
ISO
GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] GPX4 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX4 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:12566075 PMID:15496407
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Grb2
growth factor receptor bound protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRB2 mRNA
CTD
PMID:15336504
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
G
Grem1
gremlin 1, DAN family BMP antagonist
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GREM1 mRNA
CTD
PMID:15336504
NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082
G
Grhpr
glyoxylate and hydroxypyruvate reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRHPR mRNA
CTD
PMID:15003993
NCBI chr 5:59,234,179...59,243,614
Ensembl chr 5:59,234,192...59,243,603
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRIN2C mRNA
CTD
PMID:12414654
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
G
Grpel1
GrpE-like 1, mitochondrial
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRPEL1 mRNA
CTD
PMID:15336504
NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200
G
Gsk3b
glycogen synthase kinase 3 beta
increases expression decreases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of GSK3B mRNA tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein]
CTD
PMID:15336504 PMID:29128606
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSN mRNA
CTD
PMID:15003993
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gspt1
G1 to S phase transition 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSPT1 mRNA
CTD
PMID:15336504
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
G
Gspt2
G1 to S phase transition 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSPT2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr X:59,587,237...59,589,758
Ensembl chr X:59,587,276...59,594,162
G
Gsr
glutathione-disulfide reductase
multiple interactions increases expression decreases methylation increases activity decreases activity decreases expression
ISO EXP
Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GSR protein] tert-Butylhydroperoxide results in increased expression of GSR mRNA tert-Butylhydroperoxide results in decreased methylation of GSR gene tert-Butylhydroperoxide results in decreased activity of GSR protein Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of GSR protein] tert-Butylhydroperoxide results in decreased expression of GSR mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15212457 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16928893 PMID:17427263 PMID:23410634 PMID:27509014 More...
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta2
glutathione S-transferase alpha 2
increases metabolic processing decreases metabolic processing
ISO
GSTA2 protein results in increased metabolism of tert-Butylhydroperoxide GSTA2 protein polymorphism results in decreased metabolism of tert-Butylhydroperoxide
CTD
PMID:3138230 PMID:15128049
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta4
glutathione S-transferase alpha 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTA4 mRNA
CTD
PMID:15336504 PMID:31627909
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Gstk1
glutathione S-transferase kappa 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTK1 mRNA
CTD
PMID:15336504
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
G
Gstm2
glutathione S-transferase mu 2
decreases expression decreases response to substance increases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in decreased expression of GSTM2 protein GSTM2 protein results in decreased susceptibility to tert-Butylhydroperoxide; GSTM5 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in increased expression of GSTM5 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:24394546
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstm4
glutathione S-transferase mu 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTM4 mRNA
CTD
PMID:15336504
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
G
Gstp1
glutathione S-transferase pi 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA
CTD
PMID:15336504
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
affects metabolic processing
ISO
GSTT1 protein affects the metabolism of tert-Butylhydroperoxide
CTD
PMID:9854036
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gstz1
glutathione S-transferase zeta 1
affects metabolic processing
ISO
GSTZ1 protein affects the metabolism of tert-Butylhydroperoxide
CTD
PMID:9396740
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
G
Gtf2f1
general transcription factor IIF subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2F1 mRNA
CTD
PMID:15336504
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
G
Gtf2i
general transcription factor II I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2I mRNA
CTD
PMID:15336504
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
G
Gtf2ird1
GTF2I repeat domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2IRD1 mRNA
CTD
PMID:15336504
NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
G
Gtf3a
general transcription factor III A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF3A mRNA
CTD
PMID:15336504
NCBI chr12:8,136,746...8,144,690
Ensembl chr12:8,136,747...8,144,690
G
Gulp1
GULP PTB domain containing engulfment adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GULP1 mRNA
CTD
PMID:15336504
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
G
Gusb
glucuronidase, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GUSB mRNA
CTD
PMID:15336504
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
Gys1
glycogen synthase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GYS1 mRNA
CTD
PMID:15003993
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
G
H1f10
H1.10 linker histone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of H1-10 mRNA
CTD
PMID:15336504
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
G
H2ax
H2A.X variant histone
decreases expression increases phosphorylation
ISO
tert-Butylhydroperoxide results in decreased expression of H2AX mRNA tert-Butylhydroperoxide results in increased phosphorylation of H2AX protein
CTD
PMID:15336504 PMID:33207735
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H2az2
H2A.Z variant histone 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of H2AZ2 mRNA
CTD
PMID:15336504
NCBI chr14:81,293,304...81,312,209
Ensembl chr14:81,293,299...81,312,144
G
H2bc12
H2B clustered histone 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2BC12 mRNA
CTD
PMID:15336504
NCBI chr17:42,485,699...42,486,162
G
H3f4
H3.4 histone, cluster member
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of H3-4 mRNA tert-Butylhydroperoxide results in increased methylation of H3-4 gene
CTD
PMID:27509014
NCBI chr10:43,740,702...43,741,262
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
increases activity increases expression
ISO
tert-Butylhydroperoxide results in increased activity of H6PD protein tert-Butylhydroperoxide results in increased expression of H6PD mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HADH mRNA
CTD
PMID:15336504
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hamp
hepcidin antimicrobial peptide
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HAMP mRNA
CTD
PMID:23410634
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Has2
hyaluronan synthase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HAS2 mRNA
CTD
PMID:15336504
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
G
Haus7
HAUS augmin-like complex, subunit 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HAUS7 mRNA
CTD
PMID:15336504
NCBI chr X:151,154,979...151,174,441
Ensembl chr X:151,154,979...151,180,577
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HBEGF mRNA
CTD
PMID:12419474
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hbp1
HMG-box transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HBP1 mRNA
CTD
PMID:15336504
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
G
Hdac1
histone deacetylase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HDAC1 mRNA
CTD
PMID:12419474
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
G
Hdac11
histone deacetylase 11
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HDAC11 mRNA
CTD
PMID:23410634
NCBI chr 4:123,645,873...123,667,407
Ensembl chr 4:123,650,157...123,667,405
G
Hdac7
histone deacetylase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HDAC7 mRNA
CTD
PMID:15003993
NCBI chr 7:128,923,918...128,961,926
Ensembl chr 7:128,923,920...128,962,072
G
Heatr1
HEAT repeat containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HEATR1 mRNA
CTD
PMID:15336504
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
G
Heg1
heart development protein with EGF-like domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HEG1 mRNA
CTD
PMID:15336504
NCBI chr11:67,006,954...67,095,020
Ensembl chr11:66,957,190...67,095,051
G
Heph
hephaestin
decreases response to substance increases expression decreases expression
ISO
HEPH protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of HEPH mRNA tert-Butylhydroperoxide results in decreased expression of HEPH mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
G
Hes1
hes family bHLH transcription factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HES1 mRNA
CTD
PMID:15336504
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hes6
hes family bHLH transcription factor 6
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HES6 mRNA
CTD
PMID:23410634
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
G
Hgfac
HGF activator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HGFAC mRNA
CTD
PMID:12419474
NCBI chr14:75,707,588...75,714,182
Ensembl chr14:75,707,591...75,714,278
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA; [HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA]
CTD
PMID:15611089 PMID:35690295
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hikeshi
heat shock protein nuclear import factor hikeshi
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HIKESHI mRNA
CTD
PMID:15003993
NCBI chr 1:143,825,399...143,849,361
Ensembl chr 1:143,825,923...143,849,363
G
Hilpda
hypoxia inducible lipid droplet-associated
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]
CTD
PMID:20847119
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hist1h2bd
histone cluster 1 H2B family member D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2BC5 mRNA
CTD
PMID:15336504
NCBI chr17:42,792,887...42,793,268
G
Hivep1
HIVEP zinc finger 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HIVEP1 mRNA
CTD
PMID:15003993
NCBI chr17:22,585,016...22,714,517
Ensembl chr17:22,585,016...22,711,956
G
Hk1
hexokinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HK1 mRNA
CTD
PMID:15336504
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
G
Hmga1
high mobility group AT-hook 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HMGA1 mRNA tert-Butylhydroperoxide results in increased expression of HMGA1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmga2
high mobility group AT-hook 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGA2 mRNA
CTD
PMID:14729362
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb1
high mobility group box 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HMGB1 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGCR mRNA
CTD
PMID:12414654
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgn5
high mobility group nucleosome binding domain 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGN5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
G
Hmox1
heme oxygenase 1
decreases response to substance affects expression increases expression decreases expression multiple interactions
ISO EXP
HMOX1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide affects the expression of HMOX1 mRNA tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in increased expression of HMOX1 protein tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in decreased expression of HMOX1 protein [Biological Products results in increased expression of HMOX1 protein] inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; [Biological Products results in increased expression of HMOX1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA] [Apigenin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [chrysin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]
CTD
PMID:12414654 PMID:15336504 PMID:15589375 PMID:16636651 PMID:17295091 PMID:18812229 PMID:22864849 PMID:22954530 PMID:23266269 PMID:27050144 PMID:27509014 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135 More...
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hmox2
heme oxygenase 2
decreases response to substance increases methylation decreases expression
ISO
HMOX2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased methylation of HMOX2 gene tert-Butylhydroperoxide results in decreased expression of HMOX2 mRNA
CTD
PMID:15589375 PMID:27509014
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
G
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HNRNPA3 mRNA
CTD
PMID:15336504
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
multiple interactions increases expression decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of HNRNPDL mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA] tert-Butylhydroperoxide results in decreased expression of HNRNPDL mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hook2
hook microtubule-tethering protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HOOK2 mRNA
CTD
PMID:15336504
NCBI chr19:23,151,869...23,170,139
Ensembl chr19:23,151,870...23,164,181
G
Hoxd1
homeo box D1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HOXD1 mRNA
CTD
PMID:23410634
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
G
Hp1bp3
heterochromatin protein 1, binding protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HP1BP3 mRNA
CTD
PMID:15336504
NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:150,433,740...150,463,000
G
Hps1
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HPS1 mRNA
CTD
PMID:15336504
NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268
G
Hs3st3a1
heparan sulfate-glucosamine 3-sulfotransferase 3A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HS3ST3A1 mRNA
CTD
PMID:15336504
NCBI chr10:49,092,850...49,180,676
Ensembl chr10:49,094,026...49,180,676
G
Hsbp1
heat shock factor binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSBP1 mRNA
CTD
PMID:15336504
NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
multiple interactions decreases expression
ISO
Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]
CTD
PMID:29935159
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HSD11B2 mRNA
CTD
PMID:23410634
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD17B10 mRNA
CTD
PMID:15003993
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
G
Hsd17b11
hydroxysteroid (17-beta) dehydrogenase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSD17B11 mRNA
CTD
PMID:15336504
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD17B2 mRNA
CTD
PMID:15003993
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd3b7
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD3B7 mRNA
CTD
PMID:15003993
NCBI chr 1:182,412,216...182,415,447
Ensembl chr 1:182,412,151...182,415,442
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSP90AA1 mRNA
CTD
PMID:15336504
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa13
heat shock protein family A (Hsp70) member 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPA13 mRNA
CTD
PMID:12419474
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA1A mRNA
CTD
PMID:12414654
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA1B mRNA
CTD
PMID:12414654
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]
CTD
PMID:20847119
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
G
Hspa2
heat shock protein family A (Hsp70) member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPA2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa4
heat shock protein family A (Hsp70) member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA4 mRNA
CTD
PMID:15336504
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA5 mRNA
CTD
PMID:12766906
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HSPA6 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]
CTD
PMID:12414654 PMID:35690295
NCBI chr13:83,273,176...83,274,317
G
Hspb1
heat shock protein family B (small) member 1
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPB1 protein tert-Butylhydroperoxide results in decreased expression of HSPB1 mRNA
CTD
PMID:11295360 PMID:15336504
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Hspb2
heat shock protein family B (small) member 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPB2 mRNA tert-Butylhydroperoxide results in increased expression of HSPB2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 8:51,093,267...51,094,528
Ensembl chr 8:51,081,342...51,094,533
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPB8 mRNA
CTD
PMID:14729362
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HSPD1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Hsph1
heat shock protein family H (Hsp110) member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPH1 mRNA
CTD
PMID:15336504
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HTATIP2 mRNA
CTD
PMID:15336504
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Htra1
HtrA serine peptidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HTRA1 mRNA
CTD
PMID:15336504
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Icam1
intercellular adhesion molecule 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]
CTD
PMID:15336504 PMID:28063877
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icmt
isoprenylcysteine carboxyl methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ICMT mRNA
CTD
PMID:15336504
NCBI chr 5:162,804,368...162,811,129
Ensembl chr 5:162,804,368...162,811,128
G
Id1
inhibitor of DNA binding 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ID1 mRNA tert-Butylhydroperoxide results in increased expression of ID1 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id2
inhibitor of DNA binding 2
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:20847119
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Id3
inhibitor of DNA binding 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ID3 mRNA
CTD
PMID:15003993
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of IDH1 protein
CTD
PMID:16928893
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
decreases activity multiple interactions
ISO
tert-Butylhydroperoxide results in decreased activity of IDH2 protein Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]; SIRT3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
CTD
PMID:25522270
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ier2
immediate early response 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IER2 mRNA
CTD
PMID:15336504
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
G
Ier3
immediate early response 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IER3 mRNA tert-Butylhydroperoxide results in increased expression of IER3 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifi27
interferon, alpha-inducible protein 27
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFI27 mRNA tert-Butylhydroperoxide results in decreased expression of IFI27 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Ifi35
interferon-induced protein 35
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFI35 mRNA
CTD
PMID:15336504
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifih1
interferon induced with helicase C domain 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFIH1 mRNA tert-Butylhydroperoxide results in increased expression of IFIH1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit1
interferon-induced protein with tetratricopeptide repeats 1
decreases response to substance increases expression
ISO
IFIT1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of IFIT1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 1:232,152,038...232,154,103
Ensembl chr 1:232,127,170...232,154,435
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFIT3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm1
interferon induced transmembrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFITM1 mRNA
CTD
PMID:15336504
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm2
interferon induced transmembrane protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFITM2 mRNA
CTD
PMID:15336504
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFITM3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ift122
intraflagellar transport 122
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFT122 mRNA
CTD
PMID:15336504
NCBI chr 4:148,905,031...148,975,458
Ensembl chr 4:148,905,046...148,975,458
G
Igf1
insulin-like growth factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IGF1 mRNA
CTD
PMID:22659508
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGF1R mRNA
CTD
PMID:12419474
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGF2BP1 mRNA
CTD
PMID:14729362
NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP2 mRNA
CTD
PMID:15336504
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP3 mRNA tert-Butylhydroperoxide results in increased expression of IGFBP3 mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Igfbp4
insulin-like growth factor binding protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGFBP4 mRNA
CTD
PMID:15336504
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGFBP5 mRNA
CTD
PMID:12414654
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Igfbp6
insulin-like growth factor binding protein 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP6 mRNA tert-Butylhydroperoxide results in increased expression of IGFBP6 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
G
Igsf8
immunoglobulin superfamily, member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGSF8 mRNA
CTD
PMID:14729362
NCBI chr13:84,770,348...84,781,534
Ensembl chr13:84,770,279...84,778,576
G
Il11
interleukin 11
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of IL11 mRNA; tert-Butylhydroperoxide results in increased expression of IL11 protein tert-Butylhydroperoxide affects the expression of IL11 mRNA
CTD
PMID:15336504 PMID:17295091 PMID:23410634
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Il15
interleukin 15
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL15 mRNA
CTD
PMID:15336504
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
multiple interactions increases secretion increases expression
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]; tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] tert-Butylhydroperoxide results in increased expression of IL1B mRNA; tert-Butylhydroperoxide results in increased expression of IL1B protein
CTD
PMID:15336504 PMID:15705740 PMID:28063877 PMID:29111459
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il3
interleukin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL3 mRNA
CTD
PMID:12419474
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il4r
interleukin 4 receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IL4R mRNA
CTD
PMID:15336504
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of IL6 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]
CTD
PMID:15336504 PMID:28063877 PMID:29111459
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL6ST mRNA
CTD
PMID:12419474
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Il9
interleukin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL9 mRNA
CTD
PMID:12419474
NCBI chr17:8,111,772...8,114,895
Ensembl chr17:8,111,772...8,114,895
G
Ilf3
interleukin enhancer binding factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ILF3 mRNA
CTD
PMID:15336504
NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350
G
Ilvbl
ilvB acetolactate synthase like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ILVBL mRNA
CTD
PMID:15336504
NCBI chr 7:11,039,870...11,049,924
Ensembl chr 7:11,039,871...11,049,924
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IMPA2 mRNA
CTD
PMID:15336504
NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641
G
Ing1
inhibitor of growth family, member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ING1 mRNA
CTD
PMID:15336504
NCBI chr16:77,937,276...77,945,320
Ensembl chr16:77,937,279...77,946,264
G
Ing3
inhibitor of growth family, member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ING3 mRNA
CTD
PMID:15336504
NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
G
Inhba
inhibin subunit beta A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of INHBA mRNA
CTD
PMID:15336504
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Inhbb
inhibin subunit beta B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of INHBB mRNA
CTD
PMID:12414654
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Inpp5b
inositol polyphosphate-5-phosphatase B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of INPP5B mRNA
CTD
PMID:15336504
NCBI chr 5:136,996,766...137,061,315
Ensembl chr 5:136,996,686...137,061,315
G
Insig1
insulin induced gene 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of INSIG1 mRNA
CTD
PMID:15336504
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Ints7
integrator complex subunit 7
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of INTS7 gene
CTD
PMID:29432895
NCBI chr13:103,155,123...103,207,953
Ensembl chr13:103,155,090...103,208,592
G
Ipo4
importin 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IPO4 mRNA
CTD
PMID:15336504
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
G
Ipo9
importin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IPO9 mRNA
CTD
PMID:15336504
NCBI chr13:46,810,460...46,862,694
Ensembl chr13:46,813,171...46,862,673
G
Irf1
interferon regulatory factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF1 mRNA
CTD
PMID:15003993
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Irf7
interferon regulatory factor 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF7 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irf9
interferon regulatory factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF9 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
G
Irgm
immunity-related GTPase M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRGM mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Isg15
ISG15 ubiquitin-like modifier
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ISG15 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ISG20 mRNA
CTD
PMID:15336504
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itch
itchy E3 ubiquitin protein ligase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITCH mRNA
CTD
PMID:15336504
NCBI chr 3:143,642,348...143,733,745
Ensembl chr 3:143,645,637...143,733,543
G
Itga2
integrin subunit alpha 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA2 mRNA
CTD
PMID:12766906
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itga3
integrin subunit alpha 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Itga4
integrin subunit alpha 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA4 mRNA
CTD
PMID:15336504
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itga5
integrin subunit alpha 5
decreases expression increases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ITGA5 mRNA tert-Butylhydroperoxide results in increased expression of ITGA5 mRNA
CTD
PMID:12419474 PMID:22659508
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
G
Itga6
integrin subunit alpha 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGA6 mRNA tert-Butylhydroperoxide results in increased expression of ITGA6 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
G
Itga7
integrin subunit alpha 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGA7 mRNA
CTD
PMID:15336504
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
G
Itgal
integrin subunit alpha L
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGAL mRNA
CTD
PMID:12419474
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
G
Itgav
integrin subunit alpha V
multiple interactions increases expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ITGAV mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]
CTD
PMID:20847119
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Itgb3
integrin subunit beta 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITGB3 mRNA
CTD
PMID:22659508
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Itgb4
integrin subunit beta 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB4 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
G
Itgb5
integrin subunit beta 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB5 mRNA
CTD
PMID:12419474
NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472
G
Itgb6
integrin subunit beta 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB6 mRNA
CTD
PMID:12419474
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
G
Itm2b
integral membrane protein 2B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITM2B mRNA
CTD
PMID:15336504
NCBI chr15:48,545,998...48,568,904
Ensembl chr15:48,546,001...48,568,917
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ITPR3 mRNA
CTD
PMID:23410634
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
G
Itsn1
intersectin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITSN1 mRNA
CTD
PMID:12419474
NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645
G
Jak2
Janus kinase 2
decreases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in decreased phosphorylation of JAK2 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of JAK2 protein]
CTD
PMID:29128606
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jam3
junctional adhesion molecule 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of JAM3 mRNA
CTD
PMID:14729362
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Jmjd6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of JMJD6 mRNA tert-Butylhydroperoxide results in decreased methylation of JMJD6 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
G
Jpt2
Jupiter microtubule associated homolog 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JPT2 mRNA
CTD
PMID:15336504
NCBI chr10:13,963,135...13,983,212
Ensembl chr10:13,963,137...13,983,170
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]
CTD
PMID:12414654 PMID:15105052 PMID:15336504 PMID:27509014
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JUND mRNA
CTD
PMID:12419474
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Jup
junction plakoglobin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JUP mRNA
CTD
PMID:15336504
NCBI chr10:85,300,438...85,327,378
Ensembl chr10:85,300,440...85,327,057
G
Kank1
KN motif and ankyrin repeat domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KANK1 mRNA
CTD
PMID:15336504
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
G
Kank2
KN motif and ankyrin repeat domains 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KANK2 mRNA
CTD
PMID:15336504
NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900
G
Kat2a
lysine acetyltransferase 2A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KAT2A mRNA
CTD
PMID:23410634
NCBI chr10:85,632,216...85,640,561
Ensembl chr10:85,632,216...85,640,166
G
Kcnab2
potassium voltage-gated channel subfamily A regulatory beta subunit 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KCNAB2 mRNA
CTD
PMID:15003993
NCBI chr 5:162,899,511...162,988,057
Ensembl chr 5:162,901,896...162,988,243
G
Kcnb2
potassium voltage-gated channel subfamily B member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KCNB2 mRNA
CTD
PMID:15336504
NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599
G
Kcnj1
potassium inwardly-rectifying channel, subfamily J, member 1
decreases response to substance
EXP
KCNJ1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:22811560
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KCNN4 mRNA
CTD
PMID:15003993
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Kctd21
potassium channel tetramerization domain containing 21
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KCTD21 mRNA
CTD
PMID:23410634
NCBI chr 1:151,650,074...151,669,775
Ensembl chr 1:151,650,104...151,667,645
G
Kdelr3
KDEL endoplasmic reticulum protein retention receptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KDELR3 mRNA
CTD
PMID:15336504
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600
G
Kdm3a
lysine demethylase 3A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KDM3A mRNA
CTD
PMID:23410634
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
G
Kdsr
3-ketodihydrosphingosine reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KDSR mRNA
CTD
PMID:15336504
NCBI chr13:22,862,117...22,894,118
Ensembl chr13:22,862,117...22,894,108
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions increases expression
ISO
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein]
CTD
PMID:27050144
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Khnyn
KH and NYN domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KHNYN mRNA
CTD
PMID:15336504
NCBI chr15:29,365,399...29,379,650
Ensembl chr15:29,365,260...29,376,967
G
Kif15
kinesin family member 15
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of KIF15 mRNA tert-Butylhydroperoxide affects the expression of KIF15 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Kif20a
kinesin family member 20A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF20A mRNA
CTD
PMID:15003993
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif23
kinesin family member 23
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KIF23 mRNA
CTD
PMID:23410634
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif2c
kinesin family member 2C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF2C mRNA
CTD
PMID:15003993
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Kif4a
kinesin family member 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF4 mRNA
CTD
PMID:15003993
NCBI chr X:65,721,746...65,824,277
Ensembl chr X:65,721,779...65,824,139
G
Kif5c
kinesin family member 5C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF5C mRNA
CTD
PMID:15336504
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
G
Kifbp
kinesin family binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIFBP mRNA
CTD
PMID:15336504
NCBI chr20:30,512,899...30,532,504
Ensembl chr20:30,512,901...30,532,476
G
Kifc1
kinesin family member C1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KIFC1 mRNA
CTD
PMID:15336504
NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105
G
Kiss1r
KISS1 receptor
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KISS1R mRNA
CTD
PMID:23410634
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
G
Klf10
KLF transcription factor 10
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KLF10 mRNA
CTD
PMID:23410634
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
G
Klf2
KLF transcription factor 2
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]
CTD
PMID:20847119
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
G
Klf9
KLF transcription factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KLF9 mRNA
CTD
PMID:15336504
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
G
Klhdc3
kelch domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KLHDC3 mRNA
CTD
PMID:15336504
NCBI chr 9:14,302,345...14,308,736
Ensembl chr 9:14,302,354...14,308,736
G
Kmt2d
lysine methyltransferase 2D
decreases methylation decreases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of KMT2D gene tert-Butylhydroperoxide results in decreased expression of KMT2D mRNA
CTD
PMID:27509014
NCBI chr 7:129,980,744...130,022,088
Ensembl chr 7:129,962,887...130,020,325
G
Kmt5b
lysine methyltransferase 5B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KMT5B mRNA
CTD
PMID:15336504
NCBI chr 1:201,000,444...201,049,819
Ensembl chr 1:201,000,444...201,049,819
G
Kntc1
kinetochore associated 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KNTC1 mRNA
CTD
PMID:15336504
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
G
Kpnb1
karyopherin subunit beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KPNB1 mRNA
CTD
PMID:15336504
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
G
Ktn1
kinectin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KTN1 mRNA
CTD
PMID:15336504
NCBI chr15:20,913,665...21,002,588
Ensembl chr15:20,914,642...21,002,578
G
Lair1
leukocyte-associated immunoglobulin-like receptor 1
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LAIR1 intron
CTD
PMID:29432895
NCBI chr 1:70,068,571...70,187,851
Ensembl chr 1:70,157,681...70,185,807
G
Lama5
laminin subunit alpha 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LAMA5 mRNA
CTD
PMID:15336504
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
G
Lamb1
laminin subunit beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LAMB1 mRNA
CTD
PMID:15336504
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
G
Lamb3
laminin subunit beta 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAMB3 mRNA
CTD
PMID:15336504
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
G
Lamc2
laminin subunit gamma 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAMC2 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Laptm5
lysosomal protein transmembrane 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAPTM5 mRNA
CTD
PMID:15336504
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
G
Lat
linker for activation of T cells
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LAT mRNA
CTD
PMID:22659508
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
G
Lbr
lamin B receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LBR mRNA
CTD
PMID:12414654
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
G
Lcat
lecithin cholesterol acyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LCAT mRNA
CTD
PMID:12419474
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lcn2
lipocalin 2
decreases secretion
ISO
tert-Butylhydroperoxide results in decreased secretion of LCN2 protein
CTD
PMID:27888128
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lcp1
lymphocyte cytosolic protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LCP1 mRNA
CTD
PMID:14729362
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LDLR mRNA
CTD
PMID:12414654
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lgals3bp
galectin 3 binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS3BP mRNA
CTD
PMID:14729362
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
G
Lgals8
galectin 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS8 mRNA
CTD
PMID:15336504
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
G
Lgals9
galectin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS9 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LGR5 mRNA
CTD
PMID:23410634
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
G
Lhx2
LIM homeobox 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LHX2 mRNA
CTD
PMID:15336504
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
G
Lif
LIF, interleukin 6 family cytokine
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of LIF mRNA tert-Butylhydroperoxide results in increased methylation of LIF gene
CTD
PMID:12414654 PMID:15336504 PMID:23410634 PMID:27509014
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lifr
LIF receptor subunit alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIFR mRNA
CTD
PMID:15336504
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
G
Lig1
DNA ligase 1
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of LIG1 mRNA tert-Butylhydroperoxide results in increased methylation of LIG1 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lilrb4
leukocyte immunoglobulin like receptor B4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LILRB4B mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:69,805,020...69,810,628
Ensembl chr 1:69,805,250...69,810,660
G
Limch1
LIM and calponin homology domains 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMCH1 mRNA
CTD
PMID:15336504
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
G
Limk1
LIM domain kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMK1 mRNA
CTD
PMID:15003993
NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606
G
Lims1
LIM zinc finger domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMS1 mRNA
CTD
PMID:15336504
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
G
Lipa
lipase A, lysosomal acid type
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LIPA mRNA
CTD
PMID:15336504
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
G
Litaf
lipopolysaccharide-induced TNF factor
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]
CTD
PMID:20847119
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Lmbr1
limb development membrane protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LMBR1 mRNA
CTD
PMID:23410634
NCBI chr 4:5,974,687...6,146,348
Ensembl chr 4:5,974,750...6,146,368
G
Lmnb1
lamin B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LMNB1 mRNA
CTD
PMID:15336504
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lmnb2
lamin B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LMNB2 mRNA
CTD
PMID:15336504
NCBI chr 7:8,792,628...8,808,665
Ensembl chr 7:8,789,314...8,808,665
G
Lnx2
ligand of numb-protein X 2
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LNX2 intron
CTD
PMID:29432895
NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494
G
Lox
lysyl oxidase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LOX mRNA
CTD
PMID:23410634
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Loxl2
lysyl oxidase-like 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LOXL2 mRNA
CTD
PMID:15963989
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
G
Lpcat1
lysophosphatidylcholine acyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPCAT1 mRNA
CTD
PMID:15336504
NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:29,766,071...29,816,401
G
Lpcat3
lysophosphatidylcholine acyltransferase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPCAT3 mRNA
CTD
PMID:15336504
NCBI chr 4:157,468,397...157,509,889
Ensembl chr 4:157,468,290...157,509,880
G
Lpin1
lipin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPIN1 mRNA
CTD
PMID:14729362
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpin2
lipin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPIN2 mRNA
CTD
PMID:15336504
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
G
Lpl
lipoprotein lipase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPL mRNA
CTD
PMID:15336504
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lpp
LIM domain containing preferred translocation partner in lipoma
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LPP mRNA
CTD
PMID:15336504
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
G
Lrba
LPS responsive beige-like anchor protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LRBA mRNA
CTD
PMID:14729362
NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724
G
Lrp1
LDL receptor related protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LRP1 mRNA
CTD
PMID:23410634
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Lrp6
LDL receptor related protein 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LRP6 mRNA
CTD
PMID:12414654
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
G
Lrrc1
leucine rich repeat containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LRRC1 mRNA
CTD
PMID:15336504
NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490
G
Lrrc17
leucine rich repeat containing 17
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LRRC17 mRNA
CTD
PMID:15336504
NCBI chr 4:13,501,428...13,531,845
Ensembl chr 4:13,501,436...13,531,845
G
Lrrc23
leucine rich repeat containing 23
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LRRC23 intron
CTD
PMID:29432895
NCBI chr 4:157,581,285...157,592,188
Ensembl chr 4:157,581,291...157,591,860
G
Lrrc27
leucine rich repeat containing 27
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of LRRC27 promoter
CTD
PMID:29432895
NCBI chr 1:194,004,967...194,035,087
Ensembl chr 1:194,005,182...194,035,084
G
Lsm4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LSM4 mRNA
CTD
PMID:15336504
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
G
Lss
lanosterol synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LSS mRNA
CTD
PMID:14729362
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Ltbp2
latent transforming growth factor beta binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LTBP2 mRNA
CTD
PMID:15336504
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
G
Ly6a
lymphocyte antigen 6 family member A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LY6A mRNA
CTD
PMID:15003993
NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
G
Ly96
lymphocyte antigen 96
multiple interactions
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LYN mRNA
CTD
PMID:12419474
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
G
Lypd1
Ly6/Plaur domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LYPD1 mRNA
CTD
PMID:15336504
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
G
Lypla1
lysophospholipase 1
decreases response to substance
ISO
LYPLA1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15003993
NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746
G
Mab21l1
mab-21 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAB21L1 mRNA
CTD
PMID:15336504
NCBI chr 2:139,943,496...139,945,885
Ensembl chr 2:139,943,496...139,945,885
G
Mab21l2
mab-21 like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAB21L2 mRNA
CTD
PMID:15336504
NCBI chr 2:171,946,573...171,949,655
Ensembl chr 2:171,946,573...171,949,655
G
Macroh2a1
macroH2A.1 histone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MACROH2A1 mRNA
CTD
PMID:15336504
NCBI chr17:8,479,331...8,542,071
Ensembl chr17:8,479,372...8,542,072
G
Mafb
MAF bZIP transcription factor B
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of MAFB mRNA tert-Butylhydroperoxide results in increased methylation of MAFB gene
CTD
PMID:27509014
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAFF mRNA
CTD
PMID:15336504
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of MAFG mRNA tert-Butylhydroperoxide results in increased methylation of MAFG gene
CTD
PMID:12414654 PMID:27509014
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
G
Mafk
MAF bZIP transcription factor K
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of MAFK gene tert-Butylhydroperoxide results in increased expression of MAFK mRNA
CTD
PMID:27509014
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Mal
mal, T-cell differentiation protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAL mRNA
CTD
PMID:15336504
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
G
Man2a2
mannosidase, alpha, class 2A, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAN2A2 mRNA
CTD
PMID:15336504
NCBI chr 1:134,304,714...134,327,611
Ensembl chr 1:134,306,236...134,327,315
G
Mansc1
MANSC domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MANSC1 mRNA
CTD
PMID:15336504
NCBI chr 4:167,438,817...167,459,047
Ensembl chr 4:167,439,071...167,479,606
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAP1LC3B mRNA
CTD
PMID:15336504
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased expression of MAP2K3 mRNA tert-Butylhydroperoxide results in increased phosphorylation of MAP2K3 protein
CTD
PMID:15336504 PMID:17003459
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map2k4
mitogen activated protein kinase kinase 4
increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K4 protein
CTD
PMID:17003459
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP2K5 mRNA
CTD
PMID:12419474
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Map2k6
mitogen-activated protein kinase kinase 6
increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K6 protein
CTD
PMID:17003459
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAP3K5 mRNA
CTD
PMID:15336504
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k6
mitogen-activated protein kinase kinase kinase 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP3K6 mRNA
CTD
PMID:15336504
NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212
G
Map3k7
mitogen activated protein kinase kinase kinase 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP3K7 mRNA
CTD
PMID:15336504
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Map4
microtubule-associated protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP4 mRNA
CTD
PMID:15336504
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation increases phosphorylation multiple interactions decreases expression
ISO EXP
tert-Butylhydroperoxide results in decreased phosphorylation of MAPK1 protein tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein 7-methyljuglone analog inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein] tert-Butylhydroperoxide results in decreased expression of MAPK1 protein modified form [tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK1 protein; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MAPK1 protein modified form]
CTD
PMID:17003459 PMID:20100471 PMID:20922651
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk12
mitogen-activated protein kinase 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAPK12 mRNA
CTD
PMID:14729362
NCBI chr 7:120,206,005...120,216,711
Ensembl chr 7:120,206,271...120,216,664
G
Mapk14
mitogen activated protein kinase 14
decreases expression increases methylation increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAPK14 mRNA tert-Butylhydroperoxide results in increased methylation of MAPK14 gene tert-Butylhydroperoxide results in increased expression of MAPK14 mRNA
CTD
PMID:15336504 PMID:27509014 PMID:29432895
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation decreases expression decreases phosphorylation
ISO EXP
[tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK3 protein; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MAPK3 protein modified form] 7-methyljuglone analog inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein] tert-Butylhydroperoxide results in decreased phosphorylation of MAPK3 protein
CTD
PMID:17003459 PMID:20100471 PMID:20922651
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases phosphorylation
ISO
[phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK8 protein LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]
CTD
PMID:20423716 PMID:28063877
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions increases phosphorylation
ISO
[phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]
CTD
PMID:20423716 PMID:28063877
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAPRE3 mRNA
CTD
PMID:15003993
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
G
Marchf2
membrane associated ring-CH-type finger 2
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of MARCHF2 mRNA tert-Butylhydroperoxide results in increased methylation of MARCHF2 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 7:14,480,605...14,507,821
Ensembl chr 7:14,481,761...14,507,794
G
Mark3
microtubule affinity regulating kinase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MARK3 mRNA
CTD
PMID:12419474
NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of MAS1 gene
CTD
PMID:29432895
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
G
Matn2
matrilin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MATN2 mRNA
CTD
PMID:15336504
NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113
G
Mb21d2
Mab-21 domain containing 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MB21D2 mRNA]
CTD
PMID:20847119
NCBI chr11:71,825,748...71,924,770
Ensembl chr11:71,825,748...71,924,769
G
Mbd3
methyl-CpG binding domain protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBD3 mRNA
CTD
PMID:15336504
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
G
Mbnl2
muscleblind-like splicing regulator 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBNL2 mRNA
CTD
PMID:15336504
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mbtps1
membrane-bound transcription factor peptidase, site 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBTPS1 mRNA
CTD
PMID:15336504
NCBI chr19:47,561,598...47,612,769
Ensembl chr19:47,561,598...47,612,791
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCAM mRNA
CTD
PMID:15336504
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mcfd2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCFD2 mRNA
CTD
PMID:15003993
NCBI chr 6:7,274,469...7,285,841
Ensembl chr 6:7,274,469...7,285,841
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
multiple interactions decreases response to substance
ISO
[HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] MCL1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15611089
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM2 mRNA
CTD
PMID:15336504
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM3 mRNA tert-Butylhydroperoxide affects the expression of MCM3 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM4 mRNA
CTD
PMID:12419474
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcm5
minichromosome maintenance complex component 5
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM5 mRNA tert-Butylhydroperoxide affects the expression of MCM5 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM6 mRNA
CTD
PMID:15336504
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM7 mRNA
CTD
PMID:15336504
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mcrs1
microspherule protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCRS1 mRNA
CTD
PMID:15336504
NCBI chr 7:130,383,853...130,392,667
Ensembl chr 7:130,383,853...130,392,685
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MDM2 mRNA
CTD
PMID:27509014
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Me1
malic enzyme 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ME1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mecp2
methyl CpG binding protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MECP2 mRNA
CTD
PMID:15336504
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Med16
mediator complex subunit 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MED16 mRNA
CTD
PMID:15336504
NCBI chr 7:9,798,641...9,811,172
Ensembl chr 7:9,798,668...9,811,172
G
Med21
mediator complex subunit 21
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MED21 mRNA
CTD
PMID:15336504
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
G
Megf9
multiple EGF-like-domains 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MEGF9 mRNA
CTD
PMID:15336504
NCBI chr 5:83,993,565...84,105,622
Ensembl chr 5:83,993,565...84,105,622
G
Mest
mesoderm specific transcript
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MEST mRNA
CTD
PMID:15336504
NCBI chr 4:59,354,445...59,364,919
Ensembl chr 4:59,354,447...59,366,145
G
Met
MET proto-oncogene, receptor tyrosine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MET mRNA
CTD
PMID:15336504
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mfsd6
major facilitator superfamily domain containing 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MFSD6 mRNA
CTD
PMID:15336504
NCBI chr 9:48,773,171...48,858,471
Ensembl chr 9:48,773,414...48,858,465
G
Mgll
monoglyceride lipase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MGLL mRNA
CTD
PMID:15336504
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mgp
matrix Gla protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MGP mRNA
CTD
PMID:12766906 PMID:15336504
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mgst2
microsomal glutathione S-transferase 2
decreases response to substance increases expression
ISO
MGST2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MGST2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
G
Mgst3
microsomal glutathione S-transferase 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MGST3 mRNA tert-Butylhydroperoxide results in increased expression of MGST3 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
G
Mia
MIA SH3 domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MIA mRNA
CTD
PMID:14729362
NCBI chr 1:82,473,677...82,476,378
Ensembl chr 1:82,473,678...82,475,370
G
Mia2
MIA SH3 domain ER export factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MIA2 mRNA
CTD
PMID:12414654
NCBI chr 6:76,787,508...76,885,246
Ensembl chr 6:76,787,508...76,885,211
G
Mia3
MIA SH3 domain ER export factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MIA3 mRNA
CTD
PMID:15003993
NCBI chr13:94,970,421...95,012,071
Ensembl chr13:94,970,424...95,011,972
G
Mid1ip1
MID1 interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MID1IP1 mRNA
CTD
PMID:15003993
NCBI chr X:12,060,993...12,063,318
Ensembl chr X:12,060,883...12,065,774
G
Mir155
microRNA 155
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA]
CTD
PMID:35690295
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir16
microRNA 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MIR16 mRNA
CTD
PMID:15336504
NCBI chr 2:153,245,349...153,245,443
Ensembl chr 2:153,245,349...153,245,443
G
Mir184
microRNA 184
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR184 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA]
CTD
PMID:35690295
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
G
Mitf
melanocyte inducing transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MITF mRNA
CTD
PMID:15336504
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Mixl1
Mix paired-like homeobox 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of MIXL1 mRNA
CTD
PMID:23410634
NCBI chr13:92,422,031...92,426,065
Ensembl chr13:92,422,031...92,426,065
G
Mkks
MKKS centrosomal shuttling protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKKS mRNA
CTD
PMID:15336504
NCBI chr 3:124,201,877...124,221,142
Ensembl chr 3:124,201,877...124,220,162
G
Mknk2
MAPK interacting serine/threonine kinase 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKNK2 mRNA tert-Butylhydroperoxide results in increased expression of MKNK2 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
G
Mkrn1
makorin ring finger protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKRN1 mRNA
CTD
PMID:15336504
NCBI chr 4:68,175,908...68,197,216
Ensembl chr 4:68,175,909...68,197,165
G
Mlh1
mutL homolog 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of MLH1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]
CTD
PMID:12419474 PMID:35690295
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
G
Mme
membrane metallo-endopeptidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MME mRNA
CTD
PMID:15336504
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
G
Mmp11
matrix metallopeptidase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MMP11 mRNA
CTD
PMID:12419474
NCBI chr20:12,730,846...12,739,629
Ensembl chr20:12,730,836...12,739,628
G
Mmp3
matrix metallopeptidase 3
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA]
CTD
PMID:35690295
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]
CTD
PMID:35690295
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mob1a
MOB kinase activator 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MOB1A mRNA
CTD
PMID:15336504
NCBI chr 4:115,831,581...115,848,561
Ensembl chr 4:115,831,551...115,848,561
G
Mok
MOK protein kinase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOK mRNA
CTD
PMID:15336504
NCBI chr 6:129,823,794...129,854,669
Ensembl chr 6:129,823,795...129,854,700
G
Mospd1
motile sperm domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOSPD1 mRNA
CTD
PMID:15336504
NCBI chr X:133,100,200...133,127,960
Ensembl chr X:133,100,422...133,127,908 Ensembl chr 1:133,100,422...133,127,908
G
Mov10
Mov10 RNA helicase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOV10 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:192,292,041...192,315,142
Ensembl chr 2:192,293,470...192,315,083
G
Moxd1
monooxygenase, DBH-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MOXD1 mRNA
CTD
PMID:15336504
NCBI chr 1:21,075,124...21,165,348
Ensembl chr 1:21,075,122...21,161,779
G
Mpg
N-methylpurine-DNA glycosylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPG mRNA
CTD
PMID:15336504
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
G
Mphosph8
M-phase phosphoprotein 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPHOSPH8 mRNA
CTD
PMID:15336504
NCBI chr15:30,800,546...30,828,415
Ensembl chr15:30,686,613...30,828,810
G
Mphosph9
M-phase phosphoprotein 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPHOSPH9 mRNA
CTD
PMID:15336504
NCBI chr12:32,275,449...32,346,097
Ensembl chr12:32,275,558...32,342,392
G
Mpp1
MAGUK p55 scaffold protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MPP1 mRNA
CTD
PMID:15003993
G
Mppe1
metallophosphoesterase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MPPE1 mRNA
CTD
PMID:15336504
NCBI chr18:60,763,418...60,781,553
Ensembl chr18:60,763,419...60,781,553
G
Mrpl2
mitochondrial ribosomal protein L2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL2 mRNA
CTD
PMID:15336504
NCBI chr 9:14,333,233...14,337,006
Ensembl chr 9:14,333,234...14,337,040
G
Mrpl23
mitochondrial ribosomal protein L23
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL23 mRNA
CTD
PMID:14729362
NCBI chr 1:197,687,452...197,695,222
Ensembl chr 1:197,687,347...197,695,222
G
Mrpl34
mitochondrial ribosomal protein L34
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MRPL34 mRNA
CTD
PMID:15336504
NCBI chr16:18,152,470...18,153,205
Ensembl chr16:18,151,342...18,153,208
G
Mrpl48
mitochondrial ribosomal protein L48
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL48 mRNA tert-Butylhydroperoxide results in decreased expression of MRPL48 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 1:154,896,663...154,939,285
Ensembl chr 1:154,896,663...154,939,281
G
Mrps14
mitochondrial ribosomal protein S14
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MRPS14 mRNA
CTD
PMID:15336504
NCBI chr13:72,429,168...72,434,915
Ensembl chr13:72,408,558...72,434,915
G
Msh6
mutS homolog 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MSH6 mRNA
CTD
PMID:15336504
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
G
Msln
mesothelin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MSLN mRNA
CTD
PMID:15336504
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Msn
moesin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MSN mRNA
CTD
PMID:15336504
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Msra
methionine sulfoxide reductase A
decreases response to substance
ISO
MSRA protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15914630
NCBI chr15:38,363,459...38,677,406
Ensembl chr15:38,351,445...38,676,585
G
Msrb1
methionine sulfoxide reductase B1
decreases response to substance increases expression
ISO
MSRB1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MSRB1 mRNA
CTD
PMID:15003993 PMID:15914630
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
G
Msrb2
methionine sulfoxide reductase B2
decreases response to substance
ISO
MSRB2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15914630
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
G
Msrb3
methionine sulfoxide reductase B3
decreases response to substance
ISO
MSRB3 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15914630
NCBI chr 7:56,260,985...56,426,004
Ensembl chr 7:56,303,308...56,425,496
G
Mt1
metallothionein 1
affects response to substance decreases response to substance
ISO
MT1 protein affects the susceptibility to tert-Butylhydroperoxide MT1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:7890668 PMID:16150881
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
multiple interactions affects response to substance decreases response to substance increases expression
ISO
MT2A protein inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA] MT2 protein affects the susceptibility to tert-Butylhydroperoxide MT2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MT2A mRNA MT2A protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:7890668 PMID:12414654 PMID:16150881 PMID:16402917 PMID:16636651
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtarc1
mitochondrial amidoxime reducing component 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of MTARC1 mRNA
CTD
PMID:23410634
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
G
Mtf1
metal-regulatory transcription factor 1
increases response to substance
ISO
MTF1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15378601
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
G
Mtg1
mitochondrial ribosome-associated GTPase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MTG1 mRNA
CTD
PMID:15336504
NCBI chr 1:194,931,543...194,944,278
Ensembl chr 1:194,931,531...194,944,277
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA]
CTD
PMID:35690295
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MTR mRNA
CTD
PMID:27509014
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
G
Mtx1
Metaxin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MTX1 mRNA
CTD
PMID:14729362
NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:174,615,461...174,620,982
G
Muc1
mucin 1, cell surface associated
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MUC1 mRNA
CTD
PMID:15336504
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Mx1
MX dynamin like GTPase 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MX1 mRNA tert-Butylhydroperoxide results in increased expression of MX1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Mxd1
max dimerization protein 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]
CTD
PMID:20847119
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYC mRNA
CTD
PMID:27509014
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mydgf
myeloid-derived growth factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYDGF mRNA
CTD
PMID:15336504
NCBI chr 9:999,659...1,008,804
Ensembl chr 9:1,000,722...1,008,822
G
Mylk
myosin light chain kinase
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYLK mRNA tert-Butylhydroperoxide affects the expression of MYLK mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
G
Myo10
myosin X
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO10 mRNA
CTD
PMID:15336504
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
G
Myo5a
myosin VA
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO5A mRNA
CTD
PMID:15336504
NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
G
Myo5c
myosin VC
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYO5C mRNA
CTD
PMID:15336504
NCBI chr 8:75,989,497...76,066,485
Ensembl chr 8:75,989,528...76,066,483
G
Myo7a
myosin VIIA
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO7A mRNA
CTD
PMID:14729362
NCBI chr 1:152,342,611...152,414,171
Ensembl chr 1:152,344,448...152,414,157
G
N4bp1
Nedd4 binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of N4BP1 mRNA
CTD
PMID:15336504
NCBI chr19:20,222,811...20,273,570
Ensembl chr19:20,222,776...20,273,570
G
N4bp2l2
NEDD4 binding protein 2-like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of N4BP2L2 mRNA
CTD
PMID:15336504
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAA15 mRNA
CTD
PMID:15336504
NCBI chr 2:135,458,018...135,520,756
Ensembl chr 2:135,457,948...135,520,756
G
Nap1l1
nucleosome assembly protein 1-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NAP1L1 mRNA
CTD
PMID:15336504
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
G
Napsa
napsin A aspartic peptidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAPSA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:95,064,900...95,077,094
G
Nav3
neuron navigator 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAV3 mRNA
CTD
PMID:15336504
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
G
Naxd
NAD(P)HX dehydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NAXD mRNA
CTD
PMID:15336504
NCBI chr16:77,986,148...78,004,200
Ensembl chr16:77,987,726...78,004,192
G
Ncam1
neural cell adhesion molecule 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAM1 mRNA
CTD
PMID:15336504
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAPD2 mRNA
CTD
PMID:15336504
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
G
Ncapg2
non-SMC condensin II complex, subunit G2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAPG2 mRNA
CTD
PMID:15336504
NCBI chr 6:137,342,449...137,418,083
Ensembl chr 6:137,342,943...137,415,159
G
Ncf1
neutrophil cytosolic factor 1
increases expression affects localization multiple interactions
EXP ISO
tert-Butylhydroperoxide results in increased expression of NCF1 mRNA tert-Butylhydroperoxide affects the localization of NCF1 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide affects the localization of NCF1 protein]
CTD
PMID:22659508 PMID:29111459
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Ncf4
neutrophil cytosolic factor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NCF4 mRNA
CTD
PMID:14729362
NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
G
Ncor2
nuclear receptor co-repressor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NCOR2 mRNA
CTD
PMID:15336504
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
G
Ndc80
NDC80 kinetochore complex component
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NDC80 mRNA
CTD
PMID:23410634
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Ndrg1
N-myc downstream regulated 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NDRG1 mRNA]
CTD
PMID:20847119
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndrg3
NDRG family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDRG3 mRNA
CTD
PMID:15336504
NCBI chr 3:145,587,505...145,650,896
Ensembl chr 3:145,548,041...145,650,873
G
Ndrg4
NDRG family member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDRG4 mRNA
CTD
PMID:15336504
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NDUFA3 mRNA
CTD
PMID:15003993
NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFA7 mRNA
CTD
PMID:15336504
NCBI chr 7:14,609,283...14,622,064
Ensembl chr 7:14,609,146...14,631,976
G
Ndufb2
NADH:ubiquinone oxidoreductase subunit B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFB2 mRNA
CTD
PMID:15336504
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
G
Ndufb7
NADH:ubiquinone oxidoreductase subunit B7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFB7 mRNA
CTD
PMID:15336504
NCBI chr19:24,568,241...24,572,579
Ensembl chr19:24,568,241...24,572,579
G
Ndufs7
NADH:ubiquinone oxidoreductase core subunit S7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFS7 mRNA
CTD
PMID:15336504
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
G
Necap1
NECAP endocytosis associated 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NECAP1 mRNA
CTD
PMID:23410634
NCBI chr 4:156,103,935...156,119,068
Ensembl chr 4:156,103,988...156,119,068
G
Nedd4l
NEDD4 like E3 ubiquitin protein ligase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NEDD4L mRNA
CTD
PMID:15336504
NCBI chr18:58,393,759...58,726,709
Ensembl chr18:58,393,509...58,723,137
G
Nelfcd
negative elongation factor complex member C/D
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NELFCD mRNA
CTD
PMID:15336504
NCBI chr 3:163,213,765...163,224,886
Ensembl chr 3:163,213,762...163,224,884
G
Nes
nestin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NES mRNA
CTD
PMID:15003993
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NF2 mRNA
CTD
PMID:12419474
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Nfatc1
nuclear factor of activated T-cells 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFATC1 mRNA
CTD
PMID:12419474
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfatc2ip
nuclear factor of activated T-cells 2 interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFATC2IP mRNA
CTD
PMID:15336504
NCBI chr 1:180,954,834...180,971,847
Ensembl chr 1:180,955,043...180,971,747
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions affects localization increases expression decreases expression decreases response to substance
ISO
NFE2L2 protein affects the reaction [3-methylquercetin results in decreased susceptibility to tert-Butylhydroperoxide]; NFE2L2 protein affects the susceptibility to [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] tert-Butylhydroperoxide affects the localization of NFE2L2 protein tert-Butylhydroperoxide results in increased expression of NFE2L2 mRNA tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA; tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein nectandrin-B inhibits the reaction [tert-Butylhydroperoxide affects the localization of NFE2L2 protein]; NFE2L2 mRNA affects the reaction [plumbagin results in decreased susceptibility to tert-Butylhydroperoxide]; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA] NFE2L2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:19647727 PMID:20028456 PMID:20100471 PMID:20932822 PMID:24211276 PMID:27050144 PMID:27509014 PMID:27511913 PMID:28025122 PMID:30273691 More...
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfic
nuclear factor I/C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NFIC mRNA
CTD
PMID:15003993
NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936
G
Nfix
nuclear factor I X
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFIX mRNA
CTD
PMID:12419474
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of NFKB1 mRNA tert-Butylhydroperoxide results in increased expression of NFKB1 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein] tert-Butylhydroperoxide results in increased expression of NFKB1 mRNA
CTD
PMID:12419474 PMID:16704919 PMID:24394546
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
increases expression affects expression multiple interactions increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased expression of NFKBIA mRNA tert-Butylhydroperoxide affects the expression of NFKBIA mRNA Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of NFKBIA protein]
CTD
PMID:15336504 PMID:15879681 PMID:23410634
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbie
NFKB inhibitor epsilon
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NFKBIE mRNA
CTD
PMID:15336504
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Nfyb
nuclear transcription factor Y subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFYB mRNA
CTD
PMID:15336504
NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565
G
Ngf
nerve growth factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NGF mRNA
CTD
PMID:15003993
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nip7
nucleolar pre-rRNA processing protein NIP7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NIP7 mRNA
CTD
PMID:15336504
NCBI chr19:34,962,557...34,964,700
Ensembl chr19:34,962,557...34,964,711
G
Nisch
nischarin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NISCH mRNA
CTD
PMID:15336504
NCBI chr16:6,364,370...6,400,675
Ensembl chr16:6,364,374...6,400,668
G
Nit1
nitrilase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NIT1 mRNA
CTD
PMID:14729362
NCBI chr13:83,769,888...83,773,324
Ensembl chr13:83,765,941...83,773,332
G
Nkain1
Sodium/potassium transporting ATPase interacting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKAIN1 mRNA
CTD
PMID:15003993
NCBI chr 5:142,747,702...142,792,665
Ensembl chr 5:142,747,505...142,791,863
G
Nkd1
NKD inhibitor of WNT signaling pathway 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NKD1 mRNA
CTD
PMID:23410634
NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380
G
Nkiras1
NFKB inhibitor interacting Ras-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKIRAS1 mRNA
CTD
PMID:15003993
NCBI chr15:7,493,531...7,503,758
Ensembl chr15:7,493,531...7,503,854
G
Nktr
natural killer cell triggering receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NKTR mRNA
CTD
PMID:15336504
NCBI chr 8:121,380,010...121,420,495
Ensembl chr 8:121,382,436...121,418,314
G
Nkx3-1
NK3 homeobox 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKX3-1 mRNA
CTD
PMID:15336504
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nmd3
NMD3 ribosome export adaptor
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NMD3 mRNA
CTD
PMID:23410634
NCBI chr 2:154,012,973...154,038,466
Ensembl chr 2:154,013,020...154,039,259
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NME2 mRNA
CTD
PMID:12419474
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
G
Nmnat3
nicotinamide nucleotide adenylyltransferase 3
decreases response to substance
ISO
NMNAT3 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:18463239
NCBI chr 8:98,892,168...99,003,912
Ensembl chr 8:98,873,398...99,020,645
G
Nmrk1
nicotinamide riboside kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NMRK1 mRNA
CTD
PMID:15336504
NCBI chr 1:216,049,350...216,076,792
Ensembl chr 1:216,049,437...216,076,791
G
Nmt1
N-myristoyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NMT1 mRNA
CTD
PMID:15336504
NCBI chr10:87,988,826...88,025,405
Ensembl chr10:87,988,826...88,022,648
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NNT mRNA
CTD
PMID:15336504
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Noc4l
nucleolar complex associated 4 homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NOC4L mRNA
CTD
PMID:15336504
NCBI chr12:46,016,077...46,020,615
Ensembl chr12:46,016,069...46,020,614
G
Nono
non-POU domain containing, octamer-binding
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NONO mRNA
CTD
PMID:15336504
NCBI chr X:66,554,131...66,571,992
Ensembl chr X:66,554,098...66,571,952
G
Nos2
nitric oxide synthase 2
multiple interactions increases expression
EXP
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA]; tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD
PMID:10231168 PMID:18812229
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nox4
NADPH oxidase 4
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of NOX4 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:29111459
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Npc1
NPC intracellular cholesterol transporter 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NPC1 mRNA
CTD
PMID:15336504
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
G
Nphp4
nephrocystin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NPHP4 mRNA
CTD
PMID:15336504
NCBI chr 5:162,986,157...163,073,708
Ensembl chr 5:162,988,370...163,073,706
G
Nppb
natriuretic peptide B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NPPB mRNA
CTD
PMID:15336504
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of NQO1 mRNA rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA] tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA; tert-Butylhydroperoxide results in decreased expression of NQO1 protein
CTD
PMID:12414654 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NQO2 mRNA
CTD
PMID:15336504
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NR0B2 mRNA
CTD
PMID:23410634
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of NR1H4 mRNA tert-Butylhydroperoxide affects the expression of NR1H4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr2f6
nuclear receptor subfamily 2, group F, member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NR2F6 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr16:18,046,012...18,053,914
Ensembl chr16:18,046,013...18,053,459
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NR3C1 mRNA
CTD
PMID:23410634
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NR4A1 mRNA
CTD
PMID:12414654
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nrbf2
nuclear receptor binding factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NRBF2 mRNA
CTD
PMID:15336504
NCBI chr20:21,308,555...21,326,881
Ensembl chr20:21,308,576...21,326,818
G
Nsd2
nuclear receptor binding SET domain protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NSD2 mRNA
CTD
PMID:15336504
NCBI chr14:76,833,179...76,911,304
Ensembl chr14:76,835,637...76,913,641
G
Nsmaf
neutral sphingomyelinase activation associated factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NSMAF mRNA
CTD
PMID:15336504
NCBI chr 5:19,517,795...19,578,773
Ensembl chr 5:19,518,348...19,577,627
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NTRK2 mRNA
CTD
PMID:15336504
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Nucb1
nucleobindin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUCB1 mRNA
CTD
PMID:15336504
NCBI chr 1:95,968,325...95,999,183
Ensembl chr 1:95,968,326...96,003,220
G
Nudt11
nudix hydrolase 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NUDT11 mRNA
CTD
PMID:15336504
NCBI chr X:16,326,775...16,333,396
Ensembl chr X:16,326,598...16,333,145
G
Nudt21
nudix hydrolase 21
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUDT21 mRNA tert-Butylhydroperoxide results in increased expression of NUDT21 mRNA
CTD
PMID:15336504
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
G
Nudt6
nudix hydrolase 6
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NUDT6 mRNA
CTD
PMID:23410634
NCBI chr 2:120,289,908...120,306,197
Ensembl chr 2:120,290,847...120,306,230
G
Nup188
nucleoporin 188
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUP188 mRNA
CTD
PMID:15336504
NCBI chr 3:13,559,917...13,616,313
Ensembl chr 3:13,559,990...13,616,307
G
Nup205
nucleoporin 205
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUP205 mRNA
CTD
PMID:15336504
NCBI chr 4:63,854,934...63,920,852
Ensembl chr 4:63,854,783...63,920,844
G
Nup37
nucleoporin 37
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NUP37 mRNA
CTD
PMID:15336504
NCBI chr 7:22,556,544...22,609,622
Ensembl chr 7:22,573,764...22,609,616
G
Nup58
nucleoporin 58
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of NUP58 gene tert-Butylhydroperoxide results in increased expression of NUP58 mRNA
CTD
PMID:27509014
NCBI chr15:34,358,170...34,407,160
Ensembl chr15:34,358,277...34,407,060
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUSAP1 mRNA
CTD
PMID:15336504
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
G
Oas1a
2'-5' oligoadenylate synthetase 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAS1 mRNA
CTD
PMID:15336504
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
G
Oas3
2'-5'-oligoadenylate synthetase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAS3 mRNA
CTD
PMID:15336504
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
G
Oaz1
ornithine decarboxylase antizyme 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAZ1 mRNA
CTD
PMID:15336504
NCBI chr 7:8,883,855...8,886,315
Ensembl chr 7:8,883,851...8,886,310
G
Obsl1
obscurin like cytoskeletal adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OBSL1 mRNA
CTD
PMID:15336504
NCBI chr 9:76,967,802...76,993,771
Ensembl chr 9:76,974,253...76,993,560
G
Ocel1
occludin/ELL domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OCEL1 mRNA
CTD
PMID:15336504
NCBI chr16:18,042,037...18,045,080
Ensembl chr16:18,043,309...18,045,078
G
Ocln
occludin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OCLN protein
CTD
PMID:34303734
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Odc1
ornithine decarboxylase 1
increases activity
ISO
tert-Butylhydroperoxide results in increased activity of ODC1 protein
CTD
PMID:2013121
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Ogdh
oxoglutarate dehydrogenase
multiple interactions decreases activity
EXP
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein]; Dithiothreitol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein]
CTD
PMID:12680778
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
G
Ogfod3
2-oxoglutarate and iron-dependent oxygenase domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OGFOD3 mRNA
CTD
PMID:15336504
NCBI chr10:106,452,334...106,480,632
Ensembl chr10:106,452,329...106,480,134
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OGT mRNA
CTD
PMID:15336504
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Ola1
Obg-like ATPase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of OLA1 mRNA
CTD
PMID:15336504
NCBI chr 3:57,966,896...58,085,955
Ensembl chr 3:57,966,896...58,084,480
G
Opn3
opsin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OPN3 mRNA
CTD
PMID:15336504
NCBI chr13:87,589,333...87,619,847
Ensembl chr13:87,589,333...87,619,847
G
Os9
OS9, endoplasmic reticulum lectin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OS9 mRNA
CTD
PMID:15336504
NCBI chr 7:62,915,498...62,957,591
Ensembl chr 7:62,915,515...62,943,745
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSBPL1A mRNA
CTD
PMID:15336504
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
G
Oser1
oxidative stress responsive serine-rich 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSER1 mRNA
CTD
PMID:15336504
NCBI chr 3:152,066,975...152,085,180
Ensembl chr 3:152,066,975...152,085,149
G
Osgin1
oxidative stress induced growth inhibitor 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of OSGIN1 mRNA tert-Butylhydroperoxide affects the expression of OSGIN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
G
Osr2
odd-skipped related transciption factor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSR2 mRNA
CTD
PMID:15336504
NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:66,487,839...66,495,224
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of P4HA1 mRNA
CTD
PMID:15336504
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
P4htm
prolyl 4-hydroxylase, transmembrane
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of P4HTM mRNA
CTD
PMID:15336504
NCBI chr 8:109,274,629...109,292,802
Ensembl chr 8:109,274,626...109,292,473
G
Pafah1b1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAFAH1B1 mRNA
CTD
PMID:15336504
NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808
G
Pafah2
platelet-activating factor acetylhydrolase 2
multiple interactions affects response to substance affects localization decreases response to substance
ISO
PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] PAFAH2 protein affects the susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide affects the localization of PAFAH2 protein PAFAH2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:12406338 PMID:18024956
NCBI chr 5:146,607,050...146,636,203
Ensembl chr 5:146,613,498...146,634,943
G
Palb2
partner and localizer of BRCA2
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of PALB2 intron
CTD
PMID:29432895
NCBI chr 1:176,665,076...176,689,053
Ensembl chr 1:176,665,076...176,688,990
G
Palld
palladin, cytoskeletal associated protein
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PALLD mRNA
CTD
PMID:23410634
NCBI chr16:28,228,006...28,621,349
Ensembl chr16:27,981,354...28,621,337
G
Pam
peptidylglycine alpha-amidating monooxygenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAM mRNA
CTD
PMID:15336504
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Pan2
poly(A) specific ribonuclease subunit PAN2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAN2 mRNA
CTD
PMID:15336504
NCBI chr 7:729,146...747,744
Ensembl chr 7:729,562...747,744
G
Papola
poly (A) polymerase alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PAPOLA mRNA
CTD
PMID:15336504
NCBI chr 6:124,682,015...124,734,706
Ensembl chr 6:124,682,105...124,734,468
G
Papss1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAPSS1 mRNA
CTD
PMID:15336504
NCBI chr 2:220,040,343...220,114,399
Ensembl chr 2:220,040,312...220,114,395
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PAPSS2 mRNA
CTD
PMID:15336504
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
G
Pard3
par-3 family cell polarity regulator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PARD3 mRNA
CTD
PMID:15336504
NCBI chr19:55,080,282...55,630,111
Ensembl chr19:55,080,282...55,629,778
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage decreases expression
ISO EXP
Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; acetovanillone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]
CTD
PMID:15569404 PMID:16753784 PMID:27050144 PMID:27511913 PMID:28733231 PMID:29111459 More...
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pask
PAS domain containing serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PASK mRNA
CTD
PMID:15336504
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
G
Pawr
pro-apoptotic WT1 regulator
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PAWR mRNA
CTD
PMID:23410634
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pax6
paired box 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAX6 mRNA
CTD
PMID:15336504
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Paxip1
PAX interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAXIP1 mRNA
CTD
PMID:15336504
NCBI chr 4:7,525,132...7,576,659
Ensembl chr 4:7,525,004...7,576,548
G
Pbx1
PBX homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PBX1 mRNA
CTD
PMID:15336504
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
G
Pbx2
PBX homeobox 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PBX2 mRNA
CTD
PMID:15336504
NCBI chr20:4,151,500...4,156,425
Ensembl chr20:4,151,500...4,156,425
G
Pbx3
PBX homeobox 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PBX3 mRNA
CTD
PMID:15336504
NCBI chr 3:17,488,691...17,682,412
Ensembl chr 3:17,488,693...17,682,791
G
Pcdh9
protocadherin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCDH9 mRNA
CTD
PMID:15336504
NCBI chr15:69,340,108...70,237,531
Ensembl chr15:69,340,645...70,237,538
G
Pcid2
PCI domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCID2 mRNA
CTD
PMID:15336504
NCBI chr16:76,423,245...76,448,712
Ensembl chr16:76,423,245...76,448,712
G
Pcmtd2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCMTD2 mRNA
CTD
PMID:15336504
NCBI chr 3:168,960,312...168,979,504
Ensembl chr 3:168,960,305...168,979,497
G
Pcolce
procollagen C-endopeptidase enhancer
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCOLCE mRNA
CTD
PMID:15336504
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
G
PCOLCE2
procollagen C-endopeptidase enhancer 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PCOLCE2 mRNA
CTD
PMID:15336504
NCBI chr 8:96,193,461...96,251,116
Ensembl chr 8:96,193,461...96,251,114
G
Pcyox1
prenylcysteine oxidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCYOX1 mRNA
CTD
PMID:15336504
NCBI chr 4:118,832,114...118,842,951
Ensembl chr 4:118,830,638...118,842,951
G
Pcyox1l
prenylcysteine oxidase 1 like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCYOX1L mRNA
CTD
PMID:15336504
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
G
Pdap1
PDGFA associated protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDAP1 mRNA
CTD
PMID:15336504
NCBI chr12:9,470,652...9,480,880
Ensembl chr12:9,470,574...9,535,374
G
Pdcd4
programmed cell death 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDCD4 mRNA
CTD
PMID:15336504
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
G
Pdcd5
programmed cell death 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDCD5 mRNA
CTD
PMID:14729362
NCBI chr 1:88,305,869...88,311,200
Ensembl chr 1:88,305,869...88,311,200
G
Pde4dip
phosphodiesterase 4D interacting protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDE4DIP mRNA
CTD
PMID:15336504
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
G
Pdgfa
platelet derived growth factor subunit A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDGFA mRNA
CTD
PMID:15336504
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdhx
pyruvate dehydrogenase complex, component X
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDHX mRNA
CTD
PMID:15336504
NCBI chr 3:89,372,248...89,431,779
Ensembl chr 3:89,371,497...89,431,773
G
Pdia4
protein disulfide isomerase family A, member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA4 mRNA
CTD
PMID:15003993
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pdia5
protein disulfide isomerase family A, member 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA5 mRNA
CTD
PMID:15003993
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
G
Pdia6
protein disulfide isomerase family A, member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA6 mRNA
CTD
PMID:15003993
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
G
Pdlim3
PDZ and LIM domain 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDLIM3 mRNA
CTD
PMID:15336504
NCBI chr16:46,352,460...46,383,680
Ensembl chr16:46,352,467...46,383,657
G
Pdlim4
PDZ and LIM domain 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDLIM4 mRNA
CTD
PMID:15336504
NCBI chr10:38,198,686...38,212,935
Ensembl chr10:38,198,689...38,212,938
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDLIM7 mRNA
CTD
PMID:15336504
NCBI chr17:9,124,565...9,139,814
Ensembl chr17:9,124,649...9,139,811
G
Pdp1
pyruvate dehydrogenase phosphatase catalytic subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDP1 mRNA
CTD
PMID:15336504
NCBI chr 5:25,446,843...25,455,107
Ensembl chr 5:25,446,272...25,455,217
G
Pdzd2
PDZ domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDZD2 mRNA
CTD
PMID:15336504
NCBI chr 2:61,384,614...61,770,516
Ensembl chr 2:61,386,381...61,770,524
G
Peg10
paternally expressed 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PEG10 mRNA
CTD
PMID:15336504
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
G
Perp
p53 apoptosis effector related to PMP22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PERP mRNA
CTD
PMID:21382384
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
G
Pfdn6
prefoldin subunit 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFDN6 mRNA
CTD
PMID:15336504
NCBI chr20:4,945,959...4,947,433
Ensembl chr20:4,945,959...4,947,433
G
Pfkl
phosphofructokinase, liver type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFKL mRNA
CTD
PMID:15003993
NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315
G
Pfkp
phosphofructokinase, platelet
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFKP mRNA
CTD
PMID:15003993
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pfn2
profilin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PFN2 mRNA
CTD
PMID:14729362
NCBI chr 2:142,067,102...142,072,938
Ensembl chr 2:142,067,104...142,072,938
G
Pggt1b
protein geranylgeranyltransferase type I subunit beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PGGT1B mRNA
CTD
PMID:12414654
NCBI chr18:38,952,147...38,995,656
Ensembl chr18:38,952,914...38,995,503
G
Pgls
6-phosphogluconolactonase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PGLS mRNA
CTD
PMID:15336504
NCBI chr16:18,300,317...18,305,803
Ensembl chr16:18,300,317...18,305,803
G
Pgm2
phosphoglucomutase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PGM2 mRNA
CTD
PMID:15003993
NCBI chr14:44,166,314...44,199,828
Ensembl chr14:44,164,425...44,199,967
G
Phf2
PHD finger protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PHF2 mRNA
CTD
PMID:15336504
NCBI chr17:15,783,221...15,851,209
Ensembl chr17:15,781,864...15,851,208
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PHKA2 mRNA
CTD
PMID:15003993
NCBI chr X:34,170,959...34,293,498
Ensembl chr X:34,171,323...34,293,466
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PHKB mRNA
CTD
PMID:15336504
NCBI chr19:21,013,719...21,210,671
Ensembl chr19:21,025,733...21,210,633
G
Phlda1
pleckstrin homology-like domain, family A, member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PHLDA1 mRNA
CTD
PMID:15336504
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Phlda2
pleckstrin homology-like domain, family A, member 2
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of PHLDA2 mRNA tert-Butylhydroperoxide affects the expression of PHLDA2 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836
G
Pi4ka
phosphatidylinositol 4-kinase alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PI4KA mRNA
CTD
PMID:15336504
NCBI chr11:83,609,148...83,726,876
Ensembl chr11:83,609,069...83,724,080
G
Pias1
protein inhibitor of activated STAT, 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIAS1 mRNA
CTD
PMID:15336504
NCBI chr 8:63,338,150...63,451,670
Ensembl chr 8:63,338,150...63,438,905
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PID1 mRNA
CTD
PMID:15336504
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Pidd1
p53-induced death domain protein 1
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of PIDD1 mRNA tert-Butylhydroperoxide results in increased methylation of PIDD1 gene
CTD
PMID:27509014
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
G
Pign
phosphatidylinositol glycan anchor biosynthesis, class N
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIGN mRNA
CTD
PMID:15336504
NCBI chr13:21,659,092...21,812,932
Ensembl chr13:21,662,455...21,806,790
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R2 mRNA
CTD
PMID:12419474
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R3 mRNA
CTD
PMID:15336504
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Pilrb1
paired immunoglobin-like type 2 receptor beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PILRB mRNA
CTD
PMID:15336504
NCBI chr12:18,516,161...18,525,375
Ensembl chr12:18,516,156...18,525,346
G
Pkp4
plakophilin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PKP4 mRNA
CTD
PMID:15336504
NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:43,631,880...43,835,474
G
Pla2g4a
phospholipase A2 group 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G4A mRNA
CTD
PMID:15336504
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Pla2g5
phospholipase A2, group V
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G5 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
G
Pla2g7
phospholipase A2 group VII
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G7 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Pla2r1
phospholipase A2 receptor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2R1 mRNA
CTD
PMID:12414654
NCBI chr 3:44,883,943...45,013,793
Ensembl chr 3:44,883,943...45,013,660
G
Plaa
phospholipase A2, activating protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLAA mRNA
CTD
PMID:15336504
NCBI chr 5:109,428,600...109,460,373
Ensembl chr 5:109,428,265...109,460,282
G
Plagl1
PLAG1 like zinc finger 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLAGL1 mRNA
CTD
PMID:15336504
NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
G
Plaur
plasminogen activator, urokinase receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLAUR mRNA
CTD
PMID:15336504
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plbd1
phospholipase B domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLBD1 mRNA
CTD
PMID:15336504
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plcd1
phospholipase C, delta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLCD1 mRNA
CTD
PMID:15003993
NCBI chr 8:118,795,196...118,818,186
Ensembl chr 8:118,795,201...118,818,186
G
Plce1
phospholipase C, epsilon 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLCE1 mRNA
CTD
PMID:15336504
NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
G
Plek2
pleckstrin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLEK2 mRNA
CTD
PMID:15336504
NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326
G
Plekho1
pleckstrin homology domain containing O1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PLEKHO1 mRNA
CTD
PMID:23410634
NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785
G
Plin3
perilipin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLIN3 mRNA
CTD
PMID:15336504
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Plk1
polo-like kinase 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLK1 mRNA tert-Butylhydroperoxide results in increased expression of PLK1 mRNA
CTD
PMID:12414654 PMID:15003993
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Plk3
polo-like kinase 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PLK3 mRNA
CTD
PMID:23410634
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Plscr4
phospholipid scramblase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLSCR4 mRNA
CTD
PMID:15336504
NCBI chr 8:92,987,290...93,026,056
Ensembl chr 8:92,987,381...93,026,049
G
Plxna2
plexin A2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLXNA2 mRNA
CTD
PMID:15336504
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
G
Plxnb2
plexin B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLXNB2 mRNA
CTD
PMID:15336504
NCBI chr 7:120,232,276...120,258,385
Ensembl chr 7:120,232,331...120,258,330
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PMAIP1 mRNA
CTD
PMID:23410634
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pnp
purine nucleoside phosphorylase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PNP mRNA
CTD
PMID:15336504
NCBI chr15:24,170,607...24,178,269
Ensembl chr15:24,170,602...24,203,986
G
Pnpla6
patatin-like phospholipase domain containing 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PNPLA6 mRNA
CTD
PMID:15336504
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
G
Poglut2
protein O-glucosyltransferase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POGLUT2 mRNA
CTD
PMID:15336504
NCBI chr 9:46,256,388...46,268,714
Ensembl chr 9:46,256,390...46,268,532
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLD1 mRNA
CTD
PMID:12419474
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
G
Pold4
DNA polymerase delta 4, accessory subunit
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of POLD4 mRNA tert-Butylhydroperoxide affects the expression of POLD4 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:201,526,665...201,528,401
G
Pole2
DNA polymerase epsilon 2, accessory subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLE2 mRNA
CTD
PMID:12414654
NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305
G
Polr2e
RNA polymerase II, I and III subunit E
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLR2E mRNA
CTD
PMID:15336504
NCBI chr 7:9,666,695...9,670,638
Ensembl chr 7:9,666,716...9,670,643
G
Polr2j
RNA polymerase II subunit J
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLR2J mRNA
CTD
PMID:15336504
NCBI chr12:20,543,038...20,548,590
Ensembl chr12:20,543,038...20,548,594
G
Pon2
paraoxonase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PON2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
G
Popdc3
popeye domain containing 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of POPDC3 mRNA
CTD
PMID:15336504
NCBI chr20:48,772,397...48,800,677
Ensembl chr20:48,772,462...48,800,593
G
Pot1
protection of telomeres 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POT1 mRNA
CTD
PMID:15336504
NCBI chr 4:54,205,330...54,263,137
Ensembl chr 4:54,205,332...54,263,042
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions decreases expression
EXP
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein] tert-Butylhydroperoxide results in decreased expression of PPARA mRNA; tert-Butylhydroperoxide results in decreased expression of PPARA protein
CTD
PMID:26989860
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPARD mRNA
CTD
PMID:15336504
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases activity
ISO
tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]] tert-Butylhydroperoxide results in increased activity of PPARG protein
CTD
PMID:16417216 PMID:20847119
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
decreases response to substance decreases expression multiple interactions
ISO
PPARGC1A protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein AICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]]; dorsomorphin promotes the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]
CTD
PMID:17460188 PMID:25522270
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppip5k1
diphosphoinositol pentakisphosphate kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPIP5K1 mRNA
CTD
PMID:15336504
NCBI chr 3:108,284,120...108,327,683
Ensembl chr 3:108,284,120...108,323,428
G
Ppl
periplakin
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPL mRNA tert-Butylhydroperoxide results in decreased expression of PPL mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,450,919...10,496,575
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPM1D mRNA
CTD
PMID:12414654
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1CA mRNA
CTD
PMID:12419474
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1CB mRNA
CTD
PMID:15336504
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPP1R15A mRNA
CTD
PMID:15336504
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R3C mRNA tert-Butylhydroperoxide affects the expression of PPP1R3C mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Ppp1r7
protein phosphatase 1, regulatory subunit 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R7 mRNA
CTD
PMID:15336504
NCBI chr 9:93,886,068...93,911,198
Ensembl chr 9:93,886,143...93,914,850
G
Ppp1r8
protein phosphatase 1, regulatory subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R8 mRNA
CTD
PMID:12419474
NCBI chr 5:145,031,632...145,048,753
Ensembl chr 5:145,031,498...145,048,752
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPP2CB mRNA
CTD
PMID:12414654
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP3CA mRNA
CTD
PMID:12419474
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
G
Ppp3cc
protein phosphatase 3 catalytic subunit gamma
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PPP3CC mRNA
CTD
PMID:23410634
NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832
G
Pprc1
PPARG related coactivator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPRC1 mRNA
CTD
PMID:15336504
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
G
Prdx1
peroxiredoxin 1
increases expression decreases expression multiple interactions increases activity
ISO
tert-Butylhydroperoxide results in increased expression of PRDX1 protein tert-Butylhydroperoxide results in decreased expression of PRDX1 protein Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PRDX1 protein] tert-Butylhydroperoxide results in increased activity of PRDX1 protein
CTD
PMID:11295360 PMID:16880205 PMID:20100471
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prdx2
peroxiredoxin 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRDX2 mRNA tert-Butylhydroperoxide results in increased expression of PRDX2 protein
CTD
PMID:11295360 PMID:14729362 PMID:15336504
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Prdx3
peroxiredoxin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PRDX3 protein
CTD
PMID:24394546
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
G
Prdx5
peroxiredoxin 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRDX5 mRNA
CTD
PMID:14729362
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
G
Prdx6
peroxiredoxin 6
increases expression affects response to substance increases response to substance decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of PRDX6 protein PRDX6 protein affects the susceptibility to tert-Butylhydroperoxide PRDX6 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide PRDX6 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:11295360 PMID:12732627 PMID:14741336 PMID:20627125
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Prepl
prolyl endopeptidase-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PREPL mRNA
CTD
PMID:15336504
NCBI chr 6:9,580,367...9,609,957
Ensembl chr 6:9,580,217...9,607,772
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRKAR1A mRNA
CTD
PMID:15336504
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
G
Prkca
protein kinase C, alpha
decreases expression increases activity affects localization
ISO EXP
tert-Butylhydroperoxide results in decreased expression of PRKCA mRNA tert-Butylhydroperoxide results in increased activity of PRKCA protein tert-Butylhydroperoxide affects the localization of PRKCA protein
CTD
PMID:15336504 PMID:16716901
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prkce
protein kinase C, epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRKCE mRNA
CTD
PMID:27509014
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkch
protein kinase C, eta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRKCH mRNA
CTD
PMID:15336504
NCBI chr 6:92,292,000...92,490,663
Ensembl chr 6:92,292,000...92,490,654
G
Prkcq
protein kinase C, theta
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of PRKCQ mRNA tert-Butylhydroperoxide results in increased methylation of PRKCQ gene
CTD
PMID:27509014
NCBI chr17:67,246,394...67,379,049
Ensembl chr17:67,246,394...67,378,704
G
Prmt3
protein arginine methyltransferase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRMT3 mRNA
CTD
PMID:15336504
NCBI chr 1:99,492,712...99,581,774
Ensembl chr 1:99,492,724...99,579,435
G
Prnp
prion protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRNP mRNA
CTD
PMID:15336504
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
Pros1
protein S
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PROS1 mRNA
CTD
PMID:15336504
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Prr13
proline rich 13
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRR13 mRNA
CTD
PMID:15003993
NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:133,592,490...133,601,005
G
Prrg2
proline rich and Gla domain 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRRG2 mRNA
CTD
PMID:14729362
NCBI chr 1:95,534,276...95,543,364
Ensembl chr 1:95,534,290...95,543,425
G
Prune1
prune exopolyphosphatase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRUNE1 mRNA
CTD
PMID:15336504
NCBI chr 2:182,830,575...182,859,972
Ensembl chr 2:182,830,578...182,859,336
G
Prune2
prune homolog 2 with BCH domain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRUNE2 mRNA
CTD
PMID:15336504
NCBI chr 1:214,352,586...214,624,848
Ensembl chr 1:214,352,955...214,622,650
G
Psca
prostate stem cell antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSCA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
G
Psd3
pleckstrin and Sec7 domain containing 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSD3 mRNA
CTD
PMID:15336504
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
G
Psip1
PC4 and SRSF1 interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSIP1 mRNA
CTD
PMID:15336504
NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257
G
Psma6
proteasome 20S subunit alpha 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMA6 mRNA
CTD
PMID:15336504
NCBI chr 6:72,765,534...72,796,554
Ensembl chr 6:72,765,473...72,796,554
G
Psmb9
proteasome 20S subunit beta 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMB9 mRNA
CTD
PMID:15003993
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Psmd11
proteasome 26S subunit, non-ATPase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSMD11 mRNA
CTD
PMID:15336504
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
G
Psmd12
proteasome 26S subunit, non-ATPase 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMD12 mRNA
CTD
PMID:12414654
NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287
G
Psrc1
proline and serine rich coiled-coil 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSRC1 mRNA
CTD
PMID:15336504
NCBI chr 2:196,022,361...196,026,874
Ensembl chr 2:196,022,361...196,026,874
G
Ptbp2
polypyrimidine tract binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTBP2 mRNA
CTD
PMID:15336504
NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
G
Pten
phosphatase and tensin homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTEN mRNA
CTD
PMID:15336504
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptges
prostaglandin E synthase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTGES mRNA
CTD
PMID:15336504
NCBI chr 3:14,177,892...14,189,236
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTGR1 mRNA
CTD
PMID:14729362 PMID:23410634
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptgs1
prostaglandin-endoperoxide synthase 1
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of PTGS1 protein
CTD
PMID:15604817
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases activity increases expression
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]; tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] tert-Butylhydroperoxide results in increased activity of PTGS2 protein
CTD
PMID:14729362 PMID:15604817 PMID:15705740 PMID:16417216 PMID:28063877
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PTK2 mRNA
CTD
PMID:15336504
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptma
prothymosin alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PTMA mRNA
CTD
PMID:12419474
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
G
Ptp4a1
protein tyrosine phosphatase 4A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTP4A1 mRNA
CTD
PMID:15336504
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
G
Ptp4a2
protein tyrosine phosphatase 4A2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTP4A2 mRNA
CTD
PMID:15336504
NCBI chr 5:142,165,405...142,192,412
Ensembl chr 5:142,165,700...142,191,899
G
Ptprr
protein tyrosine phosphatase, receptor type, R
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTPRR mRNA
CTD
PMID:15336504
NCBI chr 7:51,662,595...51,929,605
Ensembl chr 7:51,662,595...51,929,603
G
Ptrh2
peptidyl-tRNA hydrolase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTRH2 mRNA
CTD
PMID:15336504
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTTG1 mRNA
CTD
PMID:15003993
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Pum2
pumilio RNA-binding family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PUM2 mRNA
CTD
PMID:15336504
NCBI chr 6:31,462,879...31,542,976
Ensembl chr 6:31,462,872...31,542,976
G
Pvr
PVR cell adhesion molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PVR mRNA
CTD
PMID:15336504
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Pxmp2
peroxisomal membrane protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PXMP2 mRNA
CTD
PMID:15336504
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
G
Pygl
glycogen phosphorylase L
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PYGL mRNA
CTD
PMID:15336504
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Qsox1
quiescin sulfhydryl oxidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of QSOX1 mRNA
CTD
PMID:12419474
NCBI chr13:67,949,780...67,987,434
Ensembl chr13:67,949,780...67,987,459
G
R3hdm2
R3H domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of R3HDM2 mRNA
CTD
PMID:15336504
NCBI chr 7:63,212,519...63,340,574
Ensembl chr 7:63,232,346...63,340,540
G
Rab22a
RAB22A, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB22A mRNA
CTD
PMID:15336504
NCBI chr 3:162,459,727...162,506,129
Ensembl chr 3:162,459,726...162,506,137
G
Rab27a
RAB27A, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB27A mRNA
CTD
PMID:15336504
NCBI chr 8:73,782,730...73,836,630
Ensembl chr 8:73,782,694...73,847,829
G
Rab29
RAB29, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB29 mRNA
CTD
PMID:15336504
NCBI chr13:43,307,757...43,313,420
Ensembl chr13:43,307,775...43,313,417
G
Rab4a
RAB4A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB4A mRNA
CTD
PMID:15336504
NCBI chr19:51,795,613...51,822,706
Ensembl chr19:51,795,613...51,822,703
G
Rab5c
RAB5C, member RAS oncogene family
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of RAB5C intron
CTD
PMID:29432895
NCBI chr10:85,642,553...85,666,142
Ensembl chr10:85,642,809...85,666,103
G
Rab7a
RAB7A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB7 mRNA
CTD
PMID:12419474
NCBI chr 4:120,461,966...120,510,756
Ensembl chr 4:120,461,963...120,506,889
G
Rab8a
RAB8A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB8A mRNA
CTD
PMID:15336504
NCBI chr16:17,654,027...17,675,385
Ensembl chr16:17,654,034...17,675,678
G
Rabep2
rabaptin, RAB GTPase binding effector protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABEP2 mRNA
CTD
PMID:15336504
NCBI chr 1:181,010,305...181,026,651
Ensembl chr 1:181,010,305...181,026,648
G
Rabgap1
RAB GTPase activating protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABGAP1 mRNA
CTD
PMID:15336504
NCBI chr 3:21,208,012...21,326,013
Ensembl chr 3:21,208,055...21,326,013
G
Rabgap1l
RAB GTPase activating protein 1-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABGAP1L mRNA
CTD
PMID:15336504
NCBI chr13:72,464,114...73,059,845
Ensembl chr13:72,468,110...73,059,984
G
Rac2
Rac family small GTPase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAC2 mRNA
CTD
PMID:22659508
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAD23A mRNA
CTD
PMID:15336504
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Rala
RAS like proto-oncogene A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RALA mRNA
CTD
PMID:15336504
NCBI chr17:47,092,163...47,145,192
Ensembl chr17:47,092,207...47,144,063
G
Ranbp2
RAN binding protein 2
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]
CTD
PMID:20847119
NCBI chr20:26,442,156...26,493,481
Ensembl chr20:26,442,217...26,493,481
G
Ranbp9
RAN binding protein 9
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RANBP9 mRNA
CTD
PMID:23410634
NCBI chr17:21,220,807...21,303,009
Ensembl chr17:21,220,618...21,303,004
G
Rap1gap
Rap1 GTPase-activating protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAP1GAP mRNA
CTD
PMID:23410634
NCBI chr 5:149,873,987...149,939,254
Ensembl chr 5:149,892,019...149,939,253
G
Rap1gds1
Rap1 GTPase-GDP dissociation stimulator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAP1GDS1 mRNA
CTD
PMID:15336504
NCBI chr 2:227,500,366...227,645,213
Ensembl chr 2:227,500,367...227,645,169
G
Rap2a
RAP2A, member of RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAP2A mRNA
CTD
PMID:15336504
NCBI chr15:97,596,848...97,597,338
Ensembl chr15:97,596,020...97,624,138
G
Rapgef2
Rap guanine nucleotide exchange factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAPGEF2 mRNA
CTD
PMID:15336504
NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247
G
Rarb
retinoic acid receptor, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RARB mRNA
CTD
PMID:12419474
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
G
Rasal1
RAS protein activator like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RASA4 mRNA
CTD
PMID:15003993
NCBI chr12:35,881,269...35,913,727
Ensembl chr12:35,881,270...35,913,727
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RASGRF1 mRNA
CTD
PMID:15336504
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rasgrp3
RAS guanyl releasing protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RASGRP3 mRNA
CTD
PMID:15336504
NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:19,895,390...19,958,578
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RB1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbbp8
RB binding protein 8, endonuclease
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBBP8 mRNA
CTD
PMID:15336504
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBL2 mRNA
CTD
PMID:12419474
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
G
Rbm12
RNA binding motif protein 12
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBM12 mRNA
CTD
PMID:15336504
NCBI chr 3:144,609,661...144,629,911
Ensembl chr 3:144,611,623...144,629,915 Ensembl chr 3:144,611,623...144,629,915
G
Rcn1
reticulocalbin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RCN1 mRNA
CTD
PMID:14729362
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rcn3
reticulocalbin 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RCN3 mRNA tert-Butylhydroperoxide results in increased expression of RCN3 mRNA
CTD
PMID:15336504
NCBI chr 1:95,564,503...95,573,762
Ensembl chr 1:95,564,380...95,573,725
G
Rcor3
REST corepressor 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RCOR3 mRNA
CTD
PMID:23410634
NCBI chr13:103,624,966...103,665,565
Ensembl chr13:103,624,971...103,665,565
G
Rdh14
retinol dehydrogenase 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RDH14 mRNA
CTD
PMID:15336504
NCBI chr 6:33,156,569...33,161,712
Ensembl chr 6:33,156,569...33,161,712
G
Recql
RecQ like helicase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RECQL mRNA
CTD
PMID:15336504
NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
G
Reep3
receptor accessory protein 3
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]
CTD
PMID:20847119
NCBI chr20:21,493,868...21,578,698
Ensembl chr20:21,493,954...21,578,697
G
Reep4
receptor accessory protein 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of REEP4 mRNA
CTD
PMID:23410634
NCBI chr15:45,620,317...45,623,524
Ensembl chr15:45,619,941...45,623,526
G
Reep5
receptor accessory protein 5
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of REEP5 mRNA tert-Butylhydroperoxide results in increased expression of REEP5 mRNA
CTD
PMID:15336504
NCBI chr18:25,945,375...25,983,271
Ensembl chr18:25,945,381...25,976,509
G
Rel
REL proto-oncogene, NF-kB subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of REL mRNA
CTD
PMID:12419474
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions affects localization increases expression
ISO
Catechin inhibits the reaction [tert-Butylhydroperoxide affects the localization of RELA protein] tert-Butylhydroperoxide results in increased expression of RELA mRNA
CTD
PMID:15879681 PMID:16704919
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RELB mRNA
CTD
PMID:15336504
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Renbp
renin binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RENBP mRNA
CTD
PMID:14729362
NCBI chr X:151,661,463...151,670,538
Ensembl chr X:151,661,458...151,670,516
G
Rer1
retention in endoplasmic reticulum sorting receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RER1 mRNA
CTD
PMID:15336504
NCBI chr 5:165,634,567...165,646,643
Ensembl chr 5:165,634,300...165,646,750
G
Retsat
retinol saturase
increases response to substance
ISO
RETSAT protein results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:17664141
NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310
G
Rfc3
replication factor C subunit 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RFC3 mRNA
CTD
PMID:15336504
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
G
Rfxank
regulatory factor X-associated ankyrin-containing protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RFXANK mRNA
CTD
PMID:15336504
NCBI chr16:19,280,857...19,288,886
Ensembl chr16:19,281,475...19,460,255
G
Rgn
regucalcin
multiple interactions decreases expression
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RGN protein]
CTD
PMID:16677110 PMID:24394546
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rgs10
regulator of G-protein signaling 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RGS10 mRNA
CTD
PMID:15003993
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RGS2 mRNA
CTD
PMID:15336504
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs3
regulator of G-protein signaling 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RGS3 mRNA
CTD
PMID:23410634
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
G
Rhd
Rh blood group, D antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RHD mRNA
CTD
PMID:15003993
NCBI chr 5:147,087,479...147,121,716
Ensembl chr 5:147,087,518...147,121,715
G
Rheb
Ras homolog, mTORC1 binding
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RHEB mRNA
CTD
PMID:15336504
NCBI chr 4:10,278,970...10,320,160
Ensembl chr 4:10,279,370...10,320,160
G
Rhod
ras homolog family member D
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RHOD mRNA
CTD
PMID:15336504
NCBI chr 1:201,708,699...201,724,405
Ensembl chr 1:201,708,699...201,722,632
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RHPN2 mRNA
CTD
PMID:14729362
NCBI chr 1:87,991,143...88,051,895
Ensembl chr 1:87,991,144...88,051,902
G
Rictor
RPTOR independent companion of MTOR, complex 2
multiple interactions affects expression increases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RICTOR mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA] tert-Butylhydroperoxide affects the expression of RICTOR mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 2:55,811,877...55,903,893
Ensembl chr 2:55,811,322...55,901,426
G
Riox1
ribosomal oxygenase 1
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA]
CTD
PMID:20847119
NCBI chr 6:103,579,642...103,582,260
Ensembl chr 6:103,579,642...103,582,250
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RIPK2 mRNA
CTD
PMID:15336504
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
Rmnd5b
required for meiotic nuclear division 5 homolog B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RMND5B mRNA
CTD
PMID:15336504
NCBI chr10:35,881,250...35,892,322
Ensembl chr10:35,881,268...35,892,265
G
Rnaseh2c
ribonuclease H2, subunit C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RNASEH2C mRNA
CTD
PMID:15003993
NCBI chr 1:202,894,626...202,895,675
Ensembl chr 1:202,894,643...202,897,516
G
Rnd3
Rho family GTPase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RND3 mRNA
CTD
PMID:15336504
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
G
Rnf103
ring finger protein 103
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNF103 mRNA
CTD
PMID:15003993
NCBI chr 4:103,526,456...103,542,529
Ensembl chr 4:103,526,502...103,555,919
G
Rnf13
ring finger protein 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNF13 mRNA
CTD
PMID:15336504
NCBI chr 2:141,927,887...142,061,801
Ensembl chr 2:141,927,909...142,061,801
G
Rnft2
ring finger protein, transmembrane 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNFT2 mRNA
CTD
PMID:15336504
NCBI chr12:38,329,217...38,387,303
Ensembl chr12:38,329,269...38,387,290
G
Rnh1
ribonuclease/angiogenin inhibitor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNH1 mRNA
CTD
PMID:12419474
NCBI chr 1:196,269,293...196,281,763
Ensembl chr 1:196,269,293...196,281,910
G
Rora
RAR-related orphan receptor A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RORA mRNA
CTD
PMID:15336504
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpa1
replication protein A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPA1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpgr
retinitis pigmentosa GTPase regulator
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RPGR mRNA
CTD
PMID:23410634
NCBI chr X:12,566,447...12,628,171
Ensembl chr X:12,566,645...12,747,882
G
Rpl13a
ribosomal protein L13A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPL13A mRNA
CTD
PMID:12419474
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
G
Rpl27a
ribosomal protein L27A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RPL27A mRNA
CTD
PMID:23410634
NCBI chr 1:163,539,732...163,542,771
G
Rpl5
ribosomal protein L5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RPL5 mRNA
CTD
PMID:15336504
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
G
Rps19
ribosomal protein S19
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPS19 mRNA
CTD
PMID:12419474
NCBI chr 1:80,480,718...80,486,511
Ensembl chr 1:80,480,951...80,486,508
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RPS27L mRNA
CTD
PMID:15336504
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rps6ka1
ribosomal protein S6 kinase A1
increases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein]
CTD
PMID:17003459
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
G
Rpusd2
RNA pseudouridine synthase domain containing 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RPUSD2 mRNA]
CTD
PMID:20847119
NCBI chr 3:106,017,759...106,023,010
Ensembl chr 3:106,017,864...106,023,251
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAD mRNA
CTD
PMID:15336504
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
G
Rragd
Ras-related GTP binding D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAGD mRNA
CTD
PMID:15336504
NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356
G
Rras2
RAS related 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAS2 mRNA
CTD
PMID:23410634
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
Rrm1
ribonucleotide reductase catalytic subunit M1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of RRM1 mRNA tert-Butylhydroperoxide affects the expression of RRM1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
G
Rrn3
RRN3 homolog, RNA polymerase I transcription factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRN3 mRNA
CTD
PMID:29432895
NCBI chr10:2,129,949...2,165,381
Ensembl chr10:2,129,978...2,165,663
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of RSAD2 mRNA tert-Butylhydroperoxide results in decreased expression of RSAD2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
Rsl1d1
ribosomal L1 domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RSL1D1 mRNA
CTD
PMID:29432895
NCBI chr10:4,424,868...4,436,753
Ensembl chr10:4,397,821...4,439,593
G
RT1-A2
RT1 class Ia, locus A2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HLA-E mRNA
CTD
PMID:15336504
NCBI chr20:4,870,939...4,910,183
G
RT1-DMb
RT1 class II, locus DMb
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2-DMB1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
G
RT1-Ha
RT1 class II, locus Ha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HLA-DPA1 mRNA
CTD
PMID:15336504
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HLA-DPB1 mRNA
CTD
PMID:15336504
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Rtn3
reticulon 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RTN3 mRNA
CTD
PMID:15336504
NCBI chr 1:204,612,675...204,669,212
Ensembl chr 1:204,612,675...204,669,275
G
Rtn4r
reticulon 4 receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RTN4R mRNA
CTD
PMID:29432895
NCBI chr11:82,844,309...82,869,251
Ensembl chr11:82,844,309...82,869,466
G
Rxra
retinoid X receptor alpha
decreases response to substance
ISO
RXRA protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14978233
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Rxrb
retinoid X receptor beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RXRB mRNA
CTD
PMID:12419474
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
G
Rybp
RING1 and YY1 binding protein
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of RYBP gene tert-Butylhydroperoxide results in increased expression of RYBP mRNA
CTD
PMID:27509014
NCBI chr 4:132,876,260...132,928,328
Ensembl chr 4:132,876,361...132,928,316
G
S100a3
S100 calcium binding protein A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of S100A3 mRNA
CTD
PMID:15336504
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
G
S100a4
S100 calcium-binding protein A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of S100A4 mRNA
CTD
PMID:15336504
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
S100pbp
S100P binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of S100PBP mRNA
CTD
PMID:15336504
NCBI chr 5:141,494,352...141,535,752
Ensembl chr 5:141,494,353...141,535,525
G
Samd4a
sterile alpha motif domain containing 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAMD4A mRNA
CTD
PMID:15336504
NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380
G
Sap18
Sin3A associated protein 18
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SAP18 mRNA
CTD
PMID:15336504
NCBI chr15:31,943,228...31,947,534
Ensembl chr15:31,943,230...31,950,038 Ensembl chr10:31,943,230...31,950,038
G
Sap30
Sin3A associated protein 30
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SAP30 mRNA
CTD
PMID:15336504
NCBI chr16:32,747,777...32,753,114
Ensembl chr16:32,747,734...32,753,112
G
Sapcd2
suppressor APC domain containing 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SAPCD2 mRNA
CTD
PMID:23410634
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
G
Sar1a
secretion associated, Ras related GTPase 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAR1A mRNA
CTD
PMID:15336504
NCBI chr20:29,623,529...29,635,935
Ensembl chr20:29,623,553...29,635,935
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAR1B mRNA
CTD
PMID:15336504
NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066
G
Saraf
store-operated calcium entry-associated regulatory factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SARAF mRNA
CTD
PMID:15003993
NCBI chr16:58,017,231...58,035,481
Ensembl chr16:58,017,231...58,035,545
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAT1 mRNA
CTD
PMID:15336504
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Satb1
SATB homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SATB1 mRNA
CTD
PMID:15336504
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
G
Scarb2
scavenger receptor class B, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCARB2 mRNA
CTD
PMID:15336504
NCBI chr14:15,558,271...15,609,813
Ensembl chr14:15,558,236...15,609,813
G
Scd
stearoyl-CoA desaturase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCD mRNA
CTD
PMID:15336504
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scg5
secretogranin V
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SCG5 mRNA
CTD
PMID:15336504
NCBI chr 3:100,544,101...100,588,558
Ensembl chr 3:100,544,099...100,588,463
G
Scml1
Scm polycomb group protein like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SCML1 mRNA
CTD
PMID:15336504
NCBI chr X:32,893,100...32,912,686
Ensembl chr X:32,894,327...32,911,366
G
Scp2
sterol carrier protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCP2 mRNA
CTD
PMID:15336504
NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287
G
Sdc2
syndecan 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SDC2 mRNA
CTD
PMID:15336504
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
G
Sec14l1
SEC14-like lipid binding 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SEC14L1 mRNA
CTD
PMID:15336504
NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068
G
Sec24b
SEC24 homolog B, COPII coat complex component
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SEC24B mRNA
CTD
PMID:23410634
NCBI chr 2:218,562,670...218,632,753
Ensembl chr 2:218,562,676...218,632,699
G
Sectm1b
secreted and transmembrane 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SECTM1 mRNA
CTD
PMID:15336504
NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769
G
Sel1l3
SEL1L family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEL1L3 mRNA
CTD
PMID:15336504
NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644
G
Selenbp1
selenium binding protein 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SELENBP1 mRNA tert-Butylhydroperoxide results in increased expression of SELENBP1 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Selenok
selenoprotein K
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SELENOK mRNA
CTD
PMID:15003993
NCBI chr16:5,152,066...5,160,648
Ensembl chr16:5,152,066...5,159,188
G
Selenop
selenoprotein P
multiple interactions decreases response to substance
ISO
dimethyl mercaptosuccinate inhibits the reaction [SELENOP protein results in decreased susceptibility to tert-Butylhydroperoxide]
CTD
PMID:16632112
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Sephs1
selenophosphate synthetase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEPHS1 mRNA
CTD
PMID:15336504
NCBI chr17:73,354,435...73,382,803
Ensembl chr17:73,356,530...73,382,593
G
Septin2
septin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEPTIN2 mRNA
CTD
PMID:15336504
NCBI chr 9:94,018,141...94,051,386
Ensembl chr 9:94,018,208...94,051,386
G
Septin9
septin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SEPTIN9 mRNA
CTD
PMID:15003993
NCBI chr10:102,409,798...102,579,056
Ensembl chr10:102,409,711...102,579,055
G
Serpinb1a
serpin family B member 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SERPINB1 mRNA
CTD
PMID:15336504
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
G
Serpinb2
serpin family B member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB2 mRNA
CTD
PMID:15336504
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
G
Serpinb5
serpin family B member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB5 mRNA
CTD
PMID:12414654
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Serpinb8
serpin family B member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB8 mRNA
CTD
PMID:15336504
NCBI chr13:23,626,936...23,650,277
Ensembl chr13:23,626,945...23,650,835
G
Serpine1
serpin family E member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINE1 mRNA
CTD
PMID:15336504
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpine2
serpin family E member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINE2 mRNA
CTD
PMID:15336504
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
G
Serpinh1
serpin family H member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINH1 mRNA
CTD
PMID:12766906
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Serpini1
serpin family I member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINI1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Sesn2
sestrin 2
increases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of SESN2 protein
CTD
PMID:32740777
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Setd2
SET domain containing 2, histone lysine methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SETD2 mRNA
CTD
PMID:15336504
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
G
Setd3
SET domain containing 3, actin N3(tau)-histidine methyltransferase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SETD3 mRNA
CTD
PMID:15336504
NCBI chr 6:127,023,058...127,090,020
Ensembl chr 6:127,023,058...127,090,008
G
Setdb1
SET domain bifurcated histone lysine methyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SETDB1 mRNA
CTD
PMID:15336504
NCBI chr 2:182,898,738...182,930,283
Ensembl chr 2:182,898,738...182,930,506
G
Sf1
splicing factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SF1 mRNA
CTD
PMID:12419474
NCBI chr 1:203,670,016...203,683,432
Ensembl chr 1:203,670,018...203,684,330
G
Sfpq
splicing factor proline and glutamine rich
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of SFPQ intron
CTD
PMID:29432895
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sgce
sarcoglycan, epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SGCE mRNA
CTD
PMID:15336504
NCBI chr 4:32,771,477...32,842,238
Ensembl chr 4:32,771,477...32,842,254
G
Sgk2
serum/glucocorticoid regulated kinase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SGK2 mRNA
CTD
PMID:23410634
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
G
Sh2b3
SH2B adaptor protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SH2B3 mRNA
CTD
PMID:15336504
NCBI chr12:34,731,934...34,753,617
Ensembl chr12:34,731,911...34,753,616
G
Sh2d4a
SH2 domain containing 4A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SH2D4A mRNA
CTD
PMID:15336504
NCBI chr16:21,339,010...21,409,360
Ensembl chr16:21,340,015...21,409,260
G
Sh2d5
SH2 domain containing 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SH2D5 mRNA
CTD
PMID:23410634
NCBI chr 5:150,469,738...150,480,615
Ensembl chr 5:150,467,728...150,479,955
G
Sh3glb1
SH3 domain -containing GRB2-like endophilin B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SH3GLB1 mRNA
CTD
PMID:15336504
NCBI chr 2:233,750,838...233,784,817
Ensembl chr 2:233,750,838...233,784,784
G
Shisa5
shisa family member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SHISA5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 8:109,691,504...109,706,411
Ensembl chr 8:109,691,522...109,706,408
G
Shmt1
serine hydroxymethyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SHMT1 mRNA
CTD
PMID:15336504 PMID:27509014
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
G
Siah1
siah E3 ubiquitin protein ligase 1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of SIAH1A mRNA tert-Butylhydroperoxide affects the expression of SIAH1 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Sik1
salt-inducible kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SIK1 mRNA
CTD
PMID:15336504
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Sin3a
SIN3 transcription regulator family member A
increases localization
EXP
Tert-butyl hydroperoxide increases localization of Sin3a protein at Ar promoter in hepatoma cells
RGD
PMID:18945670
RGD:2306468
NCBI chr 8:57,481,539...57,536,195
Ensembl chr 8:57,481,573...57,536,192
G
Sipa1l1
signal-induced proliferation-associated 1 like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SIPA1L1 mRNA
CTD
PMID:15336504
NCBI chr 6:101,839,351...102,118,408
Ensembl chr 6:101,839,404...102,116,950
G
Sirt1
sirtuin 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of SIRT1 protein hyperoside inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SIRT1 protein]
CTD
PMID:18552516
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sirt3
sirtuin 3
multiple interactions
ISO
SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]]; SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
CTD
PMID:25522270
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Ska3
spindle and kinetochore associated complex subunit 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SKA3 mRNA
CTD
PMID:23410634
NCBI chr15:31,951,812...31,971,010
Ensembl chr15:31,951,825...31,971,010
G
Skp2
S-phase kinase associated protein 2
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of SKP2 mRNA tert-Butylhydroperoxide results in decreased methylation of SKP2 intron
CTD
PMID:15336504 PMID:29432895
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Slamf1
signaling lymphocytic activation molecule family member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLAMF1 mRNA
CTD
PMID:12414654
NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497
G
Slc11a2
solute carrier family 11 member 2
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC11A2 mRNA tert-Butylhydroperoxide results in decreased expression of SLC11A2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc13a3
solute carrier family 13 member 3
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of SLC13A3 intron
CTD
PMID:29432895
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc16a2
solute carrier family 16 member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC16A2 mRNA
CTD
PMID:15336504
NCBI chr X:68,725,365...68,848,572
Ensembl chr X:68,723,261...68,848,771
G
Slc17a2
solute carrier family 17, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC17A2 mRNA
CTD
PMID:23410634
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc19a2
solute carrier family 19 member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC19A2 mRNA
CTD
PMID:15336504
NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172
G
Slc1a1
solute carrier family 1 member 1
decreases expression decreases activity multiple interactions
ISO EXP
tert-Butylhydroperoxide results in decreased expression of SLC1A1 mRNA tert-Butylhydroperoxide results in decreased activity of SLC1A1 protein [Tetradecanoylphorbol Acetate co-treated with Propofol] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of SLC1A1 protein]
CTD
PMID:15336504 PMID:17382927
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
G
Slc1a4
solute carrier family 1 member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC1A4 mRNA
CTD
PMID:15336504
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc20a1
solute carrier family 20 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC20A1 mRNA
CTD
PMID:15003993
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc22a18
solute carrier family 22, member 18
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC22A18 mRNA
CTD
PMID:15336504
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
G
Slc22a3
solute carrier family 22 member 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC22A3 mRNA
CTD
PMID:23410634
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc25a10
solute carrier family 25 member 10
multiple interactions increases expression
EXP ISO
[SLC25A10 protein co-treated with Glutathione] results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of SLC25A10 mRNA
CTD
PMID:12388626 PMID:15003993
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
G
Slc25a16
solute carrier family 25 member 16
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC25A16 mRNA
CTD
PMID:15336504
NCBI chr20:25,691,474...25,717,558
Ensembl chr20:25,662,055...25,716,319
G
Slc27a2
solute carrier family 27 member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC27A2 mRNA
CTD
PMID:23410634
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slc2a3
solute carrier family 2 member 3
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]
CTD
PMID:20847119
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc31a1
solute carrier family 31 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC31A1 mRNA
CTD
PMID:14729362
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc35f2
solute carrier family 35, member F2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC35F2 mRNA
CTD
PMID:15336504
NCBI chr 8:54,159,970...54,203,614
Ensembl chr 8:54,159,970...54,203,612
G
Slc35g2
solute carrier family 35, member G2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC35G2 mRNA
CTD
PMID:15336504
NCBI chr 8:101,085,579...101,113,339
Ensembl chr 8:101,085,545...101,113,349
G
Slc37a4
solute carrier family 37 member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC37A4 mRNA
CTD
PMID:15336504
NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
G
Slc39a14
solute carrier family 39 member 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC39A14 mRNA
CTD
PMID:15336504
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc44a4
solute carrier family 44, member 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC44A4 mRNA
CTD
PMID:23410634
NCBI chr20:3,903,099...3,919,215
Ensembl chr20:3,903,099...3,919,215
G
Slc46a1
solute carrier family 46 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC46A1 mRNA
CTD
PMID:22956110
NCBI chr10:63,361,504...63,367,940
Ensembl chr10:63,361,486...63,368,848
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
increases degradation
ISO
tert-Butylhydroperoxide results in increased degradation of SLC4A1 protein
CTD
PMID:15040847
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
G
Slc4a11
solute carrier family 4 member 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC4A11 mRNA
CTD
PMID:29432895
NCBI chr 3:117,900,223...117,912,787
Ensembl chr 3:117,900,223...117,912,674
G
Slc6a14
solute carrier family 6 member 14
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC6A14 mRNA
CTD
PMID:23410634
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC7A11 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC7A5 mRNA
CTD
PMID:12419474
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of SLPI mRNA SLPI protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Sltm
SAFB-like, transcription modulator
multiple interactions increases expression
ISO
[Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of SLTM mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]
CTD
PMID:20847119
NCBI chr 8:71,215,995...71,261,821
Ensembl chr 8:71,216,612...71,261,825
G
Smad1
SMAD family member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMAD1 mRNA
CTD
PMID:12419474
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smad3
SMAD family member 3
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of SMAD3 mRNA tert-Butylhydroperoxide results in increased methylation of SMAD3 gene
CTD
PMID:27509014
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Smad5
SMAD family member 5
decreases methylation increases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of SMAD5 gene tert-Butylhydroperoxide results in increased expression of SMAD5 mRNA
CTD
PMID:27509014
NCBI chr17:7,862,332...7,891,678
Ensembl chr17:7,864,720...7,891,634
G
Smad7
SMAD family member 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMAD7 mRNA
CTD
PMID:15336504
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
G
Smad9
SMAD family member 9
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of SMAD9 mRNA tert-Butylhydroperoxide results in decreased methylation of SMAD9 gene
CTD
PMID:27509014
NCBI chr 2:138,956,326...139,006,315
Ensembl chr 2:138,986,471...139,006,307
G
Smarca2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCA2 mRNA
CTD
PMID:15336504
NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684
G
Smarcc1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCC1 mRNA
CTD
PMID:15336504
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
G
Smarcc2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCC2 mRNA
CTD
PMID:15336504
NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978
G
Smc4
structural maintenance of chromosomes 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMC4 mRNA tert-Butylhydroperoxide affects the expression of SMC4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
G
Smim19
small integral membrane protein 19
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SMIM19 mRNA
CTD
PMID:23410634
NCBI chr16:69,551,507...69,564,323
Ensembl chr16:69,553,916...69,567,245
G
Smim7
small integral membrane protein 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMIM7 mRNA
CTD
PMID:15336504
NCBI chr16:17,274,417...17,278,336
Ensembl chr16:17,273,258...17,278,336
G
Smndc1
survival motor neuron domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMNDC1 mRNA
CTD
PMID:15336504
NCBI chr 1:252,389,675...252,400,749
Ensembl chr 1:252,389,673...252,401,616
G
Smox
spermine oxidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMOX mRNA
CTD
PMID:15336504
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
G
Smtn
smoothelin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMTN mRNA
CTD
PMID:15336504
NCBI chr14:78,398,595...78,420,908
Ensembl chr14:78,397,778...78,420,886
G
Snai2
snail family transcriptional repressor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SNAI2 mRNA
CTD
PMID:15336504
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Snap23
synaptosome associated protein 23
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNAP23 mRNA
CTD
PMID:15336504
NCBI chr 3:107,514,088...107,546,177
Ensembl chr 3:107,514,131...107,544,320
G
Snn
stannin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNN mRNA
CTD
PMID:15336504
NCBI chr10:4,572,933...4,581,606
Ensembl chr10:4,572,376...4,584,021
G
Snx1
sorting nexin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNX1 mRNA
CTD
PMID:15336504
NCBI chr 8:66,630,086...66,670,418
Ensembl chr 8:66,630,086...66,670,360
G
Snx4
sorting nexin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNX4 mRNA
CTD
PMID:15336504
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Soat1
sterol O-acyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOAT1 mRNA
CTD
PMID:15336504
NCBI chr13:68,552,274...68,597,529
Ensembl chr13:68,552,317...68,597,494
G
Sobp
sine oculis binding protein homolog
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SOBP mRNA
CTD
PMID:15336504
NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541
G
Socs1
suppressor of cytokine signaling 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOCS1 mRNA
CTD
PMID:15003993
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs6
suppressor of cytokine signaling 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOCS6 mRNA
CTD
PMID:15336504
NCBI chr18:82,111,866...82,139,193
Ensembl chr18:82,111,827...82,139,219
G
Sod1
superoxide dismutase 1
decreases response to substance multiple interactions increases expression increases activity
ISO
SOD1 protein results in decreased susceptibility to tert-Butylhydroperoxide [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]; LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA] tert-Butylhydroperoxide results in increased activity of SOD1 protein
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:15849717 PMID:31627909 PMID:35690295 More...
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases response to substance increases expression decreases expression multiple interactions affects response to substance increases activity
ISO
SOD2 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of SOD2 mRNA tert-Butylhydroperoxide results in decreased expression of SOD2 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD2 mRNA; LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]; SIRT3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]]; tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein SOD2 protein affects the susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased activity of SOD2 protein
CTD
PMID:15182862 PMID:15336504 PMID:16636651 PMID:16704919 PMID:17003459 PMID:20107204 PMID:25522270 PMID:27050144 PMID:27509014 PMID:29128606 PMID:31627909 PMID:35690295 More...
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sord
sorbitol dehydrogenase
increases expression decreases expression increases activity
ISO EXP
tert-Butylhydroperoxide results in increased expression of SORD mRNA tert-Butylhydroperoxide results in decreased expression of SORD protein tert-Butylhydroperoxide results in increased activity of SORD protein
CTD
PMID:15336504 PMID:16928893 PMID:24394546
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Sox9
SRY-box transcription factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOX9 mRNA
CTD
PMID:15336504
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Sp100
SP100 nuclear antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SP100 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
G
Sp2
Sp2 transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SP2 mRNA
CTD
PMID:12419474
NCBI chr10:81,940,580...81,970,040
Ensembl chr10:81,940,587...81,970,548
G
Spag5
sperm associated antigen 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPAG5 mRNA
CTD
PMID:23410634
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Sparc
secreted protein acidic and cysteine rich
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPARC mRNA tert-Butylhydroperoxide results in increased expression of SPARC mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Spata20
spermatogenesis associated 20
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPATA20 mRNA
CTD
PMID:15336504
NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368
G
Spdl1
spindle apparatus coiled-coil protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPDL1 mRNA
CTD
PMID:23410634
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
G
Sphk1
sphingosine kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPHK1 mRNA
CTD
PMID:15336504
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPINT2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 1:84,558,159...84,580,616
Ensembl chr 1:84,558,166...84,580,616
G
Spred2
sprouty-related, EVH1 domain containing 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPRED2 mRNA
CTD
PMID:15336504
NCBI chr14:94,149,210...94,250,787
Ensembl chr14:94,148,837...94,249,162
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPRR1A mRNA
CTD
PMID:15003993
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Spry4
sprouty RTK signaling antagonist 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPRY4 mRNA
CTD
PMID:23410634
NCBI chr18:30,436,513...30,451,426
Ensembl chr18:30,436,443...30,453,004
G
Spta1
spectrin, alpha, erythrocytic 1
multiple interactions
ISO
tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]
CTD
PMID:15040847
NCBI chr13:86,203,504...86,279,371
Ensembl chr13:86,203,504...86,279,371
G
Sptan1
spectrin, alpha, non-erythrocytic 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTAN1 mRNA
CTD
PMID:15336504
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
G
Sptb
spectrin, beta, erythrocytic
multiple interactions
ISO
tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]
CTD
PMID:15040847
NCBI chr 6:95,310,342...95,437,221
Ensembl chr 6:95,310,326...95,437,118
G
Sptbn1
spectrin, beta, non-erythrocytic 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTBN1 mRNA
CTD
PMID:15336504
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
G
Sptlc1
serine palmitoyltransferase, long chain base subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTLC1 mRNA
CTD
PMID:15336504
NCBI chr17:11,877,249...11,916,295
Ensembl chr17:11,877,249...11,916,295
G
Sptlc2
serine palmitoyltransferase, long chain base subunit 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPTLC2 mRNA
CTD
PMID:15336504
NCBI chr 6:106,948,682...107,031,532
Ensembl chr 6:106,950,949...107,031,542
G
Sptssa
serine palmitoyltransferase, small subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTSSA mRNA
CTD
PMID:15336504
NCBI chr 6:72,144,714...72,156,130
Ensembl chr 6:72,144,714...72,156,214
G
Sqle
squalene epoxidase
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SQLE mRNA tert-Butylhydroperoxide results in increased expression of SQLE mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Sqor
sulfide quinone oxidoreductase
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of SQOR mRNA tert-Butylhydroperoxide affects the expression of SQOR mRNA
CTD
PMID:14729362 PMID:15336504 PMID:23410634
NCBI chr 3:109,841,225...109,886,724
Ensembl chr 3:109,841,250...109,960,778
G
Sqstm1
sequestosome 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SQSTM1 mRNA
CTD
PMID:23410634
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srf
serum response factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRF mRNA
CTD
PMID:12419474
NCBI chr 9:14,426,453...14,435,734
Ensembl chr 9:14,426,472...14,435,733
G
Srgn
serglycin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRGN mRNA
CTD
PMID:15336504
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
G
Srpk2
SRSF protein kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRPK2 mRNA
CTD
PMID:15336504
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
G
Srpra
SRP receptor subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRPRA mRNA
CTD
PMID:15336504
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Srpx
sushi-repeat-containing protein, X-linked
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRPX mRNA
CTD
PMID:15336504
NCBI chr X:12,676,984...12,751,296
Ensembl chr X:12,566,645...12,747,882
G
Srrd
SRR1 domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRRD mRNA
CTD
PMID:15336504
NCBI chr12:44,294,675...44,300,287
Ensembl chr12:44,294,271...44,300,287
G
Srrt
serrate, RNA effector molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRRT mRNA
CTD
PMID:15336504
NCBI chr12:19,392,578...19,406,098
Ensembl chr12:19,392,625...19,406,095
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRSF3 mRNA
CTD
PMID:15336504
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
G
Srxn1
sulfiredoxin 1
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of SRXN1 mRNA tert-Butylhydroperoxide results in decreased methylation of SRXN1 gene
CTD
PMID:22003191 PMID:23410634 PMID:27509014
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Ss18l1
SS18L1 subunit of BAF chromatin remodeling complex
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SS18L1 mRNA
CTD
PMID:15336504
NCBI chr 3:167,143,730...167,165,253
Ensembl chr 3:167,143,994...167,165,253
G
Sst
somatostatin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SST mRNA
CTD
PMID:12414654
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SSX2IP mRNA
CTD
PMID:15336504
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]
CTD
PMID:20847119
NCBI chr 7:98,845,270...98,913,409
Ensembl chr 7:98,845,270...98,913,236
G
St6galnac4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ST6GALNAC4 mRNA
CTD
PMID:15003993
NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243
G
ST7
suppression of tumorigenicity 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ST7 mRNA
CTD
PMID:15336504
NCBI chr 4:46,041,655...46,289,745
Ensembl chr 4:46,042,236...46,289,740
G
Stag1
STAG1 cohesin complex component
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAG1 mRNA
CTD
PMID:15336504
NCBI chr 8:101,179,039...101,564,684
Ensembl chr 8:101,179,039...101,564,677
G
Stat1
signal transducer and activator of transcription 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT1 mRNA tert-Butylhydroperoxide results in increased expression of STAT1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions decreases phosphorylation
ISO
3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of STAT3 protein]
CTD
PMID:29128606
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT5A mRNA
CTD
PMID:12766906
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Stat6
signal transducer and activator of transcription 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT6 mRNA
CTD
PMID:12419474
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stc1
stanniocalcin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STC1 mRNA
CTD
PMID:15336504
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Stc2
stanniocalcin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STC2 mRNA
CTD
PMID:15336504
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stk10
serine/threonine kinase 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STK10 mRNA
CTD
PMID:15336504
NCBI chr10:17,117,860...17,212,065
Ensembl chr10:17,117,878...17,212,061
G
Stk24
serine/threonine kinase 24
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STK24 mRNA
CTD
PMID:15336504
NCBI chr15:98,363,707...98,458,940
Ensembl chr15:98,365,791...98,460,553
G
Stmn1
stathmin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STMN1 mRNA
CTD
PMID:15336504
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Stx7
syntaxin 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STX7 mRNA
CTD
PMID:15336504
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Sugp2
SURP and G patch domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SUGP2 mRNA
CTD
PMID:15336504
NCBI chr16:19,159,951...19,191,412
Ensembl chr16:19,164,767...19,191,340
G
Sumo3
small ubiquitin-like modifier 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SUMO3 mRNA
CTD
PMID:29432895
NCBI chr20:11,010,140...11,020,850
Ensembl chr20:11,007,148...11,020,877 Ensembl chr20:11,007,148...11,020,877
G
Suox
sulfite oxidase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SUOX mRNA
CTD
PMID:23410634
NCBI chr 7:1,103,149...1,107,156
Ensembl chr 7:1,103,151...1,107,038
G
Susd6
sushi domain containing 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SUSD6 mRNA
CTD
PMID:15336504
NCBI chr 6:100,437,834...100,531,621
Ensembl chr 6:100,437,642...100,531,606
G
Synj2
synaptojanin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SYNJ2 mRNA
CTD
PMID:15336504
NCBI chr 1:46,518,594...46,621,919
Ensembl chr 1:46,518,709...46,633,687
G
Syt1
synaptotagmin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SYT1 mRNA
CTD
PMID:15336504
NCBI chr 7:43,813,204...44,358,020
Ensembl chr 7:43,815,785...44,357,803
G
Tada3
transcriptional adaptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TADA3 mRNA
CTD
PMID:12419474
NCBI chr 4:146,510,213...146,521,975
Ensembl chr 4:146,510,246...146,521,590
G
Tap1
transporter 1, ATP binding cassette subfamily B member
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TAP1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tapbpl
TAP binding protein-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TAPBPL mRNA
CTD
PMID:15336504
NCBI chr 4:158,021,454...158,028,905
G
Tasor
transcription activation suppressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TASOR mRNA
CTD
PMID:15336504
NCBI chr16:2,606,807...2,669,902
Ensembl chr16:2,603,936...2,667,292
G
Tbc1d22a
TBC1 domain family, member 22a
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TBC1D22A mRNA
CTD
PMID:15336504
NCBI chr 7:117,292,481...117,577,473
Ensembl chr 7:117,292,631...117,577,483
G
Tbl1xr1
TBL1X/Y related 1
affects expression decreases methylation
ISO
tert-Butylhydroperoxide affects the expression of TBL1XR1 mRNA tert-Butylhydroperoxide results in decreased methylation of TBL1XR1 intron
CTD
PMID:23410634 PMID:29432895
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
G
Tbrg1
transforming growth factor beta regulator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TBRG1 mRNA
CTD
PMID:14729362
NCBI chr 8:37,355,274...37,362,933
Ensembl chr 8:37,354,658...37,362,930
G
Tcaf1
TRPM8 channel-associated factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCAF1 mRNA
CTD
PMID:15336504
NCBI chr 4:71,589,674...71,639,274
Ensembl chr 4:71,591,200...71,613,309
G
Tcea1
transcription elongation factor A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCEA1 mRNA
CTD
PMID:12419474
NCBI chr 5:14,631,454...14,668,769
Ensembl chr 5:14,631,454...14,668,745 Ensembl chr15:14,631,454...14,668,745
G
Tcf3
transcription factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCF3 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314
G
Tcf4
transcription factor 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCF4 mRNA
CTD
PMID:15336504
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
G
Tcfl5
transcription factor like 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCFL5 mRNA
CTD
PMID:15336504
NCBI chr 3:167,734,471...167,754,174
Ensembl chr 3:167,734,473...167,754,282
G
Tead4
TEA domain transcription factor 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of TEAD4 mRNA tert-Butylhydroperoxide affects the expression of TEAD4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 4:161,474,122...161,572,837
Ensembl chr 4:161,497,851...161,572,323
G
Tenm4
teneurin transmembrane protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TENM4 mRNA
CTD
PMID:15336504
NCBI chr 1:149,895,097...151,263,315
Ensembl chr 1:150,780,381...151,259,144
G
Tent2
terminal nucleotidyltransferase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of TENT2 mRNA
CTD
PMID:23410634
NCBI chr 2:24,380,135...24,432,099
Ensembl chr 2:24,380,225...24,432,099
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TERF1 mRNA
CTD
PMID:12419474
NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340
G
Tet1
tet methylcytosine dioxygenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TET1 mRNA
CTD
PMID:27509014
NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052
G
Tex10
testis expressed 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TEX10 mRNA
CTD
PMID:15336504
NCBI chr 5:62,762,230...62,808,373
Ensembl chr 5:62,762,230...62,808,373
G
Tfcp2
transcription factor CP2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TFCP2 mRNA
CTD
PMID:15336504
NCBI chr 7:131,616,777...131,658,995
Ensembl chr 7:131,616,785...131,658,939
G
Tfdp1
transcription factor Dp-1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TFDP1 mRNA
CTD
PMID:15336504
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TFPI2 mRNA
CTD
PMID:15336504
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Tfrc
transferrin receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TFRC mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfa
transforming growth factor alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFA mRNA
CTD
PMID:15336504
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFB1 mRNA; tert-Butylhydroperoxide results in increased expression of TGFB1 protein
CTD
PMID:15147944 PMID:15336504 PMID:15963989
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFB1I1 mRNA tert-Butylhydroperoxide affects the expression of TGFB1I1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
G
Tgm2
transglutaminase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGM2 mRNA
CTD
PMID:15336504
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Tgoln2
trans-golgi network protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TGOLN2 mRNA
CTD
PMID:15336504
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
G
Thap1
THAP domain containing 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of THAP1 mRNA
CTD
PMID:23410634
NCBI chr16:65,905,348...65,909,942
Ensembl chr16:65,904,230...65,909,942
G
Thbd
thrombomodulin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBD mRNA
CTD
PMID:15336504
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBS1 mRNA
CTD
PMID:29432895
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thbs3
thrombospondin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBS3 mRNA
CTD
PMID:14729362
NCBI chr 2:174,621,788...174,633,594
Ensembl chr 2:174,621,812...174,633,594
G
Them6
thioesterase superfamily member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of THEM6 mRNA
CTD
PMID:15336504
NCBI chr 7:106,606,570...106,609,747
Ensembl chr 7:106,606,570...106,609,746
G
Thoc6
THO complex subunit 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of THOC6 mRNA
CTD
PMID:15336504
NCBI chr10:12,700,051...12,705,411
Ensembl chr10:12,700,051...12,706,925
G
Tia1
TIA1 cytotoxic granule-associated RNA binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TIA1 mRNA
CTD
PMID:15336504
NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIAL1 mRNA
CTD
PMID:15336504
NCBI chr 1:183,008,358...183,045,092
Ensembl chr 1:183,009,253...183,031,637
G
Tie1
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIE1 mRNA
CTD
PMID:15336504
NCBI chr 5:132,000,013...132,019,658
Ensembl chr 5:132,000,015...132,019,592
G
Timm22
translocase of inner mitochondrial membrane 22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMM22 mRNA
CTD
PMID:15003993
NCBI chr10:61,253,459...61,261,217
Ensembl chr10:61,253,450...61,261,755
G
Timm9
translocase of inner mitochondrial membrane 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMM9 mRNA
CTD
PMID:15336504
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
G
Timp3
TIMP metallopeptidase inhibitor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMP3 mRNA
CTD
PMID:15336504
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tinagl1
tubulointerstitial nephritis antigen-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TINAGL1 mRNA
CTD
PMID:15003993
NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIPARP mRNA
CTD
PMID:15336504
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tjp1
tight junction protein 1
multiple interactions affects localization
EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Staurosporine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]
CTD
PMID:16716901
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tk1
thymidine kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TK1 mRNA
CTD
PMID:12414654
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tkfc
triokinase and FMN cyclase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TKFC mRNA
CTD
PMID:15336504
NCBI chr 1:207,238,230...207,253,035
Ensembl chr 1:207,236,557...207,252,737
G
Tle3
TLE family member 3, transcriptional corepressor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TLE3 mRNA
CTD
PMID:15336504
NCBI chr 8:61,857,791...61,903,505
Ensembl chr 8:61,858,200...61,903,493
G
Tle4
TLE family member 4, transcriptional corepressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TLE4 mRNA
CTD
PMID:15336504
NCBI chr 1:211,661,738...211,798,458
Ensembl chr 1:211,661,746...211,797,862
G
Tle5
TLE family member 5, transcriptional modulator
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TLE5 mRNA tert-Butylhydroperoxide results in increased expression of TLE5 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:8,143,357...8,150,295
Ensembl chr 7:8,143,357...8,150,113
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tm4sf1
transmembrane 4 L six family member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TM4SF1 mRNA
CTD
PMID:12766906 PMID:15336504
NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146
G
Tm7sf2
transmembrane 7 superfamily member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TM7SF2 mRNA
CTD
PMID:15336504
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
G
Tm9sf2
transmembrane 9 superfamily member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TM9SF2 mRNA
CTD
PMID:15336504
NCBI chr15:99,201,556...99,254,054
Ensembl chr15:99,201,489...99,254,049
G
Tm9sf3
transmembrane 9 superfamily member 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TM9SF3 mRNA
CTD
PMID:15336504
NCBI chr 1:240,032,060...240,085,125
Ensembl chr 1:240,035,003...240,084,776
G
Tmco3
transmembrane and coiled-coil domains 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMCO3 mRNA
CTD
PMID:15336504
NCBI chr16:76,217,146...76,254,309
Ensembl chr16:76,217,201...76,254,107
G
Tmem106c
transmembrane protein 106C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM106C mRNA
CTD
PMID:15336504
NCBI chr 7:129,088,468...129,094,128
Ensembl chr 7:129,088,498...129,094,130
G
Tmem132a
transmembrane protein 132A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM132A mRNA
CTD
PMID:15336504
NCBI chr 1:207,507,074...207,518,756
Ensembl chr 1:207,507,077...207,518,758
G
Tmem158
transmembrane protein 158
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM158 mRNA
CTD
PMID:15336504
NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:122,913,675...122,914,673
G
Tmem177
transmembrane protein 177
multiple interactions decreases expression increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of TMEM177 mRNA] tert-Butylhydroperoxide results in increased expression of TMEM177 mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
G
Tmem205
transmembrane protein 205
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM205 mRNA
CTD
PMID:14729362
NCBI chr 8:20,452,092...20,458,011
Ensembl chr 8:20,452,092...20,457,828
G
Tmem248
transmembrane protein 248
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM248 mRNA
CTD
PMID:15336504
NCBI chr12:26,430,775...26,457,105
Ensembl chr12:26,432,953...26,457,105
G
Tmem80
transmembrane protein 80
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM80 mRNA
CTD
PMID:15336504
NCBI chr 1:196,435,999...196,444,368
Ensembl chr 1:196,436,003...196,444,367 Ensembl chr 1:196,436,003...196,444,367
G
Tmpo
thymopoietin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMPO mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tmsb10
thymosin, beta 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMSB10 mRNA
CTD
PMID:15003993
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tmsb15b2
thymosin beta 15B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMSB15A mRNA
CTD
PMID:15336504
NCBI chr X:100,298,705...100,300,820
Ensembl chr X:100,298,514...100,300,886
G
Tmt1a
thiol methyltransferase 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMT1A mRNA
CTD
PMID:15336504
NCBI chr 7:131,452,099...131,460,154
Ensembl chr 7:131,451,641...131,460,154
G
Tmx4
thioredoxin-related transmembrane protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMX4 mRNA
CTD
PMID:15336504
NCBI chr 3:121,856,237...121,899,680
Ensembl chr 3:121,856,261...121,899,641
G
Tnc
tenascin C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNC mRNA
CTD
PMID:15336504
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
multiple interactions increases expression increases secretion
ISO EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; 8-methoxymethyl-3-isobutyl-1-methylxanthine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Verapamil inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; W 7 inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein] 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNF mRNA; acetovanillone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein] tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:10231168 PMID:17129690 PMID:17369293 PMID:29111459 PMID:29935159 PMID:35690295 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNFAIP3 mRNA
CTD
PMID:15336504
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf1a
TNF receptor superfamily member 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNFRSF1A mRNA
CTD
PMID:12419474
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNFRSF9 mRNA
CTD
PMID:15003993
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of TNFSF10 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnnc1
troponin C1, slow skeletal and cardiac type
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNNC1 mRNA tert-Butylhydroperoxide results in increased expression of TNNC1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634
G
Tnnt1
troponin T1, slow skeletal type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNNT1 mRNA
CTD
PMID:15336504
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
G
Tnnt2
troponin T2, cardiac type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNNT2 mRNA
CTD
PMID:14729362
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Tnpo1
transportin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNPO1 mRNA
CTD
PMID:15336504
NCBI chr 2:30,207,529...30,300,162
Ensembl chr 2:30,211,510...30,300,375
G
Tnpo2
transportin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNPO2 mRNA
CTD
PMID:15336504
NCBI chr19:23,099,398...23,119,696
Ensembl chr19:23,099,401...23,119,596
G
Tom1
target of myb1 membrane trafficking protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TOM1 mRNA
CTD
PMID:12414654
NCBI chr19:13,405,482...13,440,384
Ensembl chr19:13,405,501...13,440,384
G
Top6bl
TOP6B like initiator of meiotic double strand breaks
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TOP6BL mRNA
CTD
PMID:15336504
NCBI chr 1:201,902,564...201,989,945
G
Tp53
tumor protein p53
multiple interactions increases expression increases phosphorylation increases glutathionylation decreases expression
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein]; S-ethyl glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein modified form] tert-Butylhydroperoxide results in increased expression of TRP53 mRNA; tert-Butylhydroperoxide results in increased expression of TRP53 protein tert-Butylhydroperoxide results in increased phosphorylation of TRP53 protein Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of TRP53 protein] tert-Butylhydroperoxide results in increased glutathionylation of TP53 protein tert-Butylhydroperoxide results in decreased expression of TP53 mRNA
CTD
PMID:12419474 PMID:12782109 PMID:15879681 PMID:17555331 PMID:18619952 PMID:35690295 More...
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53bp1
tumor protein p53 binding protein 1
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of TP53BP1 mRNA tert-Butylhydroperoxide results in decreased methylation of TP53BP1 gene
CTD
PMID:27509014
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
G
Tp53i3
tumor protein p53 inducible protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TP53I3 mRNA
CTD
PMID:15336504
NCBI chr 6:27,818,327...27,825,753
G
Tp73
tumor protein p73
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of TP73 mRNA tert-Butylhydroperoxide results in increased methylation of TP73 gene
CTD
PMID:27509014
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
G
Tpd52l1
TPD52 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPD52L1 mRNA
CTD
PMID:15336504
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
G
Tpgs2
tubulin polyglutamylase complex subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPGS2 mRNA
CTD
PMID:15336504
NCBI chr18:16,432,628...16,489,604
Ensembl chr18:16,422,238...16,489,570
G
Tpm2
tropomyosin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPM2 mRNA
CTD
PMID:15336504
NCBI chr 5:57,770,919...57,780,278
Ensembl chr 5:57,770,864...57,779,992
G
Tpp1
tripeptidyl peptidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPP1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 1:160,097,984...160,104,108
Ensembl chr 1:160,096,833...160,104,129
G
Tpsab1
tryptase alpha/beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPSAB1 mRNA
CTD
PMID:15003993
NCBI chr10:14,360,396...14,362,811
Ensembl chr10:14,360,396...14,362,811
G
Tpst2
tyrosylprotein sulfotransferase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPST2 mRNA
CTD
PMID:15336504
NCBI chr12:44,321,875...44,363,892
Ensembl chr12:44,321,875...44,362,329
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRAF1 mRNA
CTD
PMID:15003993
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf2
Tnf receptor-associated factor 2
multiple interactions
ISO
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]
CTD
PMID:24394546
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
G
Traf4
Tnf receptor associated factor 4
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of TRAF4 mRNA tert-Butylhydroperoxide results in increased methylation of TRAF4 gene
CTD
PMID:27509014
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
G
Trak1
trafficking kinesin protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRAK1 mRNA
CTD
PMID:15336504
NCBI chr 8:120,984,445...121,139,357
Ensembl chr 8:120,984,431...121,139,367
G
Tram1
translocation associated membrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRAM1 mRNA
CTD
PMID:15336504
NCBI chr 5:5,642,579...5,667,666
Ensembl chr 5:5,642,546...5,686,971
G
Trappc1
trafficking protein particle complex subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRAPPC1 mRNA
CTD
PMID:15003993
NCBI chr10:54,045,598...54,047,184
Ensembl chr10:54,045,537...54,047,331
G
Triap1
TP53 regulated inhibitor of apoptosis 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIAP1 mRNA
CTD
PMID:15336504
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
G
Trib1
tribbles pseudokinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIB1 mRNA
CTD
PMID:15336504
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trib2
tribbles pseudokinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIB2 mRNA
CTD
PMID:15336504
NCBI chr 6:38,545,971...38,570,349
Ensembl chr 6:38,545,975...38,569,370
G
Trim21
tripartite motif-containing 21
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIM21 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:156,964,896...156,987,504
Ensembl chr 1:156,964,913...156,987,440
G
Trim25
tripartite motif-containing 25
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIM25 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:73,812,818...73,831,271
Ensembl chr10:73,812,818...73,831,257
G
Trio
trio Rho guanine nucleotide exchange factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIO mRNA
CTD
PMID:15336504
NCBI chr 2:78,505,069...78,801,384
Ensembl chr 2:78,505,070...78,803,135
G
Triobp
TRIO and F-actin binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIOBP mRNA
CTD
PMID:15336504
NCBI chr 7:110,505,916...110,569,301
Ensembl chr 7:110,506,248...110,562,474
G
Trip6
thyroid hormone receptor interactor 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIP6 mRNA
CTD
PMID:15336504
NCBI chr12:19,386,212...19,390,619
Ensembl chr12:19,386,014...19,390,618
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRPV2 mRNA
CTD
PMID:15336504
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
G
Trrap
transformation/transcription domain-associated protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRRAP mRNA
CTD
PMID:15336504
NCBI chr12:9,738,006...9,827,708
Ensembl chr12:9,738,006...9,827,674
G
Tsc22d2
TSC22 domain family, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of TSC22D2 mRNA
CTD
PMID:23410634
NCBI chr 2:142,646,778...142,697,977
Ensembl chr 2:142,644,744...142,693,606
G
Tsg101
tumor susceptibility 101
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSG101 mRNA
CTD
PMID:12419474
NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554
G
Tshb
thyroid stimulating hormone subunit beta
decreases activity increases oxidation
ISO
tert-Butylhydroperoxide results in decreased activity of TSHB protein tert-Butylhydroperoxide results in increased oxidation of TSHB protein
CTD
PMID:14751029
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Tspan14
tetraspanin 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN14 mRNA
CTD
PMID:15336504
NCBI chr16:16,784,242...16,841,368
Ensembl chr16:16,783,234...16,841,400
G
Tspan3
tetraspanin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSPAN3 mRNA
CTD
PMID:15336504
NCBI chr 8:56,546,067...56,569,815
Ensembl chr 8:56,546,069...56,569,880
G
Tspan31
tetraspanin 31
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSPAN31 mRNA
CTD
PMID:12419474
NCBI chr 7:62,889,552...62,892,428
Ensembl chr 7:62,889,552...62,898,388
G
Tspan5
tetraspanin 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN5 mRNA
CTD
PMID:15336504
NCBI chr 2:227,294,180...227,469,361
Ensembl chr 2:227,294,217...227,465,664
G
Tspan9
tetraspanin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN9 mRNA
CTD
PMID:15003993
NCBI chr 4:160,813,879...160,995,574
Ensembl chr 4:160,813,879...160,995,501
G
Ttc3
tetratricopeptide repeat domain 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TTC3 mRNA
CTD
PMID:15336504
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBA1A mRNA
CTD
PMID:12414654
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1b
tubulin, alpha 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBA1B mRNA; tert-Butylhydroperoxide results in decreased expression of TUBA1B protein
CTD
PMID:12419474 PMID:15050405
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBB2A mRNA
CTD
PMID:14729362
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Tubb2b
tubulin, beta 2B class IIb
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBB2B mRNA
CTD
PMID:15336504
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
G
Tubgcp3
tubulin gamma complex component 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBGCP3 mRNA
CTD
PMID:15336504
NCBI chr16:76,851,859...76,912,499
Ensembl chr16:76,851,810...76,912,499
G
Tulp3
TUB like protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TULP3 mRNA
CTD
PMID:15336504
NCBI chr 4:161,590,478...161,632,244
Ensembl chr 4:161,590,479...161,632,149
G
Tusc3
tumor suppressor candidate 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUSC3 mRNA
CTD
PMID:15336504
NCBI chr16:53,196,195...53,345,241
Ensembl chr16:53,196,195...53,344,781
G
Txn1
thioredoxin 1
decreases response to substance
ISO
TXN protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:10754530
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
increases oxidation decreases response to substance
ISO
tert-Butylhydroperoxide results in increased oxidation of TXN2 protein TXN2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:16797630 PMID:18550601
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Txnip
thioredoxin interacting protein
decreases expression increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in decreased expression of TXNIP mRNA tert-Butylhydroperoxide results in increased expression of TXNIP mRNA TXNIP protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnl1
thioredoxin-like 1
multiple interactions increases expression
ISO
LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNL1 mRNA]
CTD
PMID:31627909
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
G
Txnrd1
thioredoxin reductase 1
multiple interactions increases expression
ISO
MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA]
CTD
PMID:12414654 PMID:16636651
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TXNRD2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
Tymp
thymidine phosphorylase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TYMP mRNA
CTD
PMID:14729362
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Uba7
ubiquitin-like modifier activating enzyme 7
decreases expression multiple interactions increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBA7 mRNA; tert-Butylhydroperoxide results in decreased expression of UBA7 protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UBA7 protein] tert-Butylhydroperoxide results in increased expression of UBA7 mRNA
CTD
PMID:15003993 PMID:15336504 PMID:25649257
NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099
G
Ubap2
ubiquitin-associated protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBAP2 mRNA
CTD
PMID:14729362
NCBI chr 5:56,348,243...56,437,403
Ensembl chr 5:56,348,246...56,437,049
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBE2C mRNA
CTD
PMID:12414654
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2e1
ubiquitin-conjugating enzyme E2E 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2E1 mRNA
CTD
PMID:15336504
NCBI chr15:7,439,751...7,493,410
Ensembl chr15:7,439,759...7,493,400
G
Ube2k
ubiquitin-conjugating enzyme E2K
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2K mRNA
CTD
PMID:15336504
NCBI chr14:42,658,016...42,718,899
Ensembl chr14:42,658,016...42,718,630
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2L6 mRNA
CTD
PMID:15003993
NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
G
Ube3c
ubiquitin protein ligase E3C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBE3C mRNA
CTD
PMID:15336504
NCBI chr 4:5,648,932...5,749,922
Ensembl chr 4:5,648,690...5,750,011
G
Ubl5
ubiquitin-like 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBL5 mRNA
CTD
PMID:15336504
NCBI chr 8:19,181,504...19,185,224
Ensembl chr 8:19,181,615...19,185,217
G
Ubxn7
UBX domain protein 7
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBXN7 mRNA tert-Butylhydroperoxide results in increased expression of UBXN7 mRNA
CTD
PMID:15336504
NCBI chr11:68,427,896...68,460,100
G
Uck2
uridine-cytidine kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UCK2 mRNA
CTD
PMID:15336504
NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352
G
Umps
uridine monophosphate synthetase
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UMPS mRNA]
CTD
PMID:20847119
NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903
G
Ung
uracil-DNA glycosylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UNG mRNA
CTD
PMID:12414654
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
G
Upb1
beta-ureidopropionase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UPB1 mRNA
CTD
PMID:29432895
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
G
Upf3a
UPF3A, regulator of nonsense mediated mRNA decay
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UPF3A mRNA
CTD
PMID:15336504
NCBI chr16:75,757,442...75,768,478
Ensembl chr16:75,757,441...75,769,345
G
Upp1
uridine phosphorylase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UPP1 mRNA
CTD
PMID:15336504
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
multiple interactions
EXP
[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein; Cyclosporine inhibits the reaction [[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein]
CTD
PMID:16023995
NCBI chr17:33,977,908...33,982,478
Ensembl chr17:33,977,921...33,982,479
G
Usp17la
ubiquitin specific peptidase 17-like A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP17LA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:159,165,961...159,169,738
G
Usp18
ubiquitin specific peptidase 18
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP18 mRNA
CTD
PMID:15003993
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Usp21
ubiquitin specific peptidase 21
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of USP21 mRNA
CTD
PMID:15336504
NCBI chr13:83,702,672...83,709,215
Ensembl chr13:83,702,631...83,708,717
G
Usp22
ubiquitin specific peptidase 22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP22 mRNA
CTD
PMID:15003993
NCBI chr10:45,828,619...45,855,468
Ensembl chr10:45,828,622...45,855,497
G
Usp9x
ubiquitin specific peptidase 9, X-linked
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP9X mRNA
CTD
PMID:15336504
NCBI chr X:9,588,825...9,726,993
Ensembl chr X:9,588,825...9,696,711
G
Utp14a
UTP14A small subunit processome component
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UTP14A mRNA
CTD
PMID:15336504
NCBI chr X:127,439,282...127,464,634
Ensembl chr X:127,439,268...127,464,633
G
Utp25
UTP25 small subunit processome component
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UTP25 mRNA
CTD
PMID:15336504
NCBI chr13:104,630,390...104,651,681
Ensembl chr13:104,630,391...104,651,662
G
Vamp1
vesicle-associated membrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VAMP1 mRNA
CTD
PMID:15336504
NCBI chr 4:158,012,634...158,019,350
Ensembl chr 4:158,012,663...158,019,349
G
Vasn
vasorin
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]
CTD
PMID:20847119
NCBI chr10:10,917,750...10,928,259
Ensembl chr10:10,917,605...10,928,357
G
Vcam1
vascular cell adhesion molecule 1
decreases expression increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of VCAM1 mRNA tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]
CTD
PMID:12419474 PMID:28063877
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vcan
versican
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VCAN mRNA
CTD
PMID:15336504
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
G
Vdac2
voltage-dependent anion channel 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of VDAC2 mRNA
CTD
PMID:15336504
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553
G
Vegfa
vascular endothelial growth factor A
multiple interactions increases expression increases secretion
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA]; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA] tert-Butylhydroperoxide results in increased expression of VEGFA mRNA; tert-Butylhydroperoxide results in increased expression of VEGFA protein tert-Butylhydroperoxide results in increased secretion of VEGFA protein
CTD
PMID:15336504 PMID:17200665 PMID:20847119 PMID:35690295
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
increases secretion increases expression
ISO
tert-Butylhydroperoxide results in increased secretion of VEGFC protein tert-Butylhydroperoxide results in increased expression of VEGFC mRNA; tert-Butylhydroperoxide results in increased expression of VEGFC protein
CTD
PMID:15336504 PMID:17200665
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Vgll4
vestigial-like family member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VGLL4 mRNA
CTD
PMID:15336504
NCBI chr 4:147,925,630...148,038,519
Ensembl chr 4:147,927,034...148,038,471
G
Vim
vimentin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VIM protein
CTD
PMID:15050405
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vsnl1
visinin-like 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of VSNL1 mRNA
CTD
PMID:23410634
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Wbp11
WW domain binding protein 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of WBP11 mRNA
CTD
PMID:15336504
NCBI chr 4:169,680,984...169,694,431
Ensembl chr 4:169,680,983...169,694,443
G
Wdr1
WD repeat domain 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR1 mRNA
CTD
PMID:15336504
NCBI chr14:72,258,032...72,291,768
Ensembl chr14:72,257,956...72,291,766
G
Wdr26
WD repeat domain 26
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR26 mRNA
CTD
PMID:15336504
NCBI chr13:92,930,282...92,972,061
Ensembl chr13:92,930,285...92,977,295
G
Wdr43
WD repeat domain 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR43 mRNA
CTD
PMID:15336504
NCBI chr 6:23,845,499...23,884,846
Ensembl chr 6:23,845,499...23,884,846
G
Wdr77
WD repeat domain 77
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR77 mRNA
CTD
PMID:15336504
NCBI chr 2:193,435,465...193,445,534
Ensembl chr 2:193,435,468...193,445,520
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of WEE1 mRNA
CTD
PMID:15336504
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WIPI1 mRNA
CTD
PMID:15336504
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Wnt4
Wnt family member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WNT4 mRNA
CTD
PMID:15003993
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
G
Xcr1
X-C motif chemokine receptor 1
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of XCR1 exon
CTD
PMID:29432895
NCBI chr 8:123,479,454...123,516,168
Ensembl chr 8:123,479,590...123,487,226
G
Xist
X inactive specific transcript
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of XIST mRNA
CTD
PMID:15336504
NCBI chr X:68,474,987...68,492,500
G
Xpnpep1
X-prolyl aminopeptidase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of XPNPEP1 mRNA
CTD
PMID:15336504
NCBI chr 1:252,001,366...252,052,077
Ensembl chr 1:252,001,367...252,051,479
G
Xpnpep3
X-prolyl aminopeptidase 3
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of XPNPEP3 mRNA tert-Butylhydroperoxide results in decreased methylation of XPNPEP3 gene
CTD
PMID:29432895
NCBI chr 7:112,926,154...112,978,793
Ensembl chr 7:112,926,248...112,974,878
G
Ybx3
Y box binding protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YBX3 mRNA
CTD
PMID:12419474
NCBI chr 4:165,129,747...165,153,101
Ensembl chr 4:165,129,758...165,153,161
G
Yipf2
Yip1 domain family, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YIPF2 mRNA
CTD
PMID:15336504
NCBI chr 8:20,141,148...20,145,349
Ensembl chr 8:20,141,155...20,145,339
G
Ypel1
yippee-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YPEL1 mRNA
CTD
PMID:15336504
NCBI chr11:83,921,799...83,936,409
G
Ythdf1
YTH N6-methyladenosine RNA binding protein F1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YTHDF1 mRNA
CTD
PMID:15003993
NCBI chr 3:168,024,660...168,040,172
Ensembl chr 3:168,024,663...168,040,172
G
Ywhah
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YWHAH mRNA
CTD
PMID:12419474
NCBI chr14:77,696,332...77,705,715
Ensembl chr14:77,696,333...77,705,741
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ZAP70 mRNA
CTD
PMID:22659508
NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
G
Zbtb5
zinc finger and BTB domain containing 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZBTB5 mRNA
CTD
PMID:15336504
NCBI chr 5:59,244,132...59,265,461
Ensembl chr 5:59,243,307...59,265,426
G
Zc3h11a
zinc finger CCCH-type containing 11A
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]
CTD
PMID:20847119
NCBI chr13:45,073,422...45,113,901
Ensembl chr13:45,071,718...45,114,009
G
Zc3h12a
zinc finger CCCH type containing 12A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZC3H12A mRNA
CTD
PMID:15336504
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Zdhhc4
zinc finger DHHC-type palmitoyltransferase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZDHHC4 mRNA
CTD
PMID:15336504
NCBI chr12:11,230,864...11,244,898
Ensembl chr12:11,230,902...11,244,898
G
Zdhhc6
zinc finger DHHC-type palmitoyltransferase 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZDHHC6 mRNA
CTD
PMID:15003993
NCBI chr 1:254,335,472...254,356,141
Ensembl chr 1:254,335,113...254,356,108
G
Zfp217
zinc finger protein 217
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ZNF217 mRNA
CTD
PMID:23410634
NCBI chr 3:158,890,464...158,931,148
Ensembl chr 3:158,892,265...158,913,040
G
Zfp36
zinc finger protein 36
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA]
CTD
PMID:20847119
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Zfp395
zinc finger protein 395
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZNF395 mRNA
CTD
PMID:15336504
NCBI chr15:39,581,603...39,621,911
Ensembl chr15:39,608,080...39,619,950
G
Zfp593
zinc finger protein 593
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZNF593 mRNA
CTD
PMID:15336504
NCBI chr 5:146,462,670...146,464,998
Ensembl chr 5:146,462,670...146,465,198
G
Zfyve16
zinc finger FYVE-type containing 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZFYVE16 mRNA
CTD
PMID:15336504
NCBI chr 2:23,713,018...23,757,576
Ensembl chr 2:23,713,766...23,756,990
G
Zmiz1
zinc finger, MIZ-type containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZMIZ1 mRNA
CTD
PMID:15336504
NCBI chr16:1,027,083...1,232,616
Ensembl chr16:1,027,325...1,232,597
G
Zmynd19
zinc finger, MYND-type containing 19
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of ZMYND19 gene
CTD
PMID:29432895
NCBI chr 3:7,758,133...7,769,722
Ensembl chr 3:7,758,133...7,767,514
G
Znhit1
zinc finger, HIT-type containing 1
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZNHIT1 mRNA tert-Butylhydroperoxide results in decreased expression of ZNHIT1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr12:19,686,606...19,692,880
Ensembl chr12:19,686,148...19,692,880
G
Zpr1
ZPR1 zinc finger
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZPR1 mRNA
CTD
PMID:15336504
NCBI chr 8:46,564,898...46,574,719
Ensembl chr 8:46,565,146...46,574,719
G
Zswim7
zinc finger, SWIM-type containing 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZSWIM7 mRNA
CTD
PMID:15003993
NCBI chr10:46,953,311...46,969,800
Ensembl chr10:46,957,525...46,969,671
G
Zyx
zyxin
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZYX mRNA tert-Butylhydroperoxide affects the expression of ZYX mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr 4:71,236,767...71,246,553
Ensembl chr 4:71,237,451...71,246,553
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all